Alzheimer's Disease and Aging Research Publications

Berridge, C., Turner, N. R., Liu, L., Fredriksen-Goldsen, K. I., Lyons, K. S., Demiris, G., Kaye, J., & Lober, W. B. (2023). Preliminary Efficacy of Let's Talk Tech: Technology Use Planning for Dementia Care Dyads. Innovation in aging7(3), igad018.

Berridge, C., Zhou, Y., Robillard, J. M., & Kaye, J. (2023). Companion robots to mitigate loneliness among older adults: Perceptions of benefit and possible deception. Frontiers in psychology14, 1106633.

Chen, X. R., Shao, Y., Sadowski, M. J., & On Behalf Of The Alzheimer's Disease Neuroimaging Initiative (2023). Interaction between KLOTHO-VS Heterozygosity and APOE ε4 Allele Predicts Rate of Cognitive Decline in Late-Onset Alzheimer's Disease. Genes14(4), 917.

Correro Ii, A. N., Gauthreaux, K., Perales-Puchalt, J., Chen, Y. C., Chan, K. C. G., Kukull, W. A., & Flatt, J. D. (2023). Cognitive Aging with Dementia, Mild Cognitive Impairment, or No Impairment: A Comparison of Same- and Mixed-Sex Couples. Journal of Alzheimer's disease : JAD92(1), 109–128.

Fracassi, A., Marcatti, M., Tumurbaatar, B., Woltjer, R., Moreno, S., & Taglialatela, G. (2023). TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology. Brain pathology (Zurich, Switzerland)33(1), e13108.

Hantke, N. C., Kaye, J., Mattek, N., Wu, C. Y., Dodge, H. H., Beattie, Z., & Woltjer, R. (2023). Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology. PloS one18(6), e0286812.

Hartz, S. M., Mozersky, J., Schindler, S. E., Linnenbringer, E., Wang, J., Gordon, B. A., Raji, C. A., Moulder, K. L., West, T., Benzinger, T. L. S., Cruchaga, C., Hassenstab, J. J., Bierut, L. J., Xiong, C., & Morris, J. C. (2023). A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association19(4), 1452–1465.

Hicks, A., Sinclair, B., Shultz, S., Pham, W., Silbert, L. C., Schwartz, D. L., Rowe, C. C., Ponsford, J. L., Law, M., & Spitz, G. (2023). Associations of Enlarged Perivascular Spaces With Brain Lesions, Brain Age, and Clinical Outcomes in Chronic Traumatic Brain Injury. Neurology, 10.1212/WNL.0000000000207370. Advance online publication.

Holden, S. K., Bedenfield, N., Taylor, A. S., Bayram, E., Schwilk, C., Fleisher, J., Duda, J., Shill, H., Paulson, H. L., Stacy, K., Wood, J., Corsentino, P., Sha, S. J., Litvan, I., Irwin, D. J., Quinn, J. F., Goldman, J. G., Amodeo, K., Taylor, J. P., ... Armstrong, M. J. (2023). Research Priorities of Individuals and Caregivers with Lewy Body Dementia: A Web-based Survey. Alzheimer disease and associated disorders37(1), 50-58.

Huie, E. Z., Escudero, A., Saito, N., Harvey, D., Nguyen, M. L., Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., & Dugger, B. N. (2023). TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups. Journal of Alzheimer's disease : JAD91(4), 1291–1301.

Kallianpur, K. J., Masaki, K. H., Chen, R., Willcox, B. J., Allsopp, R. C., Davy, P., & Dodge, H. H. (2023). Weak Social Networks in Late Life Predict Incident Alzheimer's Disease: The Kuakini Honolulu-Asia Aging Study. The journals of gerontology. Series A, Biological sciences and medical sciences78(4), 663–672.

Kaser, A. N., Kaplan, D. M., Goette, W., & Kiselica, A. M. (2023). The impact of conventional versus robust norming on cognitive characterization and clinical classification of MCI and dementia. Journal of neuropsychology17(1), 108–124.

Hantke, N. C., Kaye, J., Mattek, N., Wu, C. Y., Dodge, H. H., Beattie, Z., & Woltjer, R. (2023). Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology. PloS one18(6), e0286812.

Kim, H., Senders, A., Simeon, E., Juarez, C., Huang, S., Dodge, H., & McConnell, K. J. (2023). Use of long-term services and supports among dual-eligible beneficiaries with Alzheimer's disease and related dementias. Journal of the American Geriatrics Society71(2), 432–442.

Klein, E., Montes Daza, N., Dasgupta, I., MacDuffie, K., Schönau, A., Flynn, G., Song, D., & Goering, S. (2023). Views of stakeholders at risk for dementia about deep brain stimulation for cognition. Brain stimulation16(3), 742–747. Advance online publication.

Lennon, J. C., Hantke, N., Mattek, N., Wu, C. Y., Dodge, H., Wall, R., Beattie, Z., Kaye, J., & Silbert, L. C. (2022). Mood and activity changes during the COVID-19 pandemic in rural and urban Veterans and their cohabitants. Clinical gerontologist, 1–8. Advance online publication.

Li, H., Liu, H., Lutz, M. W., Luo, S., & Alzheimer’s Disease Neuroimaging Initiative (2023). Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease. Journal of Alzheimer's disease : JAD91(3), 977–987.

Liampas, I., Siokas, V., Lyketsos, C. G., & Dardiotis, E. (2023). Associations between neuropsychiatric symptoms and incident Alzheimer's dementia in men versus women. Journal of neurology270(4), 2069–2083.

McDonough, I. M., Cody, S. L., Harrell, E. R., Garrett, S. L., & Popp, T. E. (2023). Cognitive differences across ethnoracial category, socioeconomic status across the Alzheimer's disease spectrum: Can an ability discrepancy score level the playing field?. Memory & cognition51(3), 543–560.

McLachlan, E., Ocal, D., Burgess, N., Reeves, S., Howard, R., & Alzheimer’s Disease Neuroimaging Initiative (2023). Association Between False Memories and Delusions in Alzheimer Disease. JAMA psychiatry, e231012. Advance online publication.

Nagaraja, N., Wang, W. E., Duara, R., DeKosky, S. T., & Vaillancourt, D. (2023). Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease. Journal of Alzheimer's disease : JAD93(2), 495–507.

Nilaver, B. I., & Urbanski, H. F. (2023). Mechanisms underlying TDP-43 pathology and neurodegeneration: An updated Mini-Review. Frontiers in aging neuroscience15, 1142617.

Öhrfelt, A., Benedet, A. L., Ashton, N. J., Kvartsberg, H., Vandijck, M., Weiner, M. W., Trojanowski, J. Q., Shaw, L. M., Zetterberg, H., Blennow, K., & Alzheimer's Disease Neuroimaging Initiative (2023). Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals. Neurology100(3), e275–e285.

Pang, Y., Kukull, W., Sano, M., Albin, R. L., Shen, C., Zhou, J., & Dodge, H. H. (2023). Predicting Progression from Normal to MCI and from MCI to AD Using Clinical Variables in the National Alzheimer's Coordinating Center Uniform Data Set Version 3: Application of Machine Learning Models and a Probability Calculator. The journal of prevention of Alzheimer's disease10(2), 301–313.

Piau, A., Steinmeyer, Z., Mattek, N., Lindauer, A., Sharma, N., Bouranis, N., Wild, K., & Kaye, J. (2023). Caregiving in Older Adults; Experiences and Attitudes toward Smart Technologies. Journal of clinical medicine12(5), 1789.

Polsinelli, A. J., Lane, K. A., Manchella, M. K., Logan, P. E., Gao, S., & Apostolova, L. G. (2023). APOE ε4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD. Alzheimer's & dementia : the journal of the Alzheimer's Association19(5), 2212–2217.

Polsinelli, A. J., Logan, P. E., Lane, K. A., Manchella, M. K., Nemes, S., Sanjay, A. B., Gao, S., & Apostolova, L. G. (2023). APOE ε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association19(5), 1983–1993.

Qin, Y., Han, H., Li, Y., Cui, J., Jia, H., Ge, X., Ma, Y., Bai, W., Zhang, R., Chen, D., Yi, F., & Yu, H. (2023). Estimating Bidirectional Transitions and Identifying Predictors of Mild Cognitive Impairment. Neurology100(3), e297–e307.

Raber, J., & Silbert, L. C. (2023). Role of white matter hyperintensity in effects of apolipoprotein E on cognitive injury. Frontiers in human neuroscience17, 1176690.

Reynolds, C. L., Tan, A., Elliott, J. E., Tinsley, C. E., Wall, R., Kaye, J. A., Silbert, L. C., & Lim, M. M. (2023). Remote Spectral Light Sensing in the Home Environment: Further Development of the TWLITE Study Concept. Sensors (Basel, Switzerland)23(8), 4134.

Sabbagh, M. N., Taylor, A., Galasko, D., Galvin, J. E., Goldman, J. G., Leverenz, J. B., Poston, K. L., Boeve, B. F., Irwin, D. J., & Quinn, J. F. (2023). Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel. Alzheimer's & dementia (New York, N. Y.)9(1), e12375.

Smith, E. E., & Silbert, L. C. (2023). Myocardial Infarction Bends the Curve of Age-Related Cognitive Decline, but How?. JAMA neurology, 10.1001/jamaneurol.2023.0466. Advance online publication.

Teipel, S., Grothe, M. J., & Alzheimer's Disease Neuroimaging Initiative (2023). MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology. Neurobiology of disease180, 106070.

Tumurbaatar, B., Fracassi, A., Scaduto, P., Guptarak, J., Woltjer, R., Jupiter, D., & Taglialatela, G. (2023). Preserved autophagy in cognitively intact non-demented individuals with Alzheimer's neuropathology. Alzheimer's & dementia : the journal of the Alzheimer's Association, 10.1002/alz.13074. Advance online publication.

Tagliabue, C. F., Bissig, D., Kaye, J., Mazza, V., & Assecondi, S. (2023). Feasibility of remote unsupervised cognitive screening with SATURN in older adults. Journal of applied gerontology : the official journal of the Southern Gerontological Society, 7334648231166894. Advance online publication.

Vasconcelos Da Silva, M., Melendez-Torres, G. J., Ismail, Z., Testad, I., Ballard, C., Creese, B., & Alzheimer's Disease Neuroimaging Initiative (2023). A data-driven examination of apathy and depressive symptoms in dementia with independent replication. Alzheimer's & dementia (Amsterdam, Netherlands)15(1), e12398.

Walker, J. M., Dehkordi, S. K., Schaffert, J., Goette, W., White Iii, C. L., Richardson, T. E., & Zare, H. (2023). The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals. Journal of Alzheimer's disease : JAD91(2), 683–695.

Walker, J. M., & Richardson, T. E. (2023). Cognitive resistance to and resilience against multiple comorbid neurodegenerative pathologies and the impact of APOE status. Journal of neuropathology and experimental neurology82(2), 110–119.

Wu C.Y., Tibbitts D., Beattie Z., Dodge H., Shannon J., Kaye J., Winters-Stone K. Using Continuous Passive Assessment Technology to Describe Health and Behavior Patterns Preceding and Following a Cancer Diagnosis in Older Adults: Proof-of-Concept Case Series Study. JMIR Form Res. 2023 Aug 10;7:e45693.

Yuan, F., Zhou, W., Dodge, H. H., & Zhao, X. (2023). Short: Causal structural learning of conversational engagement for socially isolated older adults. Smart health (Amsterdam, Netherlands)28, 100384.

Zhou, X., Chen, Y., Ip, F. C. F., Jiang, Y., Cao, H., Lv, G., Zhong, H., Chen, J., Ye, T., Chen, Y., Zhang, Y., Ma, S., Lo, R. M. N., Tong, E. P. S., Alzheimer’s Disease Neuroimaging Initiative, Mok, V. C. T., Kwok, T. C. Y., Guo, Q., Mok, K. Y., Shoai, M., … Ip, N. Y. (2023). Deep learning-based polygenic risk analysis for Alzheimer's disease prediction. Communications medicine3(1), 49. 

Anderson VC, Tagge IJ, Doud A, Li X, Springer CS, Jr., Quinn JF, Kaye JA, Wild KV, Rooney WD. DCE-MRI of Brain Fluid Barriers: In Vivo Water Cycling at the Human Choroid Plexus. Tissue Barriers 10:1963143, 2022.  PMC8794257.

Arnold MR, Coughlin DG, Brumbach BH, Smirnov DS, Concha-Marambio L, Farris CM, Ma Y, Inc A, Kim Y, Wilson EN, Kaye JA, Hiniker A, Woltjer RL, Galasko DR, Quinn JF. alpha-synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological alpha-synuclein in the context of co-pathology and non-LBD diagnoses. Annals of Neurology 92:650-662, 2022.  PMC in Process

Au-Yeung W-TM, Miller L, Beattie Z, May R, Cray HV, Kabelac Z, Katabi D, Kaye J, Vahia IV. Monitoring behaviors of patients with late-stage dementia using passive environmental sensing approaches: a case series. The American Journal of Geriatric Psychiatry 30:1-11, 2022. 

Barker MS, Gottesman RT, Manoochehri M, Chapman S, Appleby BS, Brushaber D, Devick KL, Dickerson BC, Domoto-Reilly K, Fields JA, Forsberg LK,  et al.  ALLFTD Consortium. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain 145:1079-1097, 2022.  PMC9050566.

Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, Holmans PA, Boland A, Damotte V, van der Lee SJ, Costa MR et al.  New insights into the genetic etiology of Alzheimer's disease and related dementias. Nature Genetics, 2022. 

Belloy ME, Eger SJ, Le Guen Y, Damotte V, Ahmad S, Ikram MA, Ramirez A, Tsolaki AC, Rossi G, Jansen IE, de Rojas I, Parveen K, Sleegers K, Ingelsson M, Hiltunen M, Amin N, Andreassen O, Sanchez-Juan P, Kehoe P, Amouyel P, Sims R., et al. Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping. Alzheimers Res Ther 14:22, 2022.  PMC8815198.

Benge JF, Artz JD, Kiselica AM. The ecological validity of the Uniform Data Set 3.0 neuropsychological battery in individuals with mild cognitive impairment and dementia. The Clinical Neuropsychologist. 36:1453-1470, 2022.  PMC8071839

Bernstein JP, Mattek N, Dorociak KE, Beattie ZT, Kaye JA, Ferguson JE, Hughes AM. Age Predicts Older Adults’ Driving Self-Regulation but Not Dangerous Driving Behaviors after Controlling for Executive Function. Gerontology. 68:98-105, 2022.

Bernstein JPK, Dorociak K, Mattek N, Leese M, Trapp C, Beattie Z, Kaye J, Hughes A. Unobtrusive, in-home assessment of older adults' everyday activities and health events: associations with cognitive performance over a brief observation period. Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition. 29:781-798, 2022.  PMC8522171

Berridge C, Zhou Y, Lazar  A, Porwal A, Mattek N, Gothard S, Kaye  J. Control Matters in Elder Care Technology: Evidence and Direction for Designing It In. In: ACM, ed. Designing Interactive Systems Conference,. Australia, 2022: 18 pages

Breitner J, Dodge H, Khachaturian ZS, Khachaturian A. Exceptions that prove the rule–Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome? Alzheimer's Dement, 2022. 

Buckles VD, Xiong C, Bateman RJ, Hassenstab J, Allegri R, Berman SB, Chhatwal JP, Danek A, Fagan AM, Ghetti B, Goate A, Graff-Radford N, Jucker M, Levin J, Marcus DS, Masters CL, McCue L, McDade E, Mori H, Moulder KL, Noble JM, Paumier K, Preische O, Ringman JM, Fox NC, Salloway S, Schofield PR, Martins R, Voglein J, Morris JC. Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease. Alzheimer's & Dementia: The journal of the Alzheimer's Association. 18:1754-1764, 2022.  PMC9160203.

Cothran FA, Alto R, Tomaszewski Farias S, Johnson DK, Lara E, Whitmer RA, DeCarli C, Meyer OL. Caring for the Caregivers: An Alzheimer Disease Research Center Call to Action. Alzheimer Disease and Associated Disorders 36:92-95, 2022. 

Dawson W, et al. Build Back Brainier: Base Policies on Brain Science. In: Hynes W, Linkov I, Love P, eds. A Systemic Recovery, New Approaches to Economic Challenges. Paris: OECD Publishing, 2022

Dawson W, Smith E, Booi L, Mosse M, Lavretsky H, Reynolds C, Cummings J, Brannelly P, Hynes W, Lenze E, Manes F, Ayadi R, Frank L, Chapman S, Robertson I, Rubenstein L, Jraissati J, Ibáñez A, Fillit H, Jeste  D, Rao A, Berk M, Storch E, Chadha A, Eyre H. Investing in Late-Life Brain Capital. Innovation in Aging. 6:2022, 2022

Duong MT, Das SR, Lyu X, Xie L, Richardson H, Xie SX, Yushkevich PA, Wolk DA, Nasrallah IM, Alzheimer’s Disease Neuroimaging Initiative (ADNI). Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer's disease. Nat Commun 13:1495, 2022. 

Elliott JE, Tinsley CE, Reynolds C, Olson RJ, Weymann KB, Au-Yeung WM, Wilkerson A, Kaye JA, Lim MM. Tunable White Light for Elders (TWLITE): A Protocol Demonstrating Feasibility and Acceptability for Deployment, Remote Data Collection, and Analysis of a Home-Based Lighting Intervention in Older Adults. Sensors (Basel) 22, 2022.  PMC9320387.

Fracassi A, Marcatti M, Tumurbaatar B, Woltjer R, Moreno S, Taglialatela G. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology. Brain Pathology. :e13108, 2022

Galvin-McLaughlin D, Klee D, Memmott T, Peters B, Wiedrick J, Fried-Oken M, Oken B, Consortium for Accessible Multimodal Brain-Body Interfaces (CAMBI). Methodology and Preliminary Data on Feasibility of a Neurofeedback Protocol to Improve Visual Attention to Letters in Mild Alzheimer’s Disease. Contemporary Clinical Trials. 28:100950, 2022.  PMC9228283.

Gabel M, Bollinger RM, Coble DW, Grill JD, Edwards DF, Lingler JH, Chin E, Stark SL. Retaining Participants in Longitudinal Studies of Alzheimer's Disease. Journal of Alzheimer's Disease 87:945-955, 2022.   

Gonzalez DA, Resch ZJ, Gonzales MM, Soble JR. A Novel Method for Establishing Functional Change in Older Adults With Cognitive Impairment. Alzheimer Disease and Associated Disorders. 36:238-243, 2022.  PMC9420747.

Gonzalez DA, Gonzales MM, Resch ZJ, Sullivan AC, Soble JR. Comprehensive Evaluation of the Functional Activities Questionnaire (FAQ) and Its Reliability and Validity. Assessment 29:748-763, 2022.  PMC8339133.

Graves LV, Edmonds EC, Thomas KR, Weigand AJ, Cooper S, Stickel AM, Zlatar ZZ, Clark AL, Bondi MW. Diagnostic accuracy and differential associations between ratings of functioning and neuropsychological performance in non-Hispanic Black and White older adults. Clin Neuropsychol 36:287-310, 2022.  PMC8849565.

Heath L, Earls JC, Magis AT, Kornilov SA, Lovejoy JC, Funk CC, Rappaport N, Logsdon BA, Mangravite LM, Kunkle BW, Martin ER, Naj AC, Ertekin-Taner N, Golde TE, Hood L, Price ND, Alzheimer’s Disease Genetics Consortium. Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90. Sci Rep 12:6117, 2022.  PMC9005657.

Hong Y, Zeng X, Zhu CW, Neugroschl J, Aloysi A, Sano M, Li C. Evaluating the Beijing Version of Montreal Cognitive Assessment for Identification of Cognitive Impairment in Monolingual Chinese American Older Adults. Journal of Geriatric Psychiatry and Neurology. 35:586-593, 2022.  PMC8831672.

Hupfeld KE, Richmond SB, McGregor HR, Schwartz DL, Luther MN, Beltran NE, Kofman IS, De Dios YE, Riascos RF, Wood SJ, Bloomberg JJ, Mulavara AP, Silbert LC, Iliff JJ, Seidler RD, Piantino J. Longitudinal MRI-visible perivascular space (PVS) changes with long-duration spaceflight. Sci Rep 12:7238, 2022.  PMC072425. 

Hwangbo N, Zhang X, Raftery D, Gu H, Hu SC, Montine TJ, Quinn JF, Chung KA, Hiller AL, Wang D, Fei Q, Bettcher L, Zabetian CP, Peskind E, Li G, Promislow DEL, Franks A. A Metabolomic Aging Clock Using Human Cerebrospinal Fluid. J Gerontol A Biol Sci Med Sci 77:744-754, 2022.  PMC8974344. 

Inglese M, Patel N, Linton-Reid K, Loreto F, Win Z, Perry RJ, Carswell C, Grech-Sollars M, Crum WR, Lu H, Malhotra PA, Aboagye EO, Alzheimer’s Disease Neuroimaging Initiative. A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer's disease. Commun Med (Lond) 2:70, 2022.  PMC9209493.

Jiang J, Sheng C, Chen G, Liu C, Jin S, Li L, Jiang X, Han Y, Alzheimer's Disease Neuroimaging Initiative. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment. Geroscience. 44:2319-2336, 2022.  PMC9616982.

Jin B, Capra JA, Benchek P, Wheeler N, Naj AC, Hamilton-Nelson KL, Farrell JJ, Leung YY, Kunkle B, Vadarajan B, Schellenberg GD, Mayeux R, Wang LS, Farrer LA, Pericak-Vance MA, Martin ER, Haines JL, Crawford DC, Bush WS. An association test of the spatial distribution of rare missense variants within protein structures identifies Alzheimer's disease-related patterns. Genome Res 32:778-790, 2022.  PMC8997344.

Johnson EEH, Alexander C, Lee GJ, Angers K, Ndiaye D, Suhr J. Examination of race and gender differences in predictors of neuropsychological decline and development of Alzheimer's disease. Clin Neuropsychol 36:327-352, 2022. 

Kallianpur KJ, Masaki KH, Chen R, Willcox BJ, Allsopp RC, Davy P, Dodge HH. Weak Social Networks in Late Life Predict Incident Alzheimer's Disease: The Kuakini Honolulu-Asia Aging Study. J Gerontol A Biol Sci Med Sci, 2022. 

Kaser AN, Kaplan DM, Goette W, Kiselica AM. The impact of conventional versus robust norming on cognitive characterization and clinical classification of MCI and dementia. J Neuropsychol, 2022.  Online ahead of print.

Katsumata Y, Shade LM, Hohman TJ, Schneider JA, Bennett DA, Farfel JM, Alzheimer's Disease Genetics C, Kukull WA, Fardo DW, Nelson PT. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities. Neurobiol Dis 174:"105880", 2022.

Kim H, Senders A, Simeon E, Juarez C, Huang S, Dodge H, McConnell KJ. Use of long-term services and supports among dual-eligible beneficiaries with Alzheimer's disease and related dementias. Journal of the American Geriatrics Society, 2022. 

Kundu P, Zimmerman B, Quinn JF, Kaye J, Mattek N, Westaway SK, Raber J. Serum Levels of alpha-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function. Journal of Alzheimer's Disease, 2022. 

Lahna D, Roese N, Woltjer R, Boespflug E, Schwartz D, Grinstead J, Dodge H, Wall R, Kaye J, Rooney W, Silbert L. Postmortem  7T MRI for Guided Histopathology and Evaluation of Cerebrovascular Disease. Journal of Neuropathology & Experimental Neurology, Forthcoming, 2022. 

Lahna D, Schwartz DL, Woltjer R, Black SE, Roese N, Dodge H, Boespflug EL, Keith J, Gao F, Ramirez J, Silbert LC. Venous Collagenosis as Pathogenesis of White Matter Hyperintensity. Annals of Neurology, 2022. 

Lan G, Cai Y, Li A, Liu Z, Ma S, Guo T, Alzheimer's Disease Neuroimaging Initiative. Association of presynaptic loss with Alzheimer's disease and cognitive decline. Annals of Neurology, 2022.

Leese M, Mattek N, Bernstein J, Dorociak K, Gothard S, Kaye J, Seelye A. The Survey for Memory, Attention, and Reaction Time (SMART): Preliminary Normative Online Panel Data and User Attitudes for a Brief Web-Based Cognitive Performance Measure. The Clinical Neuropsychologist 5:1-19, 2022.

Lindauer A, Wild K, Natonson A, Mattek N, Wolf M, Steeves-Reece A, Messecar D. Dementia 360 ECHO: Using technology to facilitate diagnosis and treatment. Gerontol Geriatr Educ 43:202-208, 2022. PMC8581834. 

Lennon J, Hantke N, Mattek N, C W, Dodge H, Wall R, Beattie Z, Kaye J, Silbert L. Mood and activity changes during the Covid-19 pandemic in rural and urban Veterans and their cohabitants. Clinical Gerontologist:1-8, Forthcoming, 2022.  PMC in Process.

Lennon JC, Aita SL, Bene V, Rhoads T, Resch ZJ, Eloi JM, Walker KA. Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement 18:1461-1471, 2022.  PMC9160212.

Li Z, Heckman MG, Kanekiyo T, Martens YA, Day GS, Vassilaki M, Liu CC, Bennett DA, Petersen RC, Zhao N, Bu G. Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment. Neurology 98:e2036-e2045, 2022.  PMC9162050. 

Lilly C, Wang Z, Dunlap D, Kaye J, Gohtard S, Teebagy S, Hafer N, Rogers E, Buchholz B, McManus D. 2021 Patient Preferences for Point of Care Testing Survey: More Acceptance and Less Concern. J Appl Lab Med, 2022. 

Liu H, Lutz M, Luo S, Alzheimer's Disease Neuroimaging Initiative. Genetic Association Between Epigenetic Aging-Acceleration and the Progression of Mild Cognitive Impairment to Alzheimer's Disease. J Gerontol A Biol Sci Med Sci 77:1734-1742, 2022.  PMC9434458.

Lutz MW, Khachaturian AS, Zetterberg H, Blennow K, Willette AA, Mielke MM, Hayden KM, Dodge HH, Tang Y, Greenberg BD, Kukull WA, Khachaturian ZS. Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide. Alzheimers Dement 18:1595-1601, 2022. 

McDonough IM, Cody SL, Harrell ER, Garrett SL, Popp TE. Cognitive differences across ethnoracial category, socioeconomic status across the Alzheimer's disease spectrum: Can an ability discrepancy score level the playing field? Mem Cognit, 2022. 

McGirr A, Nathan S, Ghahremani M, Gill S, Smith EE, Ismail Z. Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms. Neurology 98:e2132-e2139, 2022.   

Milicic L, Vacher M, Porter T, Dore V, Burnham SC, Bourgeat P, Shishegar R, Doecke J, Armstrong NJ, Tankard R, Maruff P, Masters CL, Rowe CC, Villemagne VL, Laws SM, Alzheimer’s Disease Neuroimaging Initiative (ADNI, Australian Imaging Biomarkers and Lifestyle (AIBL) Study. Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume. Geroscience, 2022. 

Miller LM, Solomon DN, Whitlatch CJ, Hiatt SO, Wu CY, Reynolds C, Au-Yeung WM, Kaye J, Steele JS. The Remote Assessment and Dynamic Response Program: Development of an In-Home Dementia-Related Care Needs Assessment to Improve Well-Being. Innov Aging 6:igac006, 2022.  PMC8985764.

Miller LM, Steele JS, Wu CY, Kaye J, Dodge HH, Gonzales MM, Lyons KS. Depressive symptoms in older adult couples: Associations with dyadic physical health, social engagement, and close friends. Front Psychiatry 13:989182, 2022.  PMC9513127.

Morrow CB, Leoutsakos JS, Onyike CU. Functional Disabilities and Psychiatric Symptoms in Primary Progressive Aphasia. Am J Geriatr Psychiatry 30:372-382, 2022. 

Moses, J., Sinclair, B., Schwartz, D. L., Silbert, L. C., O'Brien, T. J., Law, M., & Vivash, L. (2022). Perivascular spaces as a marker of disease severity and neurodegeneration in patients with behavioral variant frontotemporal dementia. Frontiers in neuroscience16, 1003522.

Neupane A, Lenny B, Budde JP, Wang F, Norton J, Morris JC, Cruchaga C, Fernandez MV. Replication study of AD-associated rare variants. Alzheimers Dement 18:858-862, 2022.  PMC8986593.

Nunnerley M, Kaye J, Beattie Z, Mattek N. Preferences of NIA Alzheimer’s Disease Research Center Participants Regarding Remote Assessment During the COVID-19 Pandemic. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Forthcoming, 2022.

Page ML, Vance EL, Cloward ME, Ringger E, Dayton L, Ebbert MTW, Miller JB, Kauwe JSK, Alzheimer's Disease Neuroimaging initiative. The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores. Commun Biol 5:899, 2022

Peters R, Dodge HH, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH. The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here? Alzheimer's & Dementia 18:507-512, 2022. 

Pichet Binette A, Franzmeier N, Spotorno N, Ewers M, Brendel M, Biel D, Strandberg O, Janelidze S, Palmqvist S, Mattsson-Carlgren N, Smith R, Stomrud E, Ossenkoppele R, Hansson O, Alzheimer’s Disease Neuroimaging Initiative. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease. Nat Commun 13:6635, 2022.  PMC9636262.

Pillai JA, Bena J, Rothenberg K, Boron B, Leverenz JB. Association of Variation in Behavioral Symptoms With Initial Cognitive Phenotype in Adults With Dementia Confirmed by Neuropathology. JAMA Netw Open 5:e220729, 2022.  PMC8895258.

Qiu J, Goldstein FC, Hanfelt JJ. An Exploration of Subgroups of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Risks of Conversion to Dementia or Death. Am J Geriatr Psychiatry 30:925-934, 2022.  PMC9250542.

Quinn JF, Kelly MJ, Harris CJ, Hack W, Gray NE, Kulik V, Bostick Z, Brumbach BH, Copenhaver PF. The novel estrogen modulator STX attenuates Amyloid-beta neurotoxicity in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Dis:105888, 2022. 

Quinones AR, Chen S, Nagel CL, Botoseneanu A, Allore HG, Newsom JT, Thielke S, Kaye J. Trajectories of cognitive functioning in later life: Disparities by race/ethnicity, educational attainment, sex, and multimorbidity combinations. SSM Popul Health 18:101084, 2022.  PMC8987641.

Reynolds C, Mattek N, Lim MM, Beattie Z, Dodge HH, Kaye J. Association Between Mild Cognitive Impairment and Seasonal Rest-Activity Patterns of Older Adults. Front Digit Health 4:809370, 2022.  PMC8904352.

Sandau US, McFarland TJ, Smith SJ, Galasko DR, Quinn JF, Saugstad JA. Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer's Disease Compared to Males. Front Cell Dev Biol 10:864022, 2022.  PMC9092217.

Schaffert J, LoBue C, Hynan LS, Hart J, Rossetti H, Carlew AR, Lacritz L, White CL, Cullum CM. Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease. Journal of Alzheimer's Disease 86:271-281, 2022.  PMC8966055.

Shinto LH, Raber J, Mishra A, Roese N, Silbert LC. A Review of Oxylipins in Alzheimer's Disease and Related Dementias (ADRD): Potential Therapeutic Targets for the Modulation of Vascular Tone and Inflammation. Metabolites 12:826, 2022.  PMC9501361

Sternberg Z, Podolsky R, Nir A, Yu J, Nir R, Halvorsen SW, Quinn JF, Kaye J, Kolb C. Elevated spermidine serum levels in mild cognitive impairment, a potential biomarker of progression to Alzheimer dementia, a pilot study. J Clin Neurosci 100:169-174, 2022. 

Tahami Monfared AA, Lenderking WR, Savva Y, Ladd MK, Zhang Q, Alzheimer’s Disease Neuroimaging Initiative. Assessing the Clinical Meaningfulness of the Alzheimer's Disease Composite Score (ADCOMS) Tool. Neurol Ther, 2022. 

Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA, Tauriel Investigators. Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial. JAMA Neurol 79:758-767, 2022.  PMC9194753.

Thomas N, Bhati D, Ault L, BEng L, Lariviere-Chartier J, Petriu M, BEng W, Knoefel F, Kaye J, Goubran R. Smart Home Tech: an interface to provide feedback to caregivers of persons living with cognitive impairment. Alzheimer & Dementia Forthcoming, 2022

Tian C, Stewart T, Hong Z, Guo Z, Aro P, Soltys D, Pan C, Peskind ER, Zabetian CP, Shaw LM, Galasko D, Quinn JF, Shi M, Zhang J, Alzheimer's Disease Neuroimaging Initiative. Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease. Alzheimers Dement, 2022. 

Wang M, Greenberg M, Forkert ND, Chekouo T, Afriyie G, Ismail Z, Smith EE, Sajobi TT. Dementia risk prediction in individuals with mild cognitive impairment: a comparison of Cox regression and machine learning models. BMC Med Res Methodol 22:284, 2022.  PMC9628121

Wen J, Fu CHY, Tosun D, Veturi Y, Yang Z, Abdulkadir A, Mamourian E, Srinivasan D, Skampardoni I, Singh A, Nawani H, Bao J, Erus G, Shou H, Habes M, Doshi J, Varol E, Mackin RS, Sotiras A, Fan Y, Saykin AJ, Sheline YI, Shen L, Ritchie MD, Wolk DA, Albert M, Resnick SM, Davatzikos C, iSTAGING Consortium, Alzheimer’s Disease Neuroimaging Initiative. Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression. JAMA Psychiatry 79:464-474, 2022.  PMC8908227.

Wild K, Marcoe J, Mattek  N, Sharma N, Loewy E, Tischler H, Kaye J, Karlawish J. Online monitoring of financial capacity in older adults: Feasibility and initial findings. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022. 

Weintraub S, Karpouzian-Rogers T, Peipert JD, Nowinski C, Slotkin J, Wortman K, Ho E, Rogalski E, Carlsson C, Giordani B, Goldstein F, Lucas J, Manly JJ, Rentz D, Salmon D, Snitz B, Dodge HH, Riley M, Eldes F, Ustsinovich V, Gershon R. ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods. Alzheimers & Dementia: The journal of the Alzheimer's Association. 18:1449-1460, 2022.  PMC9110564.

Winter S, Angler D, Dawson W, Bennett V, Lee C, Freeman M, Hynes W, Berk M, Sarnyai Z, Ng C, Abbott R, Ibañez A, Smith E, Hackett J, Storch E, Jraissati J, Corner L, Chen S, et al. Brain health-Directed Policymaking: A New Concept to Strengthen Democracy. Washington, DC., 2022.

Wu CY, Dodge HH, Gothard S, Mattek N, Wright K, Barnes LL, Silbert LC, Lim MM, Kaye JA, Beattie Z. Unobtrusive Sensing Technology Detects Ecologically Valid Spatiotemporal Patterns of Daily Routines Distinctive to Persons with Mild Cognitive Impairment. J Gerontol A Biol Sci Med Sci, 2022.  PMC9536445.

Wu CY, Mattek N, Wild K, Miller LM, Kaye JA, Silbert LC, Dodge HH. Can changes in social contact (frequency and mode) mitigate low mood before and during the COVID-19 pandemic? The I-CONECT project. Journal of the American Geriatrics Society 70:669-676, 2022.  PMC8904274.

Yan T, Liang J, Gao J, Wang L, Fujioka H, Zhu X, Wang X, Alzheimer Disease Neuroimaging Initiative. FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease. Nat Commun 11:4006, 2022.

Yang Z, Caldwell JZK, Cummings JL, Ritter A, Kinney JW, Cordes D, Alzheimer's Disease Neuroimaging Initiative.  Sex Modulates the Pathological Aging Effect on Caudate Functional Connectivity in Mild Cognitive Impairment. Front Psychiatry 13:804168, 2022.  PMC9037326.

Yildiz S, Grinstead J, Hildebrand A, Oshinski J, Rooney WD, Lim MM, Oken B. Immediate impact of yogic breathing on pulsatile cerebrospinal fluid dynamics. Sci Rep 12:10894, 2022.  PMC9240010.

Yu, K., Wild, K., Dowling, N. M., Kaye, J. A., Silbert, L. C., & Dodge, H. H. (2022). Emotional characteristics of socially isolated older adults with MCI using tablet administered NIH toolbox: I-CONECT study. Alzheimer's & dementia (Amsterdam, Netherlands)14(1), e12372.

Au-Yeung, W. M., Kaye, J. A., & Beattie, Z. (2020). Step Count Standardization: Validation of Step Counts from the Withings Activite using PiezoRxD and wGT3X-BT. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference2020, 4608–4611.

Au-Yeung, W. M., Miller, L., Beattie, Z., May, R., Cray, H. V., Kabelac, Z., Katabi, D., Kaye, J., & Vahia, I. V. (2021). Monitoring Behaviors of Patients With Late-Stage Dementia Using Passive Environmental Sensing Approaches: A Case Series. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, S1064-7481(21)00295-5. Advance online publication.

Agarwal A, Wallace B, Ault L, Lariviere-Chartier J, Knoelfel F, Goubran R, Kaye J, Beattie Z, Thomas N. (2021). Using Zigbee Sensors for Ambient Measurement of Human Gait Analytical Considerations. 2021.IEEE International Symposium on Medical Measurements and Applications 1-6. doi: 10.1109/MeMeA52024.2021.9478695. 

Ahn, S., Mathiason, M. A., Lindquist, R., & Yu, F. (2021). Factors predicting episodic memory changes in older adults with subjective cognitive decline: A longitudinal observational study. Geriatric nursing (New York, N.Y.)42(1), 268–275.

Anor, C. J., Dadar, M., Collins, D. L., & Tartaglia, M. C. (2021). The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set. Biological psychiatry. Cognitive neuroscience and neuroimaging6(1), 70–78.

Banning, L., Ramakers, I., Rosenberg, P. B., Lyketsos, C. G., Leoutsakos, J. S., & Alzheimer's Disease Neuroimaging Initiative (2021). Alzheimer's disease biomarkers as predictors of trajectories of depression and apathy in cognitively normal individuals, mild cognitive impairment, and Alzheimer's disease dementia. International journal of geriatric psychiatry36(1), 224–234.

Beach TG, Malek-Ahmadi M. Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old. Journal of Alzheimer's Disease 79:389-400, 2021.  PMC8034496.

Bernstein, J., Dorociak, K. E., Mattek, N., Leese, M., Beattie, Z. T., Kaye, J. A., & Hughes, A. (2021). Passively-Measured Routine Home Computer Activity and Application Use Can Detect Mild Cognitive Impairment and Correlate with Important Cognitive Functions in Older Adulthood. Journal of Alzheimer's disease : JAD81(3), 1053–1064.

Bernstein, J., Dorociak, K., Mattek, N., Leese, M., Trapp, C., Beattie, Z., Kaye, J., & Hughes, A. (2021). Unobtrusive, in-home assessment of older adults' everyday activities and health events: associations with cognitive performance over a brief observation period. Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition, 1–18. Advance online publication.

Bernstein, J., Mattek, N., Dorociak, K. E., Beattie, Z. T., Kaye, J. A., Ferguson, J. E., & Hughes, A. M. (2021). Age Predicts Older Adults' Driving Self-Regulation but Not Dangerous Driving Behaviors after Controlling for Executive Function. Gerontology, 1–8. Advance online publication.

Berridge, C., Demiris, G., & Kaye, J. (2021). Domain Experts on Dementia-Care Technologies: Mitigating Risk in Design and Implementation. Science and engineering ethics27(1), 14.

Bissig, D., Zhou, C. G., Le, V., & Bernard, J. T. (2020). Optical coherence tomography reveals light-dependent retinal responses in Alzheimer's disease. NeuroImage219, 117022.

Bonds, K., Song, M., Whitlatch, C. J., Lyons, K. S., Kaye, J. A., & Lee, C. S. (2021). Patterns of Dyadic Appraisal of Decision-Making Involvement of African American Persons Living With Dementia. The Gerontologist61(3), 383–391.

Brewster, K. K., Hu, M. C., Wall, M. M., Brown, P. J., Zilcha-Mano, S., Roose, S. P., Stein, A., Golub, J. S., & Rutherford, B. R. (2021). Age-Related Hearing Loss, Neuropsychological Performance, and Incident Dementia in Older Adults. Journal of Alzheimer's disease : JAD80(2), 855–864.

Chavda, R., Cao, J. S., & Benge, J. F. (2021). Neuropsychological impact of white matter hyperintensities in older adults without dementia. Applied neuropsychology. Adult28(3), 354–362.

Chen, S. D., Lu, J. Y., Li, H. Q., Yang, Y. X., Jiang, J. H., Cui, M., Zuo, C. T., Tan, L., Dong, Q., Yu, J. T., & Alzheimer’s Disease Neuroimaging Initiative (2021). Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study. Translational psychiatry11(1), 483.

Chung, Y., Lee, H., & the Alzheimer’s Disease Neuroimaging Initiative (2021). Correlation between Alzheimer's disease and type 2 diabetes using non-negative matrix factorization. Scientific reports11(1), 15265.

Croff, R., Hedmann, M., & Barnes, L. L. (2021). Whitest City in America: A Smaller Black Community's Experience of Gentrification, Displacement, and Aging in Place. The Gerontologist, gnab041. Advance online publication.

Das, S. R., Lyu, X., Duong, M. T., Xie, L., McCollum, L., de Flores, R., DiCalogero, M., Irwin, D. J., Dickerson, B. C., Nasrallah, I. M., Yushkevich, P. A., Wolk, D. A., & Alzheimer's Disease Neuroimaging Initiative (2021). Tau-Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease. Annals of neurology90(5), 751–762.

Davis CM, Bah TM, Zhang WH, et al. (2021).  GPR39 localization in the aging human brain and correlation of expression and polymorphism with vascular cognitive impairment. Alzheimer’s Dement., 7:e12214. 

Dawson, W. D., Boucher, N. A., Stone, R., & VAN Houtven, C. H. (2021). COVID-19: The Time for Collaboration Between Long-Term Services and Supports, Health Care Systems, and Public Health Is Now. The Milbank quarterly99(2), 565–594.

Dorociak, K. E., Mattek, N., Lee, J., Leese, M. I., Bouranis, N., Imtiaz, D., Doane, B. M., Bernstein, J., Kaye, J. A., & Hughes, A. M. (2021). The Survey for Memory, Attention, and Reaction Time (SMART): Development and Validation of a Brief Web-Based Measure of Cognition for Older Adults. Gerontology, 1–13. Advance online publication.

Dorociak, K. E., Mattek, N., Ferguson, J. E., Beattie, Z. T., Sharma, N., Kaye, J. A., Leese, M. I., Doane, B. M., & Hughes, A. M. (2021). Subtle Changes in Medication-taking Are Associated With Incident Mild Cognitive Impairment. Alzheimer disease and associated disorders35(3), 237–243.

Fracassi, A.Marcatti, M., Zolochevska, O., Tabor, N., Woltjer, R., Moreno, S., & Taglialatela, G. (2021). Oxidative Damage and Antioxidant Response in Frontal Cortex of Demented and Nondemented Individuals with Alzheimer's Neuropathology. The Journal of neuroscience : the official journal of the Society for Neuroscience41(3), 538–554.

Ge, Y., Sainz, M., Gore, J. et al. “Everything is Either Sent by God or Used by God”: An Exploratory Study on the Impact of COVID-19 Upon the Religious Lives of Black Families Living with Dementia. J Relig Health 60, 3193–3208 (2021).

Giebel, C. M., Knopman, D., Mioshi, E., & Khondoker, M. (2021). Distinguishing Frontotemporal Dementia From Alzheimer Disease Through Everyday Function Profiles: Trajectories of Change. Journal of geriatric psychiatry and neurology34(1), 66–75.

Gonneaud, J., Baria, A. T., Pichet Binette, A., Gordon, B. A., Chhatwal, J. P., Cruchaga, C., Jucker, M., Levin, J., Salloway, S., Farlow, M., Gauthier, S., Benzinger, T., Morris, J. C., Bateman, R. J., Breitner, J., Poirier, J., Vachon-Presseau, E., Villeneuve, S., Alzheimer’s Disease Neuroimaging Initiative (ADNI), Dominantly Inherited Alzheimer Network (DIAN) Study Group, … Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer’s Disease (PREVENT-AD) Research Group (2021). Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nature communications12(1), 5346.

Gumus, M., Multani, N., Mack, M. L., Tartaglia, M. C., & Alzheimer’s Disease Neuroimaging Initiative (2021). Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer's disease. GeroScience43(1), 213–223.

Hart, K. R., Fei, T., & Hanfelt, J. J. (2021). Scalable and robust latent trajectory class analysis using artificial likelihood. Biometrics77(3), 1118–1128.

Howarth, C., Mishra, A., & Hall, C. N. (2021). More than just summed neuronal activity: how multiple cell types shape the BOLD response. Philosophical transactions of the Royal Society of London. Series B, Biological sciences376(1815), 20190630.

Hu, W. T., Ozturk, T., Kollhoff, A., Wharton, W., Christina Howell, J., & Alzheimer’s Disease Neuroimaging Initiative (2021). Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's disease. Nature communications12(1), 4001.

Hwangbo, N., Zhang, X., Raftery, D., Gu, H., Hu, S. C., Montine, T. J., Quinn, J. F., Chung, K. A., Hiller, A. L., Wang, D., Fei, Q., Bettcher, L., Zabetian, C. P., Peskind, E., Li, G., Promislow, D., & Franks, A. (2021). A metabolomic aging clock using human CSF. The journals of gerontology. Series A, Biological sciences and medical sciences, glab212. Advance online publication.

Iida, M. A., Farrell, K., Walker, J. M., Richardson, T. E., Marx, G. A., Bryce, C. H., Purohit, D., Ayalon, G., Beach, T. G., Bigio, E. H., Cortes, E. P., Gearing, M., Haroutunian, V., McMillan, C. T., Lee, E. B., Dickson, D. W., McKee, A. C., Stein, T. D., Trojanowski, J. Q., Woltjer, R. L., … Crary, J. F. (2021). Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study. Acta neuropathologica communications9(1), 134.

Ismail, Z., McGirr, A., Gill, S., Hu, S., Forkert, N. D., & Smith, E. E. (2021). Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline. Journal of Alzheimer's disease : JAD80(1), 459–469.

Jicha, G. A., Abner, E. L., Arnold, S. E., Carrillo, M. C., Dodge, H. H., Edland, S. D., Fargo, K. N., Feldman, H. H., Goldstein, L. B., Hendrix, J., Peters, R., Robillard, J. M., Schneider, L. S., Titiner, J. R., Weber, C. J., & Clinical Trial Advancement & Methodology Professional Interest Area of the International Society to Advance Alzheimer's Research and Treatment (ISTAART) (2021). Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report. Alzheimer's & dementia : the journal of the Alzheimer's Association, 10.1002/alz.12461. Advance online publication.

Jones C, Reynolds C, Olson R, Bontrager A, Lambert S, Balba N, Weymann K, Kaye J, Wilkerson A, Elliott J, Lim M. (2021). Tunable White Light for Elders (TWLITE): A feasibility study of a home-based sleep intervention. Sleep 44:A111. 

Jung M, Apostolova LG, Gao S, Burney HN, Lai D, Foroud T, Saykin AJ, Pressler SJ. Testing influences of APOE and BDNF genes and heart failure on cognitive function. Heart Lung 50:51-58, 2021.

Kaye J, et al. Sleep Signal Analysis for Early Detection of Alzheimer’s Disease and Related Dementia. Journal of Translational Engineering in Health and Medicine Forthcoming, 2021. 

Khan, T., & Jacobs, P. G. (2021). Prediction of Mild Cognitive Impairment Using Movement Complexity. IEEE journal of biomedical and health informatics25(1), 227–236.

Kim, D., Wang, R., Kiss, A., Bronskill, S. E., Lanctot, K. L., Herrmann, N., & Gallagher, D. (2021). Depression and Increased Risk of Alzheimer's Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry29(9), 917–926.

Kiselica, A. M., Kaser, A. N., & Benge, J. F. (2021). An Initial Empirical Operationalization of the Earliest Stages of the Alzheimer's Continuum. Alzheimer disease and associated disorders35(1), 62–67.

Kiselica, A. M., & Benge, J. F. (2021). Quantitative and qualitative features of executive dysfunction in frontotemporal and Alzheimer's dementia. Applied neuropsychology. Adult28(4), 449–463.

Kyle, J. E., Stratton, K. G., Zink, E. M., Kim, Y. M., Bloodsworth, K. J., Monroe, M. E., Undiagnosed Diseases Network, Waters, K. M., Webb-Robertson, B. M., Koeller, D. M., & Metz, T. O. (2021). A resource of lipidomics and metabolomics data from individuals with undiagnosed diseases. Scientific data8(1), 114.

Leese, M. I., Dorociak, K. E., Noland, M., Gaugler, J. E., Mattek, N., & Hughes, A. (2021). Use of in-home activity monitoring technologies in older adult veterans with mild cognitive impairment: The impact of attitudes and cognition. Gerontechnology : international journal on the fundamental aspects of technology to serve the ageing society20(2), 1–12.

Lindauer A, Messecar D, McKenzie G, Gibson A, Wharton W, Bianchi A, Tarter R, Tadesse R, Boardman C, Golonka O, Gothard S, Dodge HH. The Tele-STELLA protocol: Telehealth-based support for families living with later-stage Alzheimer's disease. Journal of Advanced Nursing. 2021 Jul 20

Leese M, Bernstein J, Dorociak K, Mattek N, Wu C, Z B, Dodge H, Kaye J, Hughes A. (2021). Older Adults’ Daily Activity and Mood Changes Detected During the COVID-19 Pandemic Using Remote Unobtrusive Monitoring Technologies. Innovation in Aging, Volume 5, Issue 4, 2021, igab032,

Liew T. M. (2021). Neuropsychiatric symptoms in early stage of Alzheimer's and non-Alzheimer's dementia, and the risk of progression to severe dementia. Age and ageing50(5), 1709–1718.

Logsdon, A. F., Francis, K. L., Richardson, N. E., Hu, S. J., Faber, C. L., Phan, B. A., Nguyen, V., Setthavongsack, N., Banks, W. A., Woltjer, R. L., Keene, C. D., Latimer, C. S., Schwartz, M. W., Scarlett, J. M., & Alonge, K. M. (2021). Decoding perineuronal net glycan sulfation patterns in the Alzheimer's disease brain. Alzheimer's & dementia : the journal of the Alzheimer's Association, 10.1002/alz.12451. Advance online publication.

Lusardi, T. A., Sandau, U. S., Sakhanenko, N. A., Baker, S., Wiedrick, J. T., Lapidus, J. A., Raskind, M. A., Li, G., Peskind, E. R., Galas, D. J., Quinn, J. F., & Saugstad, J. A. (2021). Cerebrospinal Fluid MicroRNA Changes in Cognitively Normal Veterans With a History of Deployment-Associated Mild Traumatic Brain Injury. Frontiers in neuroscience15, 720778.

Ma, Y., Blacker, D., Viswanathan, A., van Veluw, S. J., Bos, D., Vernooij, M. W., Hyman, B. T., Tzourio, C., Das, S., & Hofman, A. (2021). Visit-to-Visit Blood Pressure Variability, Neuropathology, and Cognitive Decline. Neurology96(23), e2812–e2823.

Mehdipour Ghazi, M., Nielsen, M., Pai, A., Modat, M., Jorge Cardoso, M., Ourselin, S., & Sørensen, L. (2021). Robust parametric modeling of Alzheimer's disease progression. NeuroImage225, 117460.

Mishra, A., Hall, C. N., Howarth, C., & Freeman, R. D. (2021). Key relationships between non-invasive functional neuroimaging and the underlying neuronal activity. Philosophical transactions of the Royal Society of London. Series B, Biological sciences376(1815), 20190622.

Moniruzzaman, M., Kadota, A., Akash, M. S., Pruitt, P. J., Miura, K., Albin, R., & Dodge, H. H. (2021). Effects of physical activities on dementia-related biomarkers: A systematic review of randomized controlled trials. Alzheimer's & dementia (New York, N. Y.)6(1), e12109.

Neitzel, J., Franzmeier, N., Rubinski, A., Dichgans, M., Brendel, M., Alzheimer’s Disease Neuroimaging Initiative (ADNI), Malik, R., & Ewers, M. (2021). KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer's disease. Nature communications12(1), 3825. 

Oh, E. S., Rosenberg, P. B., Rattinger, G. B., Stuart, E. A., Lyketsos, C. G., & Leoutsakos, J. S. (2021). Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD). Journal of the American Geriatrics Society69(4), 955–963.

Ouk, M., Wu, C. Y., Rabin, J. S., Jackson, A., Edwards, J. D., Ramirez, J., Masellis, M., Swartz, R. H., Herrmann, N., Lanctôt, K. L., Black, S. E., & Swardfager, W. (2021). The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status. Alzheimer's research & therapy13(1), 43.

Oltra-Cucarella, J., Sánchez-SanSegundo, M., Rubio-Aparicio, M., Arango-Lasprilla, J. C., & Ferrer-Cascales, R. (2021). The Association Between the Number of Neuropsychological Measures and the Base Rate of Low Scores. Assessment28(3), 955–963.

Peters, R., Ee, N., Ward, S. A., Kenning, G., Radford, K., Goldwater, M., Dodge, H. H., Lewis, E., Xu, Y., Kudrna, G., Hamilton, M., Peters, J., Anstey, K. J., Lautenschlager, N. T., Fitzgerald, A., & Rockwood, K. (2021). Intergenerational Programmes bringing together community dwelling non-familial older adults and children: A Systematic Review. Archives of gerontology and geriatrics94, 104356.

Piantino, J., Schwartz, D. L., Luther, M., Newgard, C., Silbert, L., Raskind, M., Pagulayan, K., Kleinhans, N., Iliff, J., & Peskind, E. (2021). Link between Mild Traumatic Brain Injury, Poor Sleep, and Magnetic Resonance Imaging: Visible Perivascular Spaces in Veterans. Journal of neurotrauma38(17), 2391–2399.

Piau, A., Steinmeyer, Z., Cesari, M., Kornfeld, J., Beattie, Z., Kaye, J., Vellas, B., & Nourhashemi, F. (2021). Intrinsic Capacitiy Monitoring by Digital Biomarkers in Integrated Care for Older People (ICOPE). The Journal of frailty & aging10(2), 132–138.

Perales-Puchalt, J., Gauthreaux, K., Shaw, A., McGee, J. L., Teylan, M. A., Chan, K., Rascovsky, K., Kukull, W. A., & Vidoni, E. D. (2021). Risk of mild cognitive impairment among older adults in the United States by ethnoracial group. International psychogeriatrics33(1), 51–62.

Peters R, et al. The epidemiology is promising but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven’t lived up to expectations and where do we go from here? Alzheimer’s & Dementia, Forthcoming, 2021

Peters R, Breitner J, James S, Jicha G, Meyer P, Richards M, Smith D, Yassine H, et al. Dementia risk reduction, why haven’t pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors. Alzheimer’s & Dementia: Translational Research and Clinical Trials, Forthcoming, 2021

Qian, J., Betensky, R. A., Hyman, B. T., & Serrano-Pozo, A. (2021). Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease. Neurology96(19), e2414–e2428.

Richardson, S., Sinha, A., Vahia, I., Dawson, W., Kaye, J., Reynolds, C. F., 3rd, Smith, E., Cummings, J., Berk, M., Lavretsky, H., & Eyre, H. A. (2021). Brain Health Living Labs. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry29(7), 698–703.

Robinson, J. L., Richardson, H., Xie, S. X., Suh, E., Van Deerlin, V. M., Alfaro, B., Loh, N., Porras-Paniagua, M., Nirschl, J. J., Wolk, D., Lee, V. M., Lee, E. B., & Trojanowski, J. Q. (2021). The development and convergence of co-pathologies in Alzheimer's disease. Brain : a journal of neurology144(3), 953–962. 

Sanyal, N., Napolioni, V., de Rochemonteix, M., Belloy, M. E., Caporaso, N. E., Landi, M. T., Greicius, M. D., Chatterjee, N., & Han, S. S. (2021). A Robust Test for Additive Gene-Environment Interaction Under the Trend Effect of Genotype Using an Empirical Bayes-Type Shrinkage Estimator. American journal of epidemiology190(9), 1948–1960.

Schenning, K. J., Holden, S., Davis, B. A., Mulford, A., Nevonen, K. A., Quinn, J. F., Raber, J., Carbone, L., & Alkayed, N. J. (2021). Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice. Journal of Alzheimer's disease : JAD83(3), 1251–1268.

Sikkes, S., Tang, Y., Jutten, R. J., Wesselman, L., Turkstra, L. S., Brodaty, H., Clare, L., Cassidy-Eagle, E., Cox, K. L., Chételat, G., Dautricourt, S., Dhana, K., Dodge, H., Dröes, R. M., Hampstead, B. M., Holland, T., Lampit, A., Laver, K., Lutz, A., Lautenschlager, N. T., … Bahar-Fuchs, A. (2021). Toward a theory-based specification of non-pharmacological treatments in aging and dementia: Focused reviews and methodological recommendations. Alzheimer's & dementia : the journal of the Alzheimer's Association17(2), 255–270.

Smirnov, D. S., Galasko, D., Hiniker, A., Edland, S. D., & Salmon, D. P. (2021). Age-at-Onset and APOE-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease. Neurology96(18), e2272–e2283.

Staffaroni, A. M., Weintraub, S., Rascovsky, K., Rankin, K. P., Taylor, J., Fields, J. A., Casaletto, K. B., Hillis, A. E., Lukic, S., Gorno-Tempini, M. L., Heuer, H., Teylan, M. A., Kukull, W. A., Miller, B. L., Boeve, B. F., Rosen, H. J., Boxer, A. L., & Kramer, J. H. (2021). Uniform data set language measures for bvFTD and PPA diagnosis and monitoring. Alzheimer's & dementia (Amsterdam, Netherlands)13(1), e12148.

Stonebarger, G. A., Bimonte-Nelson, H. A., & Urbanski, H. F. (2021). The Rhesus Macaque as a Translational Model for Neurodegeneration and Alzheimer's Disease. Frontiers in aging neuroscience13, 734173.

Thomas N, Beattie Z, Riley  T, Hofer S, Kaye J. Home-Based Assessment of Cognition  and Health Measures: The Collaborative Aging Research using Technology (CART)  Initiative and International Collaborations. EEE Instrumentation & Measurement Magazine 2021:68-78. doi: 10.1109/MIM.2021.9513638. 

Vogel, J. W., Young, A. L., Oxtoby, N. P., Smith, R., Ossenkoppele, R., Strandberg, O. T., La Joie, R., Aksman, L. M., Grothe, M. J., Iturria-Medina, Y., Alzheimer’s Disease Neuroimaging Initiative, Pontecorvo, M. J., Devous, M. D., Rabinovici, G. D., Alexander, D. C., Lyoo, C. H., Evans, A. C., & Hansson, O. (2021). Four distinct trajectories of tau deposition identified in Alzheimer's disease. Nature medicine27(5), 871–881.

Ward, D. D., Wallace, L., & Rockwood, K. (2021). Cumulative health deficits, APOE genotype, and risk for later-life mild cognitive impairment and dementia. Journal of neurology, neurosurgery, and psychiatry92(2), 136–142.

Wild, K., Sharma, N., Mattek, N., Karlawish, J., Riley, T., & Kaye, J. (2021). Application of In-Home Monitoring Data to Transition Decisions in Continuing Care Retirement Communities: Usability Study. Journal of medical Internet research23(1), e18806.

Wu, C. Y., Dodge, H. H., Gothard, S., Mattek, N., Wright, K., Barnes, L. L., Silbert, L. C., Lim, M. M., Kaye, J. A., & Beattie, Z. (2021). Unobtrusive Sensing Technology Detects Ecologically Valid Spatiotemporal Patterns of Daily Routines Distinctive to Persons with Mild Cognitive Impairment. The journals of gerontology. Series A, Biological sciences and medical sciences, glab293. Advance online publication. 

Wu C, Dodge H, Reynolds C, Barnes L, Silbert L, Lim M, Mattek N, Gothard S, Kaye J, Beattie Z. (2021). In-Home mobility frequency and stability in older adults living alone with or without MCI: Introduction of new metrics. Frontiers in Digital Health 3:1-9. 

Wu C, Tibbitts D, Beattie Z, Dodge H, Beer T, Marks D, Shannon J, Kaye J, Winters-Stone K. (2021). Continuous unobtrusive assessment of meaningful change in older adults with cancer: The Pacific Aging & Cancer Study Collaborative—PACS collaborative. Journal of Clinical Oncology 39:1569.  DOI:10.1200/JCO.2021.39.15_suppl.1569

Wu C-Y, Dodge H, Beattie Z, Mattek N, Sharma N, Kaye J. Reproducibility and Replicability of Digital Biomarkers for Reducing Sample Sizes in Preclinical Alzheimer Trials. Alzheimer's & Dementia: Translational Research & Clinical Interventions, Forthcoming, 2021

Wu, C. Y., Miller, L. M., Wall, R. N., Beattie, Z. T., Silbert, L. C., & Kaye, J. A. (2020). Prolonged Physical Inactivity in Older Adult Couples: A Dyadic Analysis Using Actigraphy. Innovation in aging5(1), igaa066. 

Xiong, L. Y., Ouk, M., Wu, C. Y., Rabin, J. S., Lanctôt, K. L., Herrmann, N., Black, S. E., Edwards, J. D., & Swardfager, W. (2021). Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia. Alzheimer's research & therapy13(1), 147. 

Yang, D., & Masurkar, A. V. (2021). Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort. Alzheimer disease and associated disorders35(1), 14–22.

Yu K, Wild K, Potempa K, Hampstead BM, Lichtenberg PA, Struble LM, Pruitt P, Alfaro EL, Lindsley J, MacDonald M, Kaye JA, Silbert LC and Dodge HH (2021) The Internet-Based Conversational Engagement Clinical Trial (I-CONECT) in Socially Isolated Adults 75+ Years Old: Randomized Controlled Trial Protocol and COVID-19 Related Study Modifications. Frontiers in Digital Health 3:714813

Yu, Q., Mai, Y., Ruan, Y., Luo, Y., Zhao, L., Fang, W., Cao, Z., Li, Y., Liao, W., Xiao, S., Mok, V., Shi, L., Liu, J., National Alzheimer’s Coordinating Center, the Alzheimer’s Disease Neuroimaging Initiative, & Frontotemporal Lobar Degeneration Neuroimaging Initiative (2021). An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer's disease. Alzheimer's research & therapy13(1), 23.

Zweig, J. A., Brandes, M. S., Brumbach, B. H., Caruso, M., Wright, K. M., Quinn, J. F., Soumyanath, A., & Gray, N. E. (2021). Prolonged Treatment with Centella asiatica Improves Memory, Reduces Amyloid-β Pathology, and Activates NRF2-Regulated Antioxidant Response Pathway in 5xFAD Mice. Journal of Alzheimer's disease : JAD81(4), 1453–1468.

Ahn, S., Mathiason, M. A., Salisbury, D., & Yu, F. (2020). Factors Predicting the Onset of Amnestic Mild Cognitive Impairment or Alzheimer's Dementia in Persons With Subjective Cognitive Decline. Journal of gerontological nursing46(8), 28–36.

An, N., Ding, H., Yang, J., Au, R., & Ang, T. (2020). Deep ensemble learning for Alzheimer's disease classification. Journal of biomedical informatics105, 103411.

Anderson VC, Tagge IJ, Li X, et al. (2020.) Observation of Reduced Homeostatic Metabolic Activity and/or Coupling in White Matter Aging. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging. Sep;30(5):658-665.

Anstey, Kaarin J. et al. (2020.) Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus. Journal of Alzheimer’s Disease. Vol. Pre-Press. 1 Jan. : 1 – 10.

Asgari, M., Gale, R., Wild, K., Dodgeb, H., & Kaye, J. (2020). Automatic Assessment of Cognitive Tests for Differentiating Mild Cognitive Impairment: A Proof of Concept Study of the Digit Span Task. Current Alzheimer research, 10.2174/1567205017666201008110854.

Au-Yeung, W.T.M., Kaye, J., & Beattie, Z. (2020.) Step Count Standardization: Validation of Step Counts from the Withings Activite using PiezoRxD and wGT3X-BT. 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), Montreal, QC, Canada, 2020, pp. 4608-4611.

Au-Yeung, W. M., Miller, L., Beattie, Z., Dodge, H. H., Reynolds, C., Vahia, I., & Kaye, J. (2020). Sensing a problem: Proof of concept for characterizing and predicting agitation. Alzheimer's & dementia (New York, N. Y.), 6(1), e12079.

Atayde, A. L., Fischer, C. E., Schweizer, T. A., & Munoz, D. G. (2020). Neuropsychiatric Inventory-Assessed Nighttime Behavior Accompanies, but Does Not Precede, Progressive Cognitive Decline Independent of Alzheimer's Disease Histopathology. Journal of Alzheimer's disease : JAD74(3), 839–850.

Beattie Z, Miller L, Almirola C, Au-Yeung W, Bernard H, Cosgrove K, Dodge H, Gamboa C, Golonka O, Gothard S, Harbison S, Irish S, Kornfeld J, Lee J, Marcoe J, Mattek N, Quinn C, Reynolds C, Riley T, Rodrigues N, Sharma N, Siqueland M, Thomas N, Truty T, Wall R, Wild K, Wu C, Karlawish J, Silverberg N, Barnes L, Czaja S, Silbert L, Kaye K. (2020.) The Collaborative Aging Research using Technology (CART) Initiative: An open, sharable, technology-agnostic platform for the research community Digital Biomarkers, Forthcoming.

Bissig, D., Kaye, J., & Erten-Lyons, D. (2020). Validation of SATURN, a free, electronic, self-administered cognitive screening test. Alzheimer's & dementia (New York, N. Y.)6(1), e12116.

Bissig, D., Zhou, C. G., Le, V., & Bernard, J. T. (2020). Optical coherence tomography reveals light-dependent retinal responses in Alzheimer's disease. NeuroImage, 219, 117022.

Blanken, A. E., Jang, J. Y., Ho, J. K., Edmonds, E. C., Han, S. D., Bangen, K. J., & Nation, D. A. (2020). Distilling Heterogeneity of Mild Cognitive Impairment in the National Alzheimer Coordinating Center Database Using Latent Profile Analysis. JAMA network open, 3(3), e200413.

Boggess, M. B., Barber, J. M., Jicha, G. A., & Caban-Holt, A. (2020). Subjective Memory Complaints Are an Important Surrogate for Objective Cognitive Performance in African Americans. Alzheimer disease and associated disorders34(1), 79–84.

Bonds K., Song M., Whitlatch CJ., et al. (2020.) Patterns of Dyadic Appraisal of Decision-Making Involvement of African American Persons Living with Dementia. The Gerontologist. Jul. DOI: 10.1093/geront/gnaa086.

Bolton, C. J., & Tam, J. W. (2020). Differential Involvement of the Locus Coeruleus in Early- and Late-Onset Alzheimer's Disease: A Potential Mechanism of Clinical Differences?. medRxiv : the preprint server for health sciences, 2020.11.01.20224139.

Brenowitz, W. D., Besser, L. M., Kukull, W. A., Keene, C. D., Glymour, M. M., & Yaffe, K. (2020). Clinician-judged hearing impairment and associations with neuropathologic burden. Neurology95(12), e1640–e1649.

Cerino, E. S., Hooker, K., Goodrich, E., & Dodge, H. H. (2020). Personality Moderates Intervention Effects on Cognitive Function: A 6-Week Conversation-Based Intervention. The Gerontologist60(5), 958–967.

Chen, L., Dodge, H. H., & Asgari, M. (2020). Topic-Based Measures of Conversation for Detecting Mild Cognitive Impairment. Proceedings of the conference. Association for Computational Linguistics. Meeting2020, 63–67. 

Chen, L., Asgari, M., Gale, R., Wild, K., Dodge, H., Kaye, J. Improving the assessment of Mild Cognitive Impairment in advanced age with a novel multi-feature automated speech and language analysis of verbal fluency. Frontiers in Psychology: Psychology for Clinical Settings. 2020. doi: 10.3389/fpsyg.2020.00535

Croff, R., Gowen, L. K., Lindauer, A., Shofner, S., Brown, K., & Eckstrom, E. (2020). Including older rural adults in research: Practical guidance for addressing the NIH Inclusion Across the Lifespan policy. Journal of clinical and translational science4(5), 431–436.

Croff, R., Tang, W., Friedman, D. B., Balbim, G. M., & Belza, B. (2020). Training the next generation of aging and cognitive health researchers. Gerontology & geriatrics education, 1–17. Advance online publication.

Culhane, J. E., Chan, K., Teylan, M. A., Chen, Y. C., Mock, C., Gauthreaux, K., & Kukull, W. A. (2020). Factor Consistency of Neuropsychological Test Battery Versions in the NACC Uniform Data Set. Alzheimer disease and associated disorders34(2), 175–177.

Dai, D. L., Tropea, T. F., Robinson, J. L., Suh, E., Hurtig, H., Weintraub, D., Van Deerlin, V., Lee, E. B., Trojanowski, J. Q., & Chen-Plotkin, A. S. (2020). ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies. Acta neuropathologica140(4), 449–461.

Dawson, W. D., Bobrow, K., Ibanez, A., Booi, L., Pintado-Caipa, M., Yamamoto, S., Tarnanas, I., Evans, T., Comas-Herrera, A., Cummings, J., Kaye, J., Yaffe, K., Miller, B. L., & Eyre, H. A. (2020). The necessity of diplomacy in brain health. The Lancet. Neurology19(12), 972–974.

Denny, A., Streitz, M., Stock, K., Balls-Berry, J. E., Barnes, L. L., Byrd, G. S., Croff, R., Gao, S., Glover, C. M., Hendrie, H. C., Hu, W. T., Manly, J. J., Moulder, K. L., Stark, S., Thomas, S. B., Whitmer, R., Wong, R., Morris, J. C., & Lingler, J. H. (2020). Perspective on the "African American participation in Alzheimer disease research: Effective strategies" workshop, 2018. Alzheimer's & dementia : the journal of the Alzheimer's Association16(12), 1734–1744.

Dodge, H. H., Goldstein, F. C., Wakim, N. I., Gefen, T., Teylan, M., Chan, K., Kukull, W. A., Barnes, L. L., Giordani, B., Hughes, T. M., Kramer, J. H., Loewenstein, D. A., Marson, D. C., Mungas, D. M., Mattek, N., Sachs, B. C., Salmon, D. P., Willis-Parker, M., Welsh-Bohmer, K. A., Wild, K. V., … National Alzheimer's Coordinating Center (NACC) (2020). Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores. Alzheimer's & dementia (New York, N. Y.)6(1), e12103.

Fowe I. (2020.) One-Year, Weekly Online Survey to Monitor Healthcare Visits and its Association With Walking-Speed in Older Adults. In: AMIA 2020 Informatics Conference Online meeting, Forthcoming.

Franzmeier, N., Suárez-Calvet, M., Frontzkowski, L., Moore, A., Hohman, T. J., Morenas-Rodriguez, E., Nuscher, B., Shaw, L., Trojanowski, J. Q., Dichgans, M., Kleinberger, G., Haass, C., Ewers, M., & Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2020). Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration. Molecular neurodegeneration15(1), 57.

Gefen, T., Teylan, M. A., Besser, L., Pollner, E., Moshkovich, A., & Weintraub, S. (2020). Measurement and characterization of distinctive clinical phenotypes using the Frontotemporal Lobar Degeneration Module (FTLD-MOD). Alzheimer's & dementia : the journal of the Alzheimer's Association, 16(6), 918–925.

Goldberg, T.E., Huey, E.D. & Devanand, D.P. (2020). Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies. Nature Communications. 11, 4727.

Grasby, K. L., Jahanshad, N., Painter, J. N., Colodro-Conde, L., Bralten, J., Hibar, D. P., Lind, P. A., Pizzagalli, F., et al. (2020.) Enhancing NeuroImaging Genetics through Meta-Analysis Consortium (ENIGMA)—Genetics working group. The genetic architecture of the human cerebral cortex. Science (New York, N.Y.), 367(6484), eaay6690.

Gold, D., Rosowsky, E., Piryatinsky, I., & Sinclair, S. J. (2020). Comparing patient and informant ratings of depressive symptoms in various stages of Alzheimer's disease. Neuropsychology34(5), 535–550.

Howarth, C., Mishra, A., & Hall, C. N. (2021). More than just summed neuronal activity: how multiple cell types shape the BOLD response. Philosophical transactions of the Royal Society of London. Series B, Biological sciences376(1815), 20190630.

John, S. E., Evans, S. A., Hanfelt, J., Loring, D. W., & Goldstein, F. C. (2020). Subjective Memory Complaints in White and African American Participants. Journal of geriatric psychiatry and neurology33(3), 135–143.

Kabacińska, K., Sharma, N., Kaye, J., Mattek, N., Kuzeljevic, B., & Robillard, J. Investigating the concept of participant burden in aging technology researchBMC Geriatrics. 2020. 20(50). 

Kaur, D., Bucholc, M., Finn, D. P., Todd, S., Wong-Lin, K., & McClean, P. L. (2020). Multi-time-point data preparation robustly reveals MCI and dementia risk factors. Alzheimer's & dementia (Amsterdam, Netherlands)12(1), e12116.

Khan, T., & Jacobs, P. (2020). Prediction of mild cognitive impairment using movement complexity. IEEE journal of biomedical and health informatics, 10.1109/JBHI.2020.2985907. Advance online publication.

Kurasz, A. M., Smith, G. E., McFarland, M. G., & Armstrong, M. J. (2020). Ethnoracial Differences in Lewy Body Diseases with Cognitive Impairment. Journal of Alzheimer's disease : JAD77(1), 165–174.

Kunkle, B. W., Schmidt, M., Klein, H. U., Naj, A. C., Hamilton-Nelson, K. L., Larson, E. B., Evans, D. A., De Jager, P. L., Crane, P. K., et al. (2020). Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. JAMA neurology, e203536. Advance online publication.

Kiselica, A. M., Webber, T. A., & Benge, J. F. (2020). The Uniform Dataset 3.0 Neuropsychological Battery: Factor Structure, Invariance Testing, and Demographically Adjusted Factor Score Calculation. Journal of the International Neuropsychological Society : JINS26(6), 576–586.

Ledger, C., Karameh, W. K., Munoz, D. G., Fischer, C. E., & Schweizer, T. A. (2020). Gender role in sleep disturbances among older adults with traumatic brain injury. International review of psychiatry (Abingdon, England)32(1), 39–45.

Liew, T.M. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia. Alz Res Therapy 12, 35 (2020).

Liew T. M. (2020). Active case finding of dementia in ambulatory care settings: a comparison of three strategies. European journal of neurology27(10), 1867–1878.

Lindauer, A., Wild, K., Natonson, A., Mattek, N., Wolf, M., Steeves-Reece, A., & Messecar, D. (2020). Dementia 360 ECHO: Using technology to facilitate diagnosis and treatment. Gerontology & geriatrics education, 1–7. Advance online publication.

LoBue C, Schaffert J, Cullum CM, Peters ME, Didehbani N, Hart J, White CL. Clinical and neuropsychological profile of patients with dementia and chronic traumatic encephalopathy. J Neurol Neurosurg Psychiatry 91:586-592, 2020.  PMC7231625

Marawar, R., Wakim, N., Albin, R. L., & Dodge, H. (2020). Seizure occurrence and related mortality in dementia with Lewy bodies. Epilepsy & behavior: E&B, 111, 107311.

Martinez, A. I., Abner, E. L., Jicha, G. A., Rigsby, D. N., Eckmann, L. C., Huffmyer, M. J., & Moga, D. C. (2020). One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults. Journal of managed care & specialty pharmacy26(4), 520–528.

Matthews, D. G., Caruso, M., Alcazar Magana, A., Wright, K. M., Maier, C. S., Stevens, J. F., Gray, N. E., Quinn, J. F., & Soumyanath, A. (2020). Caffeoylquinic Acids in Centella asiatica Reverse Cognitive Deficits in Male 5XFAD Alzheimer's Disease Model Mice. Nutrients12(11), 3488.

Moniruzzaman M, Kadota A, Akash M, Pruitt P, Miura K, Albin R, Dodge H. (2020.) Effects of physical activities on dementia-related biomarkers: a systematic review of randomized controlled trials. Alzheimer's & Dementia: Translational Research & Clinical Interventions. Forthcoming.

Moloney, M., Oh, G., & Moga, D. C. (2020). Determinants of Sleep Medication Use among Participants in the National Alzheimer's Coordinating Center Uniform Data Set. Journal of applied gerontology : the official journal of the Southern Gerontological Society39(12), 1340–1349.

Ordaz-Johnson, O. H., Croff, R. L., Robinson, L. D., Shea, S. A., & Bowles, N. P. (2020). More Than a Statistic: a Qualitative Study of COVID-19 Treatment and Prevention Optimization for Black Americans. Journal of general internal medicine35(12), 3750–3752.

Pelcher, I., Puzo, C., Tripodis, Y., Aparicio, H. J., Steinberg, E. G., Phelps, A., Martin, B., Palmisano, J. N., Vassey, E., Lindbergh, C., McKee, A. C., Stein, T. D., Killiany, R. J., Au, R., Kowall, N. W., Stern, R. A., Mez, J., & Alosco, M. L. (2020). Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures. Journal of Alzheimer's disease : JAD78(4), 1393–1408.

Piantino, J., Boespflug, E. L., Schwartz, D. L., Luther, M., Morales, A. M., Lin, A., Fossen, R. V., Silbert, L., & Nagel, B. J. (2020). Characterization of MR Imaging-Visible Perivascular Spaces in the White Matter of Healthy Adolescents at 3T. AJNR. American journal of neuroradiology41(11), 2139–2145.

Piau, A., Mattek, N., Crissey, R., Beattie, Z., Dodge, H., & Kaye, J. (2020). When Will My Patient Fall? Sensor-Based In-Home Walking Speed Identifies Future Falls in Older Adults. The journals of gerontology. Series A, Biological sciences and medical sciences, 75(5), 968–973.

Pradeep, T., Bray, M., Arun, S., Richey, L. N., Jahed, S., Bryant, B. R., LoBue, C., Lyketsos, C. G., Kim, P., & Peters, M. E. (2020). History of traumatic brain injury interferes with accurate diagnosis of Alzheimer's dementia: a nation-wide case-control study. International review of psychiatry (Abingdon, England)32(1), 61–70.

Quinn, K., Miyawaki, C. E., Croff, R., Vogel, M. T., Belza, B., Souza, A. M., Liu, M., Edwards, V. J., & Friedman, D. B. (2020). Terms and Measures of Cognitive Health Associated With Dementia and Alzheimer's Disease: A Scoping Review. Research on aging, 42(5-6), 174–185.

Quiñones, A. R., Kaye, J., Allore, H. G., Botoseneanu, A., & Thielke, S. M. (2020). An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementia. American journal of Alzheimer's disease and other dementias35, 1533317520960874.

Rajkumar A, Wallace B, Ault L, Larivière-Chartier J, Knoefel F, Goubran R, Kaye J, Thomas N. Visualizing Effects of COVID-19 Social Isolation with Residential Activity Big Data Sensor Data In: Conference Paper, IEEE BigData 2020 Workshop on Data Science in Medicine and Healthcare (DSMH). 2020. doi: 10.1109/BigData50022.2020.9377830. 

Reiman, E., Arboleda-Velasquez J., Quiroz Y. et al. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nature Communications. 2020. 11 (67). 

Ren D., Lopez O., Lingler J., Conley Y. The effect of the APOE epsilon2epsilon4 genotype on the development of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) in non-Latino whites. Journal of the American Geriatrics Society. 2020. doi: 10.1111/jgs.16337 

Saari, T. T., Hallikainen, I., Hintsa, T., & Koivisto, A. M. (2020). Network structures and temporal stability of self- and informant-rated affective symptoms in Alzheimer's disease. Journal of affective disorders, 276, 1084–1092.

Sachs, B. C., Steenland, K., Zhao, L., Hughes, T. M., Weintraub, S., Dodge, H. H., Barnes, L. L., Craft, S., Parker, M. L., & Goldstein, F. C. (2020). Expanded Demographic Norms for Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set. Alzheimer Disease and Associated Disorders, 34(3), 191-197.

Sandau, U. S., Wiedrick, J. T., Smith, S. J., McFarland, T. J., Lusardi, T. A., Lind, B., Harrington, C. A., Lapidus, J. A., Galasko, D. R., Quinn, J. F., & Saugstad, J. A. (2020). Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment. Journal of Alzheimer's disease: JAD, 10.3233/JAD-200396. Advance online publication.

Schaffert, J., LoBue, C., White, C. L., 3rd, Wilmoth, K., Didehbani, N., Lacritz, L., Nguyen, T., Peters, M. E., Fields, L., Li, C., & Cullum, C. M. (2020). Risk factors for earlier dementia onset in autopsy-confirmed Alzheimer's disease, mixed Alzheimer's with Lewy bodies, and pure Lewy body disease. Alzheimer's & dementia : the journal of the Alzheimer's Association16(3), 524–530.

Seelye, A., Leese, M. I., Dorociak, K., Bouranis, N., Mattek, N., Sharma, N., Beattie, Z., Riley, T., Lee, J., Cosgrove, K., Fleming, N., Klinger, J., Ferguson, J., Lamberty, G. J., & Kaye, J. (2020). Feasibility of In-Home Sensor Monitoring to Detect Mild Cognitive Impairment in Aging Military Veterans: Prospective Observational Study. JMIR formative research, 4(6), e16371.

Singh, A., Allen, D., Fracassi, A., Tumurbaatar, B., Natarajan, C., Scaduto, P., Woltjer, R., Kayed, R., Limon, A., Krishnan, B., & Taglialatela, G. (2020). Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers. Journal of Alzheimer's disease : JAD78(4), 1661–1678.

Squillario, M., Abate, G., Tomasi, F. et al. A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease. Sci Rep 10, 12063 (2020).

Shinohara, M., Tashiro, Y., Suzuki, K., Fukumori, A., Bu, G., & Sato, N. (2020). Interaction between APOE genotype and diabetes in cognitive decline. Alzheimer's & dementia (Amsterdam, Netherlands), 12(1), e12006.

Shinto, L., Lahna, D., Murchison, C. F., Dodge, H., Hagen, K., David, J., Kaye, J., Quinn, J. F., Wall, R., & Silbert, L. C. (2020). Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults. Journal of Alzheimer's disease: JAD, 74(1), 65–77.

Strickland, S. L., Reddy, J. S., Allen, M., N'songo, A., Burgess, J. D., Corda, M. M., Ballard, T., Wang, X., Carrasquillo, M. M., Biernacka, J. M., Jenkins, G. D., Mukherjee, S., Boehme, K., Crane, P., Kauwe, J. S., Ertekin-Taner, N., & Alzheimer's Disease Genetics Consortium (2020). MAPT haplotype-stratified GWAS reveals differential association for AD risk variants. Alzheimer's & dementia : the journal of the Alzheimer's Association16(7), 983–1002.

Sullivan, K. J., Liu, A., Dodge, H. H., Andreescu, C., Chang, C. H., & Ganguli, M. (2020). Depression Symptoms Declining Among Older Adults: Birth Cohort Analyses From the Rust Belt. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry28(1), 99–107.

Tang, F., Uchendu, I., Wang, F., Dodge, H. H., & Zhou, J. (2020). Scalable diagnostic screening of mild cognitive impairment using AI dialogue agent. Scientific Reports, 10(1), [5732].

Taylor-Rodriguez D, Lovitz D, Mattek N, C-Y W, Kaye J, Dodge H, Jedynak B. (2020). Reducing sample size in high-frequency biomarkers RCTs. Alzheimer’s & Dementia: A Journal of the Alzheimer's Association.

Ternes, K., Iyengar, V., Lavretsky, H., Dawson, W. D., Booi, L., Ibanez, A., Vahia, I., Reynolds, C., Dekosky, S., Cummings, J., Miller, B., Perissinotto, C., Kaye, J., & Eyre, H. A. (2020). Brain health INnovation Diplomacy: A model binding diverse disciplines to manage the promise and perils of technological innovation. International Psychogeriatrics, 32(8), 955-979.

Teylan, M., Mock, C., Gauthreaux, K., Chen, Y. C., Chan, K., Hassenstab, J., Besser, L. M., Kukull, W. A., & Crary, J. F. (2020). Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy. Brain: a journal of neurology, 143(2), 611–621.

Thomas N., Beattie, Z., Marcoe, J., Sharma, N., Mattek, N., Dodge, H., Wild, K., Kaye, J. EVALUATE-AD: Ecologically valid, longitudinal, and unbiased assessment of treatment efficacy in Alzheimer’s disease. JMIR Research Protocols. 2020. DOI: 10.2196/17603

Tomaszewski, N., He, X., Solomon, V., Lee, M., Mack, W. J., Quinn, J. F., Braskie, M. N., & Yassine, H. N. (2020). Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial. Journal of Alzheimer's disease : JAD74(3), 975–990.

Toshkhujaev, S., Lee, K. H., Choi, K. Y., Lee, J. J., Kwon, G. R., Gupta, Y., & Lama, R. K. (2020). Classification of Alzheimer's Disease and Mild Cognitive Impairment Based on Cortical and Subcortical Features from MRI T1 Brain Images Utilizing Four Different Types of Datasets. Journal of healthcare engineering2020, 3743171.

Vöglein, J., Ricard, I., Noachtar, S. et al. Seizures in Alzheimer’s disease are highly recurrent and associated with a poor disease course. Journal of  Neurology, 267, 2941–2948 (2020).

Waki, T., Tanaka-Mizuno, S., Takashima, N., Takechi, H., Hayakawa, T., Miura, K., Ueshima, H., Kita, Y., & Dodge, H. H. (2020). Waist Circumference and Domain-Specific Cognitive Function Among Non-Demented Japanese Older Adults Stratified by Sex: Results from the Takashima Cognition Study. Journal of Alzheimer's disease: JAD, 73(3), 887–896.

Wakima N, Braun T, Kaye J, Dodge H. (2020.) Choosing the right time granularity for analysis of digital biomarker trajectories. Alzheimer's & Dementia: Translational Research & Clinical Interventions, Forthcoming.

Wallace B, Knoefel F, Goubtan R, Thomas N. (2020.) Comparison of Bed-Sensors for Nocturnal Behaviour Assessment. eTELEMED, Forthcoming.

Wang, G., & Li, W. (2020). Diabetes as a Risk Factor for Abnormal Cognition Development. Journal of Alzheimer's disease reports, 4(1), 237–242.

Woodworth, D. C., Nguyen, H. L., Khan, Z., Kawas, C. H., Corrada, M. M., & Sajjadi, S. A. (2021). Utility of MRI in the identification of hippocampal sclerosis of aging. Alzheimer's & dementia : the journal of the Alzheimer's Association17(5), 847–855.

Wright, K. M., Magana, A. A., Laethem, R. M., Moseley, C. L., Banks, T. T., Maier, C. S., Stevens, J. F., Quinn, J. F., & Soumyanath, A. (2020). Centella asiatica Water Extract Shows Low Potential for Cytochrome P450-Mediated Drug Interactions. Drug metabolism and disposition: the biological fate of chemicals48(10), 1053–1063.

Xie, B., Charness, N., Fingerman, K., Kaye, J., Kim, M. T., & Khurshid, A. (2020). When Going Digital Becomes a Necessity: Ensuring Older Adults' Needs for Information, Services, and Social Inclusion During COVID-19. Journal of aging & social policy, 32(4-5), 460–470.

Xiong, C., Luo, J., Coble, D., Agboola, F., Kukull, W., & Morris, J. C. (2020). Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia. Alzheimer's & dementia: the journal of the Alzheimer's Association, 16(4), 589–597.

Xu, C., Apostolova, L. G., Oblak, A. L., & Gao, S. (2020). Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy. Journal of Alzheimer's disease : JAD73(4), 1305–1311.

Yan T., Liang J., Gao J., et al. FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease. Nature Communications. 2020. 11 (411). 

Zhang, F., Gannon, M., Chen, Y., Yan, S., Zhang, S., Feng, W., Tao, J., Sha, B., Liu, Z., Saito, T., Saido, T., Keene, C. D., Jiao, K., Roberson, E. D., Xu, H., & Wang, Q. (2020). β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade. Science translational medicine12(526), eaay6931.

Andrews JS, Desai U, Kirson NY, Zichlin ML, Ball DE, Matthews BR. Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials. Alzheimer’s & Dementia (New York, NY). 2019.  5:354-363.

Bardach, S. H., Jicha, G. A., Karanth, S., Zhang, X., & Abner, E. L. Genetic Sample Provision Among National Alzheimer's Coordinating Center Participants. Journal of Alzheimer's disease: JAD. 2019. 69(1), 123–133. 

Bayram, E., Shan, G., & Cummings, J. L. Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease. Journal of Alzheimer's disease : JAD. 2019. 69(4), 953–961. 

Besser, L. M., Mock, C., Teylan, M. A., Hassenstab, J., Kukull, W. A., & Crary, J. F. (2019). Differences in Cognitive Impairment in Primary Age-Related Tauopathy Versus Alzheimer Disease. Journal of neuropathology and experimental neurology, 78(3), 219–228.

Bowman G, Gouskova N, Dodge H, Donohue J, Bichsel A, Silbert L, Quinn J, Kaye J. Pre-Analytical and Within-Person Reproducibility of Nutritional Metabolomics over 2 Years in Elders at Risk for Dementia. Current Developments in Nutrition. 2019. 3. PMC6574566.

Bowman, G. L., Dodge, H. H., Guyonnet, S., Zhou, N., Donohue, J., Bichsel, A., Schmitt, J., Hooper, C., Bartfai, T., Andrieu, S., Vellas, B., & MAPT/DSA Study Group (2019). A blood-based nutritional risk index explains cognitive enhancement and decline in the multidomain Alzheimer prevention trial. Alzheimer's & dementia (New York, N. Y.), 5, 953–963.

Bowman B, Silbert L, Dodge H, Lahna D, Hagen K, Murchison C, Howieson H, Kaye J, Quinn J, Shinto L. Randomized trial of n-3 polyunsaturated fatty acids for the prevention of cerebral small vessel disease and inflammation in aging (PUFA trial):  Rationale, design and baseline results. Nutrients. 2019. 11:1-18.

Burke, S. L., Hu, T., Fava, N. M., Li, T., Rodriguez, M. J., Schuldiner, K. L., Burgess, A., & Laird, A. (2019). Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. Journal of women & aging, 31(2), 140–164. 

Burke, S. L., Hu, T., Naseh, M., Fava, N. M., O'Driscoll, J., Alvarez, D., Cottler, L. B., & Duara, R. (2019). Factors influencing attrition in 35 Alzheimer's Disease Centers across the USA: a longitudinal examination of the National Alzheimer's Coordinating Center's Uniform Data Set. Aging clinical and experimental research, 31(9), 1283–1297.

Cerino ES, Hooker K, Goodrich E, Dodge HH. Personality Moderates Intervention Effects on Cognitive Function: A 6-Week Conversation-Based Intervention. The Gerontologist. 2019. PMC31112605

Chauhan G, Adams HHH, Satizabal CL, Bis JC, Teumer A, Sargurupremraj M, Hofer E, Trompet S, Hilal S, Smith AV, et al. Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting. Neurology. 2019. [Epub ahead of print].

Cho H, Matthews GJ, Harel O. Confidence Intervals for the Area Under the Receiver Operating Characteristic Curve in the Presence of Ignorable Missing Data. International Statistical Review. 2019. 87:152-177. PMC6472951.

Consel C, Kaye J. Aging with the Internet of Things. The Bridge (Spring 2019 edition: Technologies for Aging). 2019. 49:6-10, 2019. Not peer reviewed.

Croff R, Witter P, Walker M, Francois E, Quinn C, Riley T, Sharma N, J Kaye. Things Are Changing so Fast: Integrative Technology for Preserving Cognitive Health and Community History. The Gerontologist. 2019. 59:147-157. PMC6326255.

Curcio N, Wilmoth K, LoBue C, Cullum CM. Reliability of Medical History Reporting in Older Adults With and Without Cognitive Impairment. Journal of Central Nervous System Disease. 2019. 11:1179573519843874. PMC6477758.

Dallaire-Théroux, C., Beheshti, I., Potvin, O., Dieumegarde, L., Saikali, S., Duchesne, S., & Alzheimer's Disease Neuroimaging Initiative (2019). Braak neurofibrillary tangle staging prediction from in vivo MRI metrics. Alzheimer's & dementia (Amsterdam, Netherlands), 11, 599–609.

Duggan EC, Piccinin AM, Clouston S, Koval AV, Robitaille A, Zammit AR, Wu C, Brown CL, Lee LO, Finkel D, Beasley WH, Kaye J. et al. A Multi-Study Coordinated Meta-Analysis of Pulmonary Function and Cognition in Aging. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences. 2019. 

Franzmeier N, Rubinski A, Neitzel J, Ewers M. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory. Nature Communications. 2019. 10(1):1766. PMC6467911.

Giebel, C., Flanagan, E., & Sutcliffe, C. (2019). Predictors of finance management in dementia: managing bills and taxes matters. International psychogeriatrics, 31 2, 277-286.

Goudey B, Fung BJ, Schieber C, Faux NG, Alzheimer’s Disease Metabolomics Consortium, Alzheimer’s Disease Neuroimaging Initiative. A blood-based signature of cerebrospinal fluid Abeta1-42 status. Scientific Reports. 2019. 9:4163.

Gouskova N, Bichsel A, Dodge H, Donohue J, Silbert L, Kaye J, Bowman G. Blood-based Nutritional Risk Index for Cognition in the Nutrition and Brain Aging Study (NBAS): Emphasis on n-3 PUFA, Vitamin D and Homocysteine. Current Developments in Nutrition. 2019. 3(1): P14-005-19. PMC6574722.

Grill, J. D., Kwon, J., Teylan, M. A., Pierce, A., Vidoni, E. D., Burns, J. M., Lindauer, A., Quinn, J., Kaye, J., Gillen, D. L., & Nan, B. (2019). Retention of Alzheimer Disease Research Participants. Alzheimer disease and associated disorders, 33(4), 299–306.

Gupta, Y., Lama, R. K., Kwon, G. R., & Alzheimer's Disease Neuroimaging Initiative (2019). Prediction and Classification of Alzheimer's Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers. Frontiers in computational neuroscience, 13, 72.

Han, J. Y., Besser, L. M., Xiong, C., Kukull, W. A., & Morris, J. C. (2019). Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia. Alzheimer disease and associated disorders, 33(2), 87–94.

Hett, K., Ta, V. T., Catheline, G., Tourdias, T., Manjón, J. V., Coupé, P., & Alzheimer’s Disease Neuroimaging Initiative (2019). Multimodal Hippocampal Subfield Grading For Alzheimer's Disease Classification. Scientific Reports, 9(1), 13845.

Horgusluoglu-Moloch, E., Risacher, S.L., Crane, P.K. et al. (2019.) Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways. Scientific Reports. 9, 14498.

Insel P, Weirner M, MacKin S, Mornino E, Lim Y, Stomrud E, Palmqvist S, Masters C, Marfuff P, Hansson O, Mattsson N. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. 2019. 93(4):e322-e333. 

Irimata, KM, Broatch, J, Wilson, JR. (2019). Partitioned GMM logistic regression models for longitudinal data. Statistics in Medicine. 38: 2171– 2183

Katsumata, Y., Nelson, P. T., Estus, S., Alzheimer's Disease Neuroimaging Initiative (ADNI), & Fardo, D. W. (2019). Translating Alzheimer's disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs. Neurobiology of aging. 74, 135–146.

Kaye, J. Silbert, L. Beattie, Z. Mattek, N. et al. High compliance, continuous long-term home monitoring of sleep activity in diverse populations differentiates lower cognitive functioning older adults. Alzheimer's and Dementia. 2019. 15(7): P152-P153

Koo, K., Schweizer, T. A., Fischer, C. E., & Munoz, D. G. (2019). Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies. Current Alzheimer research, 16(3), 243–250.

Kornak, J., Fields, J., Kremers, W., Farmer, S., Heuer, H. W., Forsberg, L., Brushaber, D., Rindels, A., Dodge, H., Weintraub, S., Besser, L., Appleby, B., et al. ARTFL/LEFFTDS Consortium (2019). Nonlinear Z-score modeling for improved detection of cognitive abnormality. Alzheimer's & dementia (Amsterdam, Netherlands), 11, 797–808.

Kundu, S., Lukemire, J., Wang, Y., Guo, Y., & Alzheimer’s Disease Neuroimaging Initiative (2019). A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer's Disease Data. Scientific reports, 9(1), 19589.

Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau immunity and lipid processing. Nature Genetics. 2019. 51(3): 414-430.

Lee G, Nho K, Kang B, Sohn KA, Kim D, for Alzheimer’s Disease Neuroimaging Initiative. Predicting Alzheimer's disease progression using multi-modal deep learning approach. Scientific Reports. 2019. 9(1):1952.

Leoutsakos JS, Wise EA, Lyketsos CG, Smith GS. (2019). Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia. International Journal of Geriatric Psychiatry. Dec;34(12):1865-1873.

Li, Y., Yao, Z., Yu, Y., Fu, Y., Zou, Y., Hu, B., & Alzheimer’s Disease Neuroimaging Initiative (2019). The Influence of Cerebrospinal Fluid Abnormalities and APOE 4 on PHF-Tau Protein: Evidence From Voxel Analysis and Graph Theory. Frontiers in aging neuroscience, 11, 208.

Lindauer A, McKenzie G, LaFazia D, McNeill L, Mincks K, Spoden N, Myers M, Mattek N, Teri LL. Using Technology to Facilitate Fidelity Assessments: The Tele-STAR Caregiver Intervention. Journal of Medical Internet Research. 2019. 21(5): e13599. PMC6555120.

Liew T. M. (2019). Depression, subjective cognitive decline, and the risk of neurocognitive disorders. Alzheimer's research & therapy, 11(1), 70.

Ma, Y., Jun, G. R., Chung, J., Zhang, X., Kunkle, B. W., Naj, A. C., White, C. C., Bennett, D. A., De Jager, P. L., Alzheimer’s Disease Genetics Consortium, Mayeux, R., Haines, J. L., Pericak-Vance, M. A., Schellenberg, G. D., Farrer, L. A., & Lunetta, K. L. (2019). CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease. Aging cell, 18(4), e12964.

Mattek N, Thomas N, Sharma N, Beattie Z, Marcoe J, Dodge H, Kaye J. Home Based Digital Activity Biomarkers Remotely Monitor Relevant Activities of MCI and Alzheimer’s Disease Patients and Their Care Partners, Abstract #34490. In: Alzheimer’s Association International Conference. Forthcoming, 2019.

Matthews, D. G., Caruso, M., Murchison, C. F., Zhu, J. Y., Wright, K. M., Harris, C. J., Gray, N. E., Quinn, J. F., & Soumyanath, A. (2019). Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice. Antioxidants (Basel, Switzerland), 8(12), 630.

Meguro K, Dodge H. Vascular Mild Cognitive Impairment: Identifying Disease in Community- Dwelling Older Adults, Reducing Risk Factors, and Providing Support. The Osaki-Tajiri and Kurihara Projects. Journal of Alzheimer's Disease: JAD. 2019. 70(s1): S293 – S302.

Mejia Maza, A., Carmen-Orozco, R. P., Carter, E. S., Dávila-Villacorta, D. G., Castillo, G., Morales, J. D., Mamani, J., Gavídia, C. M., Alroy, J., Sterling, C. R., Gonzalez, A. E., García, H. H., Woltjer, R. L., Verástegui, M. R., Gilman, R. H., & Cysticercosis Working Group in Peru (2019). Axonal swellings and spheroids: a new insight into the pathology of neurocysticercosis. Brain pathology (Zurich, Switzerland), 29(3), 425–436.

Milani, S. A., Marsiske, M., & Striley, C. W. (2019). Discriminative Ability of Montreal Cognitive Assessment Subtests and Items in Racial and Ethnic Minority Groups. Alzheimer disease and associated disorders, 33(3), 226–232.

Miller L, Kaye J, Lyons K, Lee C, Whitlatch C, Caserta M. Well-being in dementia: a cross-sectional dyadic study of the impact of multiple dimensions of strain on persons living with dementia and their family care partners. International Psychogeriatrics. 2019. [Epub ahead of print].   

Miller, L. Beattie, Z., Kaye, J., et al. Days and nights of dyads: Examining behavioral interdependence in co-residing couples using actigraphy. Innovation in Aging. 2019. 3, S767-S767. 

Oh, G., Abner, E. L., Fardo, D. W., Freeman, P. R., & Moga, D. C. (2019). Patterns and predictors of chronic opioid use in older adults: A retrospective cohort study. PloS one, 14(1), e0210341.

Opel, R. A., Christy, A., Boespflug, E. L., Weymann, K. B., Case, B., Pollock, J. M., Silbert, L. C., & Lim, M. M. (2019). Effects of traumatic brain injury on sleep and enlarged perivascular spaces. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 39(11), 2258–2267.

Perales-Puchalt, J., Gauthreaux, K., Flatt, J., Teylan, M. A., Resendez, J., Kukull, W. A., Chan, K., Burns, J., & Vidoni, E. D. (2019). Risk of dementia and mild cognitive impairment among older adults in same-sex relationships. International journal of geriatric psychiatry, 34(6), 828–835.

Piau A, Mattek N, Crissey R, Beattie Z, Dodge H, Kaye J. When will my patient fall? Sensor-based in-home walking speed identifies future falls in older adults. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences. 2019. [Epub ahead of print].

Piau A, Mattek N, Duncan C, Sharma N, Riley T, Kaye J. The five W's of falls - weekly online health survey of community-dwelling older adults: analysis of four years prospective follow-up. The Journals of Gerontology, Series A: Biological Sciences & Medical Sciences. 2019. [Epub ahead of print].

Piau A, Wild K. Performance of eHealth devices for frailty evaluation in real life settings is far from being demonstrated. Gerontology. 2019. 65(3): 309-310.

Piau A, Wild K, Mattek N, Kaye J. Current state of digital biomarker technologies for real life in-home monitoring of cognitive function for MCI to mild AD and implications for clinical care: systematic review. Journal of Medical Internet Research. 2019. 21(8):e12785.   

Puzo, C., Labriola, C., Sugarman, M. A., Tripodis, Y., Martin, B., Palmisano, J. N., Steinberg, E. G., Stein, T. D., Kowall, N. W., McKee, A. C., Mez, J., Killiany, R. J., Stern, R. A., & Alosco, M. L. (2019). Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set. Alzheimer's research & therapy, 11(1), 64.

Qian W, Schweizer TA, Churchill NW, et al. (2019.) Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry. May;27(5):490-498.

Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors. Journal of Gastrointestinal Oncology. 2019. 10(4): 674-687.

Sano M, Zhu CW, Kaye J, Mundt JC, Hayes TL, Ferris S, Thomas RG, Sun CK, Jiang Y, Donohue MC, et al. A randomized clinical trial to evaluate home-based assessment of people over 75 years old. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2019. [Epub ahead of print].

Schaser AJ, Osterberg VR, Dent SE, Stackhouse TL, Wakeham CM, Boutros SW, Weston LJ, Owen N, Weissman TA, Luna E. et al. Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders. Scientific Reports. 2019. 9(1): 10919.

Schenning K, Murchison C, Mattek N, Kaye J, Quinn J. Sex and genetic differences in postoperative cognitive dysfunction: a longitudinal cohort analysis. Biology of Sex Differences. 2019. 10:14.

Schwartz, D. L., Boespflug, E. L., Lahna, D. L., Pollock, J., Roese, N. E., & Silbert, L. C. (2019). Autoidentification of perivascular spaces in white matter using clinical field strength T1 and FLAIR MR imaging. NeuroImage, 202, 116126.

Specketer K, Zabetian CP, Edwards KL, Tian L, Quinn JF, Peterson-Hiller AL, Chung KA, Hu SC, Montine TJ, Cholerton BA. Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 2019. 41(8): 803-813.

Stasenko, A., Jacobs, D. M., Salmon, D. P., & Gollan, T. H. (2019). The Multilingual Naming Test (MINT) as a Measure of Picture Naming Ability in Alzheimer's Disease. Journal of the International Neuropsychological Society : JINS, 25(8), 821–833.

Sternberg Z, Podolsky R, Nir A, Yu J, Nir R, Halvorsen SW, Chadha K, Quinn JF, Kaye J, Kolb C. Increased free prostate specific antigen serum levels in Alzheimer's disease, correlation with cognitive decline. Journal of Neurological Sciences. 2019. 400:188-193.  

Stuart S, Belluscio V, Quinn JF, Mancini M. Pre-frontal cortical activity during walking and turning Is reliable and differentiates across young, older adults and people with Parkinson's disease. Frontiers in Neurology. 2019. 10:536. PMC6540937.

Sugarman, M. A., McKee, A. C., Stein, T. D., Tripodis, Y., Besser, L. M., Martin, B., Palmisano, J. N., Steinberg, E. G., et al. (2019). Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association, 15(5), 686–698.

Sullivan KJ, Liu A, Dodge HH, Andreescu C, Chang CH, Ganguli M. Depression Symptoms Declining Among Older Adults: Birth Cohort Analyses From the Rust Belt. The American Journal of Geriatric Psychiatry. 2019. [Epub ahead of print].

Teylan, M., Besser, L. M., Crary, J. F., Mock, C., Gauthreaux, K., Thomas, N. M., Chen, Y. C., & Kukull, W. A. (2019). Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer's neuropathology. Laboratory investigation; a journal of technical methods and pathology, 99(7), 1049–1055.

Thomas NWD, Lindauer A, Kaye J. EVALUATE-AD and Tele-STAR: Novel Methodologies for Assessment of Caregiver Burden in a Telehealth Caregiver Intervention - A Case Study. Dementia and Geriatric Cognitive Disorders. 2019. 47(3): 176-184.

Umegaki, H., Makino, T., Uemura, K., Shimada, H., Cheng, X. W., Dodge, H., & Kuzuya, M. (2020). Falls in community-dwelling prefrail older adults. Health & social care in the community, 28(1), 110–115.

van Dyck CH, Nygaard HB, Chen K, Donohue MC, Raman R, Rissman RA, Brewer JB, Koeppe RA, Chow TW, Rafii MS, Gessert D, Choi J, Turner RS, Kaye JA, et al. Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial. JAMA Neurology. 2019. [Epub ahead of print].

Varatharajah Y, Ramanan VK, Iyer R, Vemuri P, Alzheimer's Disease Neuroimaging Initiative. Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics. Scientific Reports. 2019. 9(1): 2235.

Vöglein, J., Paumier, K., Jucker, M., Preische, O., McDade, E., Hassenstab, J., Benzinger, T. L., Noble, J. M., Berman, S. B., et al. Dominantly Inherited Alzheimer Network (2019). Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease. Brain: a journal of neurology, 142(5), 1429–1440.

Wang Y, Haaksma ML, Ramakers I, Verhey FRJ, van de Flier WM, Scheltens P, van Maurik I, Olde Rikkert MGM, Leoutsakos JS, Melis RJF. Cognitive and functional progression of dementia in two longitudinal studies. International Journal of Geriatric Psychiatry. 2019. [Epub ahead of print].   

Werry, A. E., Daniel, M., & Bergström, B. (2019). Group differences in normal neuropsychological test performance for older non-Hispanic White and Black/African American adults. Neuropsychology, 33(8), 1089–1100.

Wiedrick, J. T., Phillips, J. I., Lusardi, T. A., McFarland, T. J., Lind, B., Sandau, U. S., Harrington, C. A., Lapidus, J. A., Galasko, D. R., Quinn, J. F., & Saugstad, J. A. (2019). Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid. Journal of Alzheimer's disease: JAD, 67(3), 875–891.

Wild, K. Mattek, N. Sharma, N. Marcoe, J. Wall, R. Kaye, J. Use of technology by four diverse cohorts of older adults: Findings from the CART study. Innovation in Aging. 2019. 3(Suppl 1): S328. 

Wingo, T. S., Cutler, D. J., Wingo, A. P., Le, N. A., Rabinovici, G. D., Miller, B. L., Lah, J. J., & Levey, A. I. (2019). Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB. JAMA neurology, 76(7), 809–817.

Wise EA, Rosenberg PB, Lyketsos CG, Leoutsakos JM. Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers. Alzheimer’s & Dementia (Amsterdam, Netherlands). 2019. 11:333-339.

Yang Z, Zhuang X, Bird C, Sreenivasan K, Mishra V, Banks S, Cordes D. Performing sparse regularization and dimension reduction simultaneously in multimodal data fusion. Frontiers in Neuroscience. 2019. 13:642.

Yildiz, S., Opel, R. A., Elliott, J. E., Kaye, J., Cao, H., & Lim, M. M. (2019). Categorizing Sleep in Older Adults with Wireless Activity Monitors Using LSTM Neural Networks. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2019, 3368–3372.

Zammit AR, Piccinin AM, Duggan EC, Koval A, Clouston S, Robitaille A, Brown CL, Handschuh P, Wu C, Jarry V, Finkel D, Graham RB, Muniz-Terrera G, Bjork MP, Bennett D, Deeg DJ, Johansson B, Katz MJ, Kaye J, et al. A coordinated multi-study analysis of the longitudinal association between handgrip strength and cognitive function in older adults. The Journals of Gerontology, Series B: Psychological Sciences & Social Sciences. 2019. [Epub ahead of print].

Zhao, Q., Liu, M., Ha, L., Zhou, Y., & Alzheimer's Disease Neuroimaging Initiative (2019). Quantitative 18F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients. Frontiers in neurology, 10, 486.

Zhang X, et al. MetaPred: Meta-Learning for clinical risk prediction with limited patient electronic health records. In: Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining. 2019. 2487-2495.

Zhou X, Chen Y, Mok KY, Kwok TCY, Mok VCT, Guo Q, Ip FC, Chen Y, Mullapudi N, Giusti-Rodriguez P, Sullivan PF, Hardy J, Fu AKY, Li Y, Ip NY, Alzheimer’s Disease Neuroimaging Initiative. Non-coding variability at the APOE locus contributes to the Alzheimer's risk. Nature Communications. 2019. 10(1):3310.

Angel CM, Smith BP, Pinter JM, Young BB, Armstrong NJ, Quinn JP, Brostek DF, Goodrich DE, Hoerster KD et al. Team Red, White & Blue: a community-based model for harnessing positive social networks to enhance enrichment outcomes in military veterans reintegrating to civilian life. Translational Behavioral Medicine. 2018. 8(4):554-564.

The Brainstorm Consortium, Anttila V, Bulik-Sullivan B, Finucane H, Walters R, Bras J, Duncan L, Escott-Price V, Falcone G, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018. 360(6395).

Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, Jicha G, Carlsson C, Burns J, Quinn J et al. Neuropsychology Work Group D, and Clinical Core leaders of the National Institute on Aging-funded US Alzheimer's Disease Centers,. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer's Disease and Associated Disorders. 2018. 32(4):351-358.

Blue E, Bis J, Dorschner M, Tsuang D, Barral S, Beecham G, Below J, Bush W, et al. Genetic variation in genes underlying diverse dementias may explain a small proportion of cases in the Alzheimer's Disease sequencing project. Dementia and Geriatric Cognitive Disorders. 2018. 45(1-2): 1-17. 

Boespflug EL, Iliff JJ. The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-beta, and Sleep. Biological Psychiatry. 2018. 83(4): 328-336. 

Boespflug E, Schwartz D, Lahna D, Pollock J, Iliff J, Kaye J, Rooney W, Silbert L, et al. MR Imaging-based multimodal autoidentification of perivascular spaces (mMAPS): Automated morphologic segmentation of enlarged perivascular spaces at clinical field strength. Radiology. 2018. 286(2): 632-642. 

Boespflug EL, Simon MJ, Leonard E, Grafe M, Woltjer R, Silbert LC, Kaye JA, Iliff JJ. Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement 
Specific to Alzheimer's Disease. 
Journal of Alzheimer's Disease (JAD). 2018. 66(4): 1587 - 1597. 

Bowman GL, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin IC, Henry H, Oikonomidi A, Migliavacca E, et al. Blood-brain barrier breakdown,neuroinflammation, and cognitive decline in older adults. Alzheimer's and Dementia: The Journal of the Alzheimer's Association. 2018. 14(12): 1640-1650.

Brenowitz WD, Han F, Kukull WA, Nelson PT. Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiology of Aging. 2018. 62: 64-71.

Brent RJ. Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Applied Economics. 2018. 50(58): 6327-6340.

Burke SL, Maramaldi P, Cadet T, Kukull W. Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoproteinInternational Journal of Geriatric Psychiatry. 2018. 33(1): 200-211.  

Cholerton B, Johnson C, Fish B, Quinn J, Chung K, Peterson-Hiller A, Rosenthal L, Dawson T, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism & Related Disorders. 2018. 50: 29-36. 

Croff R, Witter P, Walker M, Francois E, Quinn C, Riley T, Sharma N, Kaye J. Things are changing so fast: Integrative technology for preserving cognitive health and community history. The Gerontologist. 2018. [Epub ahead of print].

Dayon L, Nunez Galindo A, Wojcik J, Cominetti O, Corthesy J, Oikonomidi A, Henry H, Kussmann M, Migliavacca E, Severin I, et al.Alzheimer disease pathology and the cerebrospinal fluid proteome. Alzheimer's Research & Therapy. 2018. 10(1): 66.

Duell PB, Salen G, Eichler FS, DeBarber AE, Connor SL, Casaday L, Jayadev S, Kisanuki Y, Lekprasert P, Malloy MJ, et al. Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis. Journal of Clinical Lipidology. 2018. 12(5): 1169-1178.

Gallagher D, Kiss A, Lanctot KL, Herrmann N. Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. The Journal of Clinical Psychiatry. 2018. 80(1): pii: 18m12331.

Goodman JR, Adham ZO, Woltjer RL, Lund AW, Iliff JJ. Characterization of dural sinus-associated lymphatic vasculature in human Alzheimer's dementia subjects. Brain, Behavior and Immunity. 2018. 73:34-40.

Gray NE, Zweig JA, Caruso M, Martin MD, Zhu JY,Quinn JF, Soumyanath A. Centella asiatica increases hippocampal synapticdensity and improves memory and executive function in aged mice. Brain and Behavior. 2018. 8(7): e01024.

Haaksma ML, Calderon-Larranaga A, Olde Rikkert MGM, Melis RJF, Leoutsakos JS. Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. International journal of geriatric psychiatry. 2018. 33(8): 1057-1064.

Huang SY, Hsu JL, Lin KJ, Liu HL, Wey SP, Hsiao IT, Alzheimer's Disease Neuroimaging Initiative. Characteristic patterns ofinter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease. Scientific Reports. 2018. 8(1): 13807.

Kaye J, Reynolds C, Bowman M, Sharma N, Riley T, Austin J, et al. Methodology for establishing a community-wide life laboratory for capturing unobtrusive and continuous remote activity and health data. JoVE. 2018. Forthcoming. PMC in Progress.

Kirson NY, Scott Andrews J, Desai U, King SB, Schonfeld S, Birnbaum HG, Ball DE, Kahle-Wrobleski K. Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. Journal of Alzheimer's Disease: JAD. 2018. 61(1): 295-307.

Kovaleva M, Bilsborough E, Griffiths P, Nocera J, Higgins M, Epps F, Kilgore K, Lindauer A, et al. Testing Tele-Savvy: Protocol for a randomized controlled trial. Research in Nursing & Health. 2018. 41(2): 107-120.

Kolanowski A, Fortinsky RH, Calkins M, Devanand DP, Gould E, Heller T, Hodgson NA, Kales HC, Kaye J, Lyketsos C, et al. Advancing Research on Care Needs and Supportive Approaches for Persons With Dementia: Recommendations and Rationale. Journal of the American Medical Directors Association. 2018. 19(12): 1047-1053. 

Lancour D, Naj A, Mayeux R, Haines J, Pericak-Vance M, Schellenberg G, Crovella M, Farrer L. One for all and all for One: Improving replication of genetic studies through network diffusion. PLoS Genetics. 2018. 14(4):e1007306. 

Leach J, Mancini M, Kaye J, Hayes T, Horak F. Day-to-day variability of postural sway and its association with cognitive function in older adults: A pilot study. Frontiers in Aging Neuroscience. 2018. 10:126.

Lin M, Gong P, Yang T, Ye J, Albin R, Dodge H. Big data analytical approaches to the NACC dataset: Aiding preclinical trial enrichment. Alzheimer's Disease and Associated Disorders. 2018. 32(1): 18-27.

Lindauer A, Croff R, Mincks K, Mattek N, Shofner S, Bouranis N. It took the stress out of gettting help: The Star-Ctelemedicine mixed methods pilot. Care Weekly. 2018. 2:14-17.

Lobach I, Sampson J, Alekseyenko A, Lobach S, Zhang L. Case-control studies of gene-environment interactions. When a case might not be the case. PLoS One. 2018. 13(8): e0201140. 

Lu D, Popuri K, Ding G, Balachandar R, Beg M. Multimodal and multiscale deep neural networks for the early diagnosis of 
Alzheimer's Disease using structural MR and FDG-PET images
. Scientific Reports. 2018. 8(1): 5697.

Lusardi TA, Wiedrick JT, Malone M, Phillips JI,Sandau US, Lind B, Quinn JF, Lapidus JA, Saugstad JA. Analytics of Cerebrospinal Fluid MicroRNA Quantitative PCR Studies. Molecular Neurobiology. 2018. [Epub ahead of print].

Mejia Maza A, Carmen-Orozco RP, Carter ES, Davila-Villacorta DG, Castillo G, Morales JD, Mamani J, Gavidia CM, Alroy J, Sterling CR, et al. Axonal swelling and spheroids: a new insight into the pathology of neurocysticercosis. Brain Pathology. 2018. [Epub ahead of print].

Mitchell JA, Cadet T, Burke S, Williams ED, Alvarez D. The Paradoxical Impact of Companionship on the Mental Health of Older African American Men. The Journals of Gerontology: Series B, Psychological Sciences and Social Sciences. 2018. 73(2): 230-239.

Nguyen MT, Mattek N, Woltjer R, Howieson D, Silbert L, Hofer S, Kaye J, Dodge H, Erten-Lyons D. Pathologies Underlying Longitudinal Cognitive Decline in the Oldest Old. Alzheimer Disease and Associated Disorders. 2018. 32(4): 265-269.  

Opel RA, Christy A, Boespflug EL, Weymann KB, Case B, Pollock JM, Silbert LC, Lim MM. Effects of traumatic brain injury on sleep and enlarged perivascular spaces. Journal of cerebral blood flow and metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 2018. [Epub ahead of print].

Promjunyakul N, Dodge H, Lahna D, Boespflug E, Kaye J, Rooney W, Silbert L. Baseline NAWM structural integrity and CBF predict periventricular WMH expansion over time. Neurology. 2018. 90(24): e2119-e2126. 

Proulx J, Bergen-Cico D, Fleming C, Croff R, Le T, Noorani M, Aldwin C, Oken B. Considerations for research and development of culturally relevant mindfulness interventions in American minority communities. Mindfulness. 2018. 9(2):361-370.

Qian W, Fischer CE, Schweizer TA, Munoz DG. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Current Alzheimer's Research. 2018. 15(2): 187-194.

Qiu S, Chang GH, Panagia M, Gopal DM, Au R, Kolachalama VB. Fusion of deep learning models of MRI scans, Mini-Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment. Alzheimer's & Dementia. 2018. 10: 737-749. 

Quinn J. Lost in translation? Finding our way to effective Alzheimer's Disease therapies. Journal of Alzheimer's Disease. 2018. 64(s1): S33-S39. 

Ramsey C, Gnjidic D, Agogo G, Allore H, Moga D. Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimer's Disease & Dementia: Translational Research & Clinical Interventions. 2018. 4:1-10.

Sano M, Egelko S, Zhu CW, Li C, Donohue MC, Ferris S, Kaye J, Mundt JC, Sun CK, Aisen PS, Feldman HH. Participant satisfaction with dementia prevention research: Results from Home-Based Assessment trial. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2018. 14(11): 1397-1405.

Schilling LP, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, de Mello Rieder CR, Gauthier S, Palmini A, Rosa-NetoP,; Alzheimer's Disease Neuroimaging Initiative. Regional Amyloid-beta Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia. Molecular Neurobiology. 2018. [Epub ahead of print].

Seelye A, Mattek N, Sharma N, Riley T, Austin J, Wild K, Dodge H, Lore E. Weekly observations of online survey metadata obtained through home computer use allow for detection of changes in everyday cognition before transition to mild cognitive impairment. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2018. 14(2): 187-194. 

Silbert L, Lahna D, Promjunyakul N, Boespflug E, Ohya Y, Higashiuesato Y, Nishihira J, Katsumata Y, Tokashiki T, Dodge H. Risk factors associated with cortical thickness and white matter hyper intensities in dementia free Okinawan elderly. Journal of Alzheimer's Disease. 2018. 63(1): 365-372.

Sullivan KJ, Dodge HH, Hughes TF, Chang CH, ZhuX, Liu A, Ganguli M. Declining Incident Dementia Rates Across Four Population-Based Birth Cohorts. The Journals of Gerontology: Series A, Biological Sciences and Medical Sciences. 2018. [Epub ahead of print]. 

Teipel S, Konig A, Hoey J, Kaye J, Kruger F, Robillard J, Kirste T, Babilioni C. Use of non-intrusive sensor-based information and communication technology for real world evidence for clinical trials in dementia. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2018. [Epub ahead of print] 

Thomas N, Mattek N, Riley T, Reynolds C, Austin J, Sharma N, Marcoe J, Kaye J. Using digital biomarkers as objective measures of activity and effort related to caregiving. Neurology. 2018. 90(15 Supplement). P6.195.

Thomas N, Mattek N, Riley T, Witter P, Reynolds C, Austin J, Sharma N, Marcoe J, Kaye J. Establishing digital biomarkers for clinical trials. Neurology. 2018. 90(15 Supplement). P6.181. 

Ting SKS, Foo H, Chia PS, Hameed S, Ng KP, Ng A,Kandiah N. Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. Journal of Neuropsychiatry and Clinical Neurosciences. 2018.  30(1): 31-37. 

Tulloch J, Leong L, Chen S, Keene C, Millard S, Shutes-David A, Lopez O, Kofler J, Kaye J. APOE DNA methylation is altered in Lewy body dementia. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2018. PMC in Progress. 

Wang L, Raskind M, Wilkinson C, Shofer J, Sikkema C, Szot P, Quinn J, Galasko D, Peskind E. Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia. International Journal of Geriatric Psychiatry. 2018. 33(5): 763-768.

Wang Q, Guo L, Thompson PM, Jack CR, Dodge H, Zhan L, Zhou J. The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation 1. Journal of Alzheimer's Disease: JAD. 2018. 64(1): 149-169.  

Wardzala C, Murchison C, Loftis J, Schenning K, Mattek N, Woltjer R, Kaye J, Quinn J, Wilhelm C. Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenarians. Psychopharmacology. 2018. 236(3): 761-770.

Weintraub S, Besser L, Dodge H, Teylan M, Ferris S, Goldstein F, Giordani B, Kramer J, et al. Version 3 of the Alzheimer Disease Centers' neuropsychological test battery in the uniform data set (UDS). Alzheimer's Disease and Associated Disorders. 2018. 32(1):10-17. 

Wood P, Tippireddy S, Feriante J, Woltjer R. Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease. PLOS One. 2018. 13(3):e0191815.

Young AL, Marinescu RV, Oxtoby NP, Bocchetta M,Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI). Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nature Communications. 2018. 9(1): 4273.

Zhang H, Zhu F, Dodge HH, Higgins GA, Omenn GS, Guan Y. A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease. GigaScience. 2018. 7(7).

Zhou HH, Singh V, Johnson SC, Wahba G, Alzheimer's Disease Neuroimaging Initiative. Statistical tests and identifiability conditions for pooling and analyzing multisite datasets. Proceedings of the National Academy of Sciences of the United States of America. 2018. 115(7): 1481-1486.

Asgari M, Kaye JA, Dodge HH. Predicting mild cognitive impairment (MCI) from spontaneous spoken utterances.  Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2017. 3(2): 219-228.

Austin J, Klein K, Mattek N, Kaye J. Variability in medication taking is associated with cognitive performance in 
nondemented older adults
Alzheimer's & Dementia: Diagnosis, Assessment and Disease Monitoring. 2017. 6: 210-213.

Dodge HH, Zhu J, Woltjer R, Nelson PT, Bennett DA, Cairns NJ, Fardo DW, Kaye JA, Lyons DE, Mattek N. et al.  Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease. Alzheimer's and Dementia: The Journal of the Alzheimer's Association. 2017. 13(6): 613-623. 

Franzmeier N, Duering M, Weiner M, Dichgans M, Ewers M, Alzheimer's Disease Neuroimaging Initiative. Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer diseaseNeurology. 2017. 88(11): 1054-1061.  

Gray NE, Zweig JA, Murchison C, Caruso M, Matthews DG, Kawamoto C, Harris CJ, Quinn JF, Soumyanath A. Centella asiatica attenuates Abeta - induced neurodegenerative spine loss and dendritic simplification. Neuroscience Letters. 2017. 646: 24-29.

Harvey PD, Cosentino S, Curiel R, Goldberg TE, Kaye J, Loewenstein D, Marson D, Salmon D, Wesnes K, Posner H. Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease SpectrumInnovations in Clinical Neuroscience. 2017. 14(1-2): 30-39. 

Herrick KS, Woltjer R, Pham T, Chalupsky M, Hiller AL. Central hypoventilation in progressive supranuclear palsyMovement Disorders Clinical Practice. 2017. 4(1): 42-45.

Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK. et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: A retrospective analysisThe Lancet Neurology. 2017. 16(1): 55-65.

Jun GR, Chung J, Mez J, Barber R, Beecham GW, Bennett DA, Buxbaum JD, Byrd GS, Carrasquillo MM, Crane PK. et al. Alzheimer's Disease Genetics Consortium. Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2017. 13(7): 727-738. 

Jutkowitz E, MacLehose RF, Gaugler JE, Dowd B, Kuntz KM, Kane RL. Risk Factors Associated With Cognitive, Functional, and Behavioral Trajectories of Newly Diagnosed Dementia Patients. The Journals of Gerontology: Series A, Biological Sciences and Medical Sciences. 2017. 72(2): 251-258.

Kaye J. Making pervasive computing technology pervasive for health &wellness in agingPublic Policy & Aging Report. 2017. 27(2): 53-61. 

Li G, Shofer JB, Petrie EC, Yu CE, Wilkinson CW, Figlewicz DP, Shutes-David A, Zhang J, Montine TJ, Raskind MA. et al. Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adultsAlzheimers Research & Therapy. 2017. 9(1): 48.

Li K, Chan W, Doody RS, Quinn J, Luo S, Alzheimer's Disease Neuroimaging Initiative. Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data. Journal of Alzheimer's Disease: JAD. 2017. 58(2): 361-371. 

Licking N, Murchison C, Cholerton B, Zabetian C, Hu S, Montine T, Peterson-Hiller A, Chung K, Edwards K, Leverenz J, Quinn F. Homocysteine and cognitive function in Parkinson's disease. Parkinsonism & Related Disorders. 2017. 44:1-5.

Lindauer A, Seelye A, Lyons B, Dodge HH, Mattek N, Mincks K, Kaye J, Erten-Lyons D. Dementia Care Comes Home: Patient and Caregiver Assessment via Telemedicine. The Gerontologist. 2017. 57(5): e85-e93. 

Moga DC, Taipale H, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and FinlandDrugs & Aging. 2017. 34(1): 55-65.

Pottiez G, Yang L, Stewart T, Song N, Aro P, Galasko D, Quinn J, Peskind E, Shi M, Zhang J. A mass spectrometry-based method to quantify in parallel Tau and amyloid beta 1-42 in CSF for the diagnostic of Alzheimer's DiseaseJournal of Proteome Research. 2017. 16(3): 1228 - 1238. 

Proulx J, Croff R, Hebert M, Boise L, Oken B. Results of a Mindfulness Intervention Feasibility Study Among Elder African American Women. Innovation in Aging. 2017. 1(1): 422.

Qian J, Hyman BT, Betensky RA. Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design. JAMA Neurology. 2017. 74(5): 540-548. 

Quinn JF, Licking N, Murchison C, Cholerton, B, et al. Homocysteine and cognitive function in Parkinson's disease. Parkinsonism & Related Disorders. 2017. 44:1-5.

Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS. A phase 3 trial of IV immunoglobulin for Alzheimer diseaseNeurology. 2017. 88(18): 1768-1775.

Ritchie K, Ropacki M, Albala B, Harrison J, Kaye J, Kramer J, Randolph C, Ritchie CW. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia projectAlzheimer's & Dementia: The Journal of the Alzheimer's Association. 2017. 13(2): 186-195. 

Seelye. Weekly observations of online survey metadata obtained through home computer use allow for detection of changes in everyday cognition before transition to mild cognitive impairment. Alzheimer's &Dementia, Forthcoming, 2017. 

Seelye A, Mattek N, Sharma N, Witter P, Brenner A, Wild K, Dodge H, Kaye J. Passive Assessment of Routine Driving with Unobtrusive Sensors: A New Approach for Identifying and Monitoring Functional Level in Normal Aging and Mild Cognitive Impairment. Journal of Alzheimer's Disease. 59(4): 1427-1437.

Sengupta U, Portelius E, Hansson O, Farmer K, Castillo-Carranza D, Woltjer R, Zetterberg H, Galasko D, Blennow K, Kayed R. Tau oligomers in cerebrospinal fluid in Alzheimer's diseaseAnnals of Clinical and Translational Neurology. 2017. 4(4): 226-235.

Singanamalli A, Wang H, Madabhushi A, Alzheimer's Disease Neuroimaging Initiative. Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic FeaturesScientific Reports. 2017. 7: 8137.

Stead A, Kaye J, Dodge H, Wild K, Mattek N, Hallet T, Steiger J. Assessment of everyday conversation and acoustic environments to objectively identify changes in cognition: A proof-of-concept study. Alzheimer's & Dementia: Diagnosis, Assessment and Disease Monitoring. 2017. Online. 

Sternberg Z, Hu Z, Sternberg D, Waseh S, Quinn JF, Wild K, Jeffrey K, Zhao L, Garrick M. Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease. Aging and Disease. 2017. 8(2): 215-227.

Zeppenfeld DM, Simon M, Haswell JD, D'Abreo D, Murchison C, Quinn JF, Grafe MR, Woltjer RL, Kaye J, Iliff JJ. Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging BrainsJAMA Neurology. 2017. 74(1): 91-99.  

Abner E, Nelson P, Kryscio R, Schmitt F, Fardo D, Woltjer R, Cairns N, Yu L, Dodge H, Xiong C, Masaki K, Tyas S, Bennett D, Schneider J, Arvanitakis Z.; Diabetes is Associated with Cerebrovascular but not Alzheimer Neuropathology. Alzheimers and Dementia: The Journal of the Alzheimer's Association. 2016. 12(8): 882-889.

Akl A, Chikhaoui B, Mattek N, Kaye J, Austin D, Mihailidis A.  Clustering Home Activity Distributions for Automatic Detection of Mild Cognitive Impairment in Older Adults. Journal of Ambient Intelligence and Smart Environments. 2016. 8(4): 437-451.

Austin J, Dodge H, Riley T, Jacobs P, Thielke S, Kaye J.  A Smart-Home System to Unobtrusively and Continuously Assess Loneliness in Older Adults. IEEE Journal of Translational Engineering in Health and Medicine. 2016. 4:2800311.

Boise L, Hinton L, Rosen H, Ruhl M.  Will My Soul Go to Heaven if They Take My Brain? Beliefs and Worries About Brain Donation Among Four Ethnic Groups. The Gerontologist. 57(4): 719-734.

Brodaty H., et al.,  ICC-dementia (International Centenarian Consortium - dementia): An International Consortium to Determine the Prevalence and Incidence of Dementia in Centenarians Across Diverse Ethnoracial and Sociocultural Groups. BMC Neurology. 2016. 16(1): 52.

Chapman K, Bing-Canar H, Alosco M, Steinberg E, Martin B,Chaisson C, Kowall N, Tripodis Y, Stern R. Mini Mental State Examination and Logical Memory Scores for Entry into Alzheimer's Disease Trials. Alzheimer's Research and Therapy. 2016. 8:9.

Dinwoodie I. Computational Methods for Asynchronous Basins. Discrete and Continuous Dynamical Systems, Series B. 2016. 21(10): 3391-3405.

Goeres L, Gille A, Furuno J, Erten-Lyons D, Hartung D, Calvert J, Ahmed S, Lee D.  Rural-Urban Differences in Chronic Disease and Drug Utilization in Older Oregonians. Journal of Rural Health. 2016. 32(3): 269-279.

Gray N, Harris C, Quinn J, Soumyanath A. Centella Asiatica Modulatesantioxidant and Mitochondrial Pathways and Improves Cognitive Function in Mice. Journal of Ethnopharmacology. 2016. 180: 78-86.

Hohman T, et al. Discovery of Gene-Gene Interactions Across Multiple Independent Data Sets of Late Onset Alzheimer Disease from the Alzheimer Disease Genetics Consortium. Neurobiology of Aging. 2016. 38:141-150.

Hohman T et al.  Global and Local Ancestry in African-Americans: Implications for Alzheimer's Disease Risk. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 12(3): 233-243.

Insel P, Mattsson N, Mackin R, Scholl M, Nosheny R, Tosun D, Donohue M, Aisen P, Jagust W, Weiner M.  Accelerating Rates of Cognitive Decline and Imaging Markers Associated with beta-amyloid Pathology. Neurology. 2016. 86(20): 1887-1897.

John S, Gurnani A, Bussell C, Saurman J, Griffin J, Gavett B. The Effectiveness and Unique Contribution of Neuropsychological Tests and the Delta Latent Phenotype in the Differential Diagnosis of Dementia in the Uniform Dataset. Neuropsychology. 2016. 30(8): 946-960.

Jun G., et al.,  A Novel Alzheimer Disease Locus Located Near the Gene Encoding Tau Protein. Molecular Psychiatry. 2016. 21(1): 108-117.

Karch C, Ezerskiy LA, Bertelsen S, Goate A.  Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One. 2016. 11(2) :e0148717.

Kryscio R,. et al.,  The Effect of Vascular Neuropathology on Late-Life Cognition: Results from the SMART Project. The Journal of Prevention of Alzheimer's Disease. 2016. 3(2): 85-91.

Lindauer A, Harvath T, Berry P, Wros P.  The Meanings African American Caregivers Ascribeto Dementia-Related Changes: The Paradox of Hanging on to Loss. The Gerontologist. 2016. 56(4): 733-742.

Liu H, Zhou X, Jiang H, He H, Liu X.  A Semi-Mechanism Approach Based on MRI and Proteomics for Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Disease. Scientific Reports. 6: 26712.

Mancini M, Schlueter H, El-Gohary M, Mattek N, Duncan C, Kaye J, Horak F.  Continuous Monitoring of Turning Mobility and Its Association to Falls and Cognitive Function: A Pilot Study. The Journals of Gerontology: Series A, Biological Sciences and Medical Sciences. 2016. 71(8): 1102-1108.

Mazzo F, Zwart R, Serratto G, Gardinier K, Porter W, Reel J, Maraula G, Sher E.  Reconstitution of Synaptic Ion Channels from Rodent and Human Brain in Xenopus Oocytes: a Biochemical and Electrophysiological Characterization. Journal of Neurochemistry. 2016. 138(3): 384-396.

Mez J, et al. The Executive Prominent/memory Prominent Spectrum in Alzheimer's Disease is Highly Heritable. Neurobiology of Aging. 2016. 41:115-121.

Monsell A, Dodge H, Zhou A, Bu Y, Besser L, Mock C, Hawes S, Kukull W, Weintraub A.  Results from the NACC Uniform Data Set Neuropsychological Battery Crosswalk Study. Alzheimer's Disease and Associated Disorders. 2016. 30(2): 134-139.

Nishihira J, Tokashiki T, Higashiuesato Y, Willcox D, Mattek N, Shinto L, Ohya Y, Dodge H.  Associations between Serum Omega-3 Fatty Acid Levels and Cognitive Functions among Community-Dwelling Octogenarians in Okinawa, Japan: The KOCOA Study. Journal of Alzheimer's Disease. 2016. 51(3): 857-866.

Petersen J, Kaye J, Jacobs P, Quinones A, Dodge H, Arnold A, Thielke S.  Longitudinal Relationship Between Loneliness and Social Isolation in Older Adults: Results From the Cardiovascular Health Study. Journal of Aging and Health. 2016. 28(5):775-795.

Promjunyakul N, Lahna D, Kaye J, Dodge H, Erten-Lyons D, Rooney W, Silbert L.  Comparison of Cerebral Blood Flow and Structural Penumbras in Relation to White Matter Hyperintensities: A Multi-Modal Magnetic Resonance Imaging Study. Journal of Cerebral Blood Flow and Metabolism. 2016. 36(9): 1528-1536.

Quinn J.  Gene-Environment Interactions in Dementia-: Not Just Another Fish Story. Neurology. 2016. 86(22): 2069.

Quinn J.  Do Omega-3 Fatty Acids Regulate Cerebral beta Amyloid? JAMA Neurology. 2016. 73(10): 1183-1184.

Rana R, Austin A, Jacobs P, Karunanithi M, Kaye J. Gate Velocity Estimation Using Time-Interleaved Between Consecutive Passive IR Sensor Activations. IEEE Sensors Journal. 2016. 16(16): 6351-6358.

Ridge P, Hoyt K, Boehme K, Mukherjee S, Crane P, Haines J, Mayeux R, Farrer L, Pericak-Vance M, Schellenberg G, Kauwe J. Assessment of the Genetic Variance of Late-Onset Alzheimer's Disease. Neurobiology of Aging. 2016. 41: 200.

Ringman J, et al.,  Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database. Journal of Neuropathology and Experimental Neurology. 2016. 75(3): 284-290.

Ronquillo J, Baer M, Lester W. Sex-Specific Patterns and Differences in Dementia and Alzheimer's Disease Using
Informatics Approaches
. Journal of Women and Aging. 2016. 28(5): 403-411.

Schenning K, Murchison C, Mattek N, Silbert L, Kaye J, Quinn J.  Surgery is Associated with Ventricular Enlargement as Well as Cognitive and Functional Decline. Alzheimer's and Dementia: The Journal of the Alzheimer's Association. 2016.12(5): 590-597.

Seelye A, Mattek N, Howieson D, Austin D, Wild K, Dodge H, Kaye J.  Embedded Online Questionnaire Measures are Sensitive to Identifying Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders. 2016. 30(2):152-159.

Shi M, et al.,  CNS Tau Efflux via Exosomes is Likely Increased in Parkinson's Disease but not in Alzheimer Disease. Alzheimer's and Dementia: The Journal of the Alzheimer's Association. 2016. 12(11): 1125-1131.

Silbert L, Dodge H, Lahna D, Promjunyakul N, Austin D, Mattek N, Erten-Lyons D, Kaye J.  Less Daily Computer Use is Related to Smaller Hippocampal Volumes in Cognitively Intact Elderly. Journal of Alzheimer's Disease. 2016. 52(2): 713-717.

Sundermann E, Biegon A, Rubin L, Lipton R, Mowrey W, Landau S, Maki P. Better Verbal Memory in Women Than Men in MCI Despite Similar Levels of Hippocampal Atrophy. Neurology. 2016. 86(15): 1368-1376.

Teipel S, Babiloni C, Hoey J, Kaye J, Kirste T, Burmeister O.  Information and Communication Technology Solutions for Outdoor Navigation in Dementia. Alzheimers and Dementia: The Journal of the Alzheimer's Association. 2016. 12(6): 695-707.

Wahbeh H, Goodrich E., Oken, B.  Internet Mindfulness Meditation for Cognition andMood in Older Adults: A Pilot Study. Alternative Therapies in Health and Medicine. 2015. 22(2): 44–53.

Yassine H, Rawat V, Mack W, Quinn J, Yurko-Mauro K, Bailey-Hall E, Aisen P, Chui H, Schneider L.  The Effect of APOE Genotype on the Delivery of DHA to Cerebrospinal Fluid in Alzheimer's Disease. Alzheimers Research and Therapy. 2016. 8:25.

Zhu F, Panwar B, Dodge H, Li H, Hampstead B, Albin R, Paulson H, Guan Y.  COMPASS: A Computational Model to Predict Changes in MMSE Scores 24-Months After Initial Assessment of Alzheimer's Disease. Scientific Reports. 2016. 6: 34567.

Abner, E., et al., The Statistical Modeling of Aging and Risk of Transition Project: Data Collection and Harmonization Across 11 Longitudinal Cohort Studies of Aging, Cognition, and Dementia. Observational Studies. 2015. 1(2015): 56-73.

Akl A, Taati B, & Mihailidis A. Autonomous Unobtrusive Detection of Mild Cognitive Impairment in Older Adults. IEEE Transactions on Bio-Medical Engineering. 2015. 62(5): 1383–1394.

Albers M., et al., At the Interface of Sensory and Motor Dysfunctions and Alzheimer's Disease. Alzheimer's and Dementia: The Journal of the Alzheimer's Association. 2015. 11(1): 70-98.

Allen M, Kachadoorian M, Quicksall Z, et al. Convergent genetic and expression data implicate immunity in Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association. 2015. 11(6): 658-71.

Apostolova L, et al., Brain Amyloidosis Ascertainment from Cognitive, Imaging, and Peripheral Blood Protein Measures. Neurology. 2015. 84(7): 729-737.

Austin D, Dinwoodie I. Monomials and Basin Cylinders for Network Dynamics. SIAM Journal on Applied Dynamical Systems. 2015. 14(1): 25-42.

Austin J, Kaye J, Austin D, Mattek N. Time Out-of-Home and Cognitive, Physical, and Emotional Wellbeing of Older Adults: A Longitudinal Mixed Effects Model. PLoS One.2015.10(10):e0139643.

Brendel M, Hogenauer M, Delker A, Sauerbeck J, Bartenstein P, Seibyl J, Rominger A,. Improved Longitudinal [(18)F]-AV45 Amyloid PET by White Matter Reference and VOI-Based Partial Volume Effect Correction. NeuroImage.2015.108:450-459.

Caroli A,. et al., Mild Cognitive Impairment with Suspected Nonamyloid Pathology (SNAP): Prediction of Progression. Neurology. 2015.84(5): 508-515.

Chamine, I., & Oken, B. S. Expectancy of Stress-Reducing Aromatherapy Effect and Performance on a Stress-Sensitive Cognitive Task. Evidence-Based Complementary and Alternative Medicine: eCAM. 2015.419812.

Chung E, Babulal G, Monsell S, Cairns N, Roe C, Morris J. Clinical Features of Alzheimer Disease With and Without Lewy Bodies. JAMA Neurology. 72(7): 789-796.

Dodge H, Kaye J, Mattek N, Bowman M, Gregor M, Ybarra' O, Wild K. Web-Enabled Conversational Interactions as a Means to Improve Cognitive Functions: Results of a 6-Week Randomized Controlled Trial. Alzheimer's & Dementia: Translational Research & Clinical Interventions.2015.1(1):1-12.

Dodge H, MattekN, Gregor M, Bowman M, Seelye A, Ybarra O, Asgari M, Kaye J. Social Markers of Mild Cognitive Impairment: Proportion of Word Counts in Free Conversational Speech. Current Alzheimer Research.2015.12(6):513-519.

Dodge H, Zhu J, Mattek N, Austin D, Kornfeld J, Kaye J. Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials. PLoS One.2015. 10(9): e0138095.

Erten-Lyons D, Silbert L. Depressive Symptoms are Associated with Late Life Cognitive Decline Independent of Common age-Related Pathologies. Evidence-Based Mental Health. 2015.18(2): 50.

Favela J, Kaye J, Skubic M, Rantz M, Tentori M. Living Labs for Pervasive Healthcare Research. IEEE Pervasive Computing. 2015.14(2): 86-89.

Frisoni, G. et al., The EADC-ADNI Harmonized Protocol for Hippocampal Segmentation on Magnetic Resonance: Evidence of Validity.Alzheimer's and Dementia : The Journal of the Alzheimer's Association. 2015. 11(2):111-125.

Gray N, Sampath H, Zweig J, Quinn J, Soumyanath A. Centella asiatica Attenuates Amyloid-beta-Induced Oxidative Stress and Mitochondrial Dysfunction. Journal of Alzheimer's Disease. 2015. 45(3): 933-946.

Hibar D., et al., Common Genetic Variants Influence Human Subcortical Brain Structures. Nature.2015.520(7546):224-229.

Howieson D, Mattek N, Dodge H, Erten-Lyons D, Zitzelberger T, Kaye J. Memory Complaints in the Older Adults:Prognostic Value and Stability in Reporting Over Time. SAGE Open Medicine. 2015. 3.

Jacobs P, Kaye J. Ubiquitous Real-World Sensing and Audiology-Based Health Informatics. Journal of theAmerican Academy ofAudiology. 2015. 26(9):777-783.

Jones L., et al., Convergent Genetic and Expression DataImplicate Immunity in Alzheimer's Disease. Alzheimer's and Dementia: The Journal of the Alzheimer's Association. 2015. 11(6): 658-671.

Li G, Xiong K, Korff A, Pan C, Quinn J, Galasko D, Liu C, Montine T, Peskind E, Zhang J. Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Abeta42 and Tau. Journal of Alzheimer's Disease.2015.47 (2015): 883-887.

Lunsford R, Heeman P. Using Linguistic Indicators of Difficulty to Identify Mild Cognitive Impairment. 16th Annual Conference of the International Speech Communication Association, INTERSPEECH. 2015. 658-662.

Lyons B, Austin D, Seelye A, Petersen J, Yeargers J, Riley T, Sharma N, Mattek N, Wild K, Dodge H, Kaye J. Pervasive Computing Technologies to Continuously Assess Alzheimer's Disease Progression and Intervention Efficacy. Frontiers inAging Neuroscience.2015. 7:102.

Mattsson N, Insel P, Aisen P, Jagust W, Mackin S, Weiner M. Brain Structure and Function as Mediators of the Effects of Amyloid on Memory. Neurology. 2015.84(11): 1136-1144.

Osterberg V, Spinelli K, Weston L, Luk K, Woltjer R, Unni V. Progressive Aggregation of Alpha-Synuclein and Selective Degeneration of Lewy Inclusion-Bearing Neurons in a Mouse Model of Parkinsonism. Cell Reports.2015.10(8):1252-1260.

Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J. Diagnostic Values of Cerebrospinal Fluid T-Tau and Abeta(4)(2) using Meso Scale Discovery Assays for Alzheimer's Disease. Journal of Alzheimer's Disease. 2015. 45(3): 709-719.

Petersen J, Thielke S, Austin D, Kaye J. Phone Behavior and its Relationship to Loneliness in Older Adults. Aging and Mental Health. 2015. 20(10): 1084-1091.

Promjunyakul N, Lahna D, Kaye J, Dodge H, Erten-Lyons D, Rooney W, Silbert L. Characterizing the White Matter Hyperintensity Penumbra with Cerebral Blood Flow Measures. NeuroImage: Clinical.2015.8: 224-229.

Quinn J.,etal., Extracellular RNAs: Development as Biomarkers of Human Disease. JournalofExtracellular Vesicles. 2015. 4: 27495.

Romero K,.et al., The Future is Now: Model-Based Clinical Trial Design for Alzheimer's Disease. Clinical Pharmacology andTherapeutics. 2015.97(3):210-214.

Sachdev P,.et al., The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration. PLoS One.2015. 10(11):e0142388.

Schreiber S, Landau S, Fero A, Schreiber F, Jagust W. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes. JAMA Neurology.2015.72(10):1183-1190.

Seelye A, Mattek N, Howieson D, Riley T, Wild K, Kaye J. The Impact of Sleep on Neuropsychological Performance in Cognitively Intact Older Adults Using a Novel In-Home Sensor-Based Sleep Assessment Approach. The Clinical Neuropsychologist. 2015. 29(1): 53-66.

Seelye A, Mattek N, Kaye J, Wild K, Howieson H, Dodge H, Hagler S. Computer Mouse Movement Patterns: A Potential Marker of Mild Cognitive Impairment. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2015. 1(4): 472-480.

Wang L, et al., Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States. JAMA Neurology.2015.72(2):209-216.

Wild K, Mattek N, Austin D, Kaye J. Are you sure?: Lapses in Self-Reported Activities Among Healthy Older Adults Reporting Online. Journal of Applied Gerontology. 2015. 35 (6): 627-641.

Wood P, Barnette B, Kaye J, Quinn J, Woltjer R. Non-Targeted Lipidomics of CSF and Frontal Cortex Grey and White Matter in Control, Mild Cognitive Impairment, and Alzheimer's Disease Subjects. Acta Neuropsychiatra. 2015. 27(5): 270-278.

Wood P, Medicherla S, Sheikh N, Terry B, Phillipps A, Kaye J, Quinn J, Woltjer R. Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease. Journal of Alzheimer's Disease.2015.48(2):537-546.

Allen M, Kachadoorian M, Quicksall Z, et al. Association of MAPT Haplotypes with Alzheimer's Disease Risk and MAPT Brain Gene Expression Levels. Alzheimer's Research and Therapy. 2014. 6:39.

Anderson V, Obayashi J, Kaye J, Quinn J, Berryhill P, Riccelli L, Peterson D, Rooney, W. Longitudinal Relaxographic Imaging of White Matter Hyperintensities in the Elderly. Fluids and Barriers of the CNS. 2014. 11: 24.

Austin D, Cross R, Hayes T, Kaye J. Regularity and Predictability of Human Mobility in Personal Space. PLoS One. 2014. 9(2): e90256.

Boise L. Ethnicity and Dementia. In: Downs M, Bowers B, eds. Excellence in Dementia Care: Research into practice, 2nd edition. Berkshire, England: McGraw Hill, 2014.

Davis M, Currey J, Howk S, DeSordi M, Boise L, Fagnan L, Vuckovic N. A Qualitative Study of Rural Primary Care Clinician Views on Remote Monitoring Technologies. The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association.2014.30(1):10.1111.

Davis M, Freeman M, Kaye J, Vuckovic N, Buckley D. A Systematic Review of Clinician and Staff Views on the Acceptability of Incorporating Remote Monitoring Technology into Primary Care. Telemed JournalandE-Health.2014. 20(5): 428-438.

Dodge H, Katsumata Y, Zhu J, Mattek N, Bowman B, Gregor B, Wild K, Kaye J. Characteristics Associated with Willingness to Participate in a Randomized Controlled Behavioral Clinical Trial using Home-Based Personal Computers and a Webcam. Trials.2014.15:508.

Dodge H, Zhu J, Harvey D, Saito N, Silbert L, Kaye J, Koeppe R, Albin R. Biomarker Progressions Explain Higher Variability in Stage-Specific Cognitive Decline than Baseline Values in Alzheimer Disease. Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association.2014.10(6): 690-703.

Dodge H, Ybarra O, Kaye J. Tools for Advancing Research into Social Networks and Cognitive Function in Older Adults. International Psychogeriatrics.2014. 26(4): 533-539.

Dodge H, Zhu J, Lee C, Chang C, Ganguli M. Cohort Effects in Age-Associated Cognitive Trajectories. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences.2014.69(6):687-694.

Hagler S, Jimison H, Pavel M. Assessing executive function using a computer game: Computational modeling of 
cognitive processes
. IEEE Journal of Biomedical and Health Informatics. 2014. 18(4): 1442-1452.

Escott-Price V, et al., Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease. PLoS One.2014.9(6):e94661.

Fonareva I, Oken BS. Physiological and Functional Consequences of Caregiving for Relatives with Dementia. International Psychogeriatrics.2014. 26(5): 725-747.

Frisoni G, et al., The EADC-ADNI Harmonized Protocol for Manual Hippocampal Segmentation on Magnetic Resonance: Evidence of Validity. Alzheimer's and Dementia:The Journalof theAlzheimer'sAssociation. 2014. Epub. Sep. 27.

Gallagher M,etal., TMEM106B is a Genetic Modifier of Frontotemporal Lobar Degeneration with C9orf72 Hexanucleotide Repeat Expansions. Acta Neuropathologica. 2014. 127(3): 407-418.

Gray N, Morre J, Kelley J, Maier C, Stevens J, Quinn J, Soumyanath A. Caffeoylquinic Acids in Centella Asiatica Protect Against Amyloid-beta Toxicity. Journal of Alzheimer's Disease. 2014. 40(2): 359-373.

Harris C, Voss K, Murchison C, Ralle M, Frahler K, Carter R, Rhoads A, Lind B, Robinson E, Quinn J. Oral Zinc Reduces Amyloid Burden in Tg2576 Mice. Journal of Alzheimer's Disease. 2014. 41(1): 179-192.

Harrison F, Bowman G, Polidori M. Ascorbic Acid and the Brain: Rationale for the Use against Cognitive Decline. Nutrients. 2014. 6(4): 1752-1781.

Hill-Burns E, Wissemann W, Hamza T, Factor S, Zabetian C, Payami H. Identification of a Novel Parkinson's Disease Locus via Stratified Genome-Wide Association Study. BMC Genomics.2014.Feb10(15):118.

Jacobs P, Wan E, Schafermeyer E, Adenwala F, Paul A, Preiser N, Kaye J. Measuring In-Home Walking Speed using Wall-Mounted RF Transceiver Arrays. Engineering in Medicine and Biology Society (EMBC), 2014 36th Annual International Conference of the IEEE. 2014.Aug. 2014: 914-917.

Kaye J, Mattek N, Dodge H, Campbell I, Hayes T, Austin D, Hatt W, Wild K, Jimison H, Pavel M. Unobtrusive Measurement of Daily Computer Use to Detect Mild Cognitive Impairment. Alzheimer's and Dementia:The Journalof theAlzheimer'sAssociation.2014. 10(1): 10-17.

Kilgour A, Todd O, Starr J. A Systematic Review of the Evidence that Brain Structure is Related to Muscle Structure and Their Relationship to Brain and Muscle Function in Humans over the Lifecourse. BMC Geriatrics. 2014. 14: 85.

Li G. et al., Cross-Sectional and Longitudinal Relationships Between Cerebrospinal Fluid Biomarkers and Cognitive Function in People Without Cognitive Impairment from Across the Adult Life Span. JAMA Neurology. 2014. 71(6): 742-751.

Linnertz C, et al., The Cis-Regulatory Effect of an Alzheimer's Disease-Associated Poly-T Locus on Expression of TOMM40 and Apolipoprotein E Genes. Alzheimer's and Dementia: The Journal of the Alzheimer's Association. 2014. 10(5): 541-551.

Miller L, Dieckmann N, Mattek N, Lyons K, Kaye J. Social Activity Decreases Risk of Placement in a Long-Term Care Facility for a Prospective Sample of Community-Dwelling Older Adults. Research inGerontological Nursing.2014. 7(3): 106-112.

Naj A,etal., Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease:A Genome-Wide Association Study. JAMA Neurology. 2014. 71 (11): 1394-1404.

Nelson J, Young J, Borkar R, Woltjer R, Quinn J, Silbert L, Grafe M, Alkayed N. Role of Soluble Epoxide Hydrolase in Age-Related Vascular Cognitive Decline. Prostaglandins and Other Lipid Mediators. 2014.113-115: 30-37.

Peskind E, Li G, Shofer J, Millard S, Leverenz J, Yu C, Raskind M, Quinn J, Galasko D, Montine T. Influence of Lifestyle Modifications on Age-Related Free Radical Injury to Brain.JAMA Neurology. 2014. 71(9):1150-1154.

Petersen J, Austin D, Kaye J, Pavel M, Hayes T. Unobtrusive In-Home Detection of Time Spent Out-of-Home with Applications to Loneliness and Physical Activity. IEEE Journal of Biomedical and Health Informatics. 2014. 18(5):1590-1596.

Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J. A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer's Disease. Journal of Alzheimer's Disease.2014.38(1):111-120.

Stark A, Shafran I, Kaye J. Inferring Social Nature of Conversations from Words:Experiments on a Corpous of Everyday Telephone Conversations. Computer Speech and Language. 2014. 28(1): 224-239.

Thielke S, Mattek N, Hayes T, Dodge H, Quinones A, Austin D, Petersen J, Kaye J. Associations Between Observed In-Home Behaviors and Self-Reported Low Mood in Community-Dwelling Older Adults. Journal of the American Geriatrics Society. 2014.62 (4): 685-689.

Wang L,et al. Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States. JAMA Neurology. 2014.72(2): 209-16.

Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C,Pulko V, Currier NL, Nikolich-Zugich D, Kaye J, Nikolich-Zugich J. Aging and Cytomegalovirus Infection Differentially and Jointly Affect Distinct Circulating T Cell Subsets in Humans. Journal of Immunology. 2014. 192 (5): 2143-2155.

Wild K, Musser E. The Cambridge Neuropsychological Test Automated Battery in the Assessment of Executive Functioning. Handbook of Executive Functioning: Springer. 2014: 171-190.

Beattie ZT, Hayes TL, Guilleminault C, Hagen CC. Accurate scoring of the apnea-hypopnea index using a simple non-contact breathing sensor. Journal of Sleep Research 22:356-362, 2013.  PMC3641178.

Boise L, Wild K, Mattek N, Ruhl M, Dodge H, Kaye J. Willingness to share data and privacy concerns of Older Adults after exposure to unobtrusive In-home Monitoring. Gerontechnology 11:428-435, 2013.  PMC3604979.

Bowman G, Dodge H, Mattek N, Barbey A, Silbert L, Shinto L, Howieson D, Kaye J, Quinn J. Plasma omega 3 PUFA and white matter mediated executive decline in older adults.  . Frontiers in Aging Neuroscience 5, 2013.  PMC3863786.

Davis M, Freeman M, Kaye J, Vuckovic N, Buckley D. A systematic review of clinician and staff views of the acceptability and feasibility of incorporating remote monitoring technologies into primary care. Telemedicine and e-Health, Forthcoming, 2013.
Dodge H, Ybara O, Kaye J. Tools for advancing research into social networks and cognitive functions in older adults. International Psychogeriatrics International Psychogeriatrics 23:1-7, 2013.

Eskildsen SF, Coupe P, Garcia-Lorenzo D, Fonov V, Pruessner JC, Collins DL. Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning. Neuroimage 65:511-521, 2013.   

Fjell A, McEvoy L, Holland D, Dale A, Walhovd K. Brain changes in older adults at very low risk for Alzheimer's disease. Journal of Neuroscience 33:8237-8242, 2013.  PMC3570420
Fonareva I, Oken B. Physiological and functional consequences of caregiving for relatives with dementia. International Psychogeriatrics. International Psychogeriatrics, Forthcoming, 2013.

Frisoni G, Bocchetta M, Chételat G, Rabinovici G, de Leon M, Kaye J, Reiman E, Scheltens P, Barkhof F, Black S, Brooks D, Carrillo M, Fox N, Herholz K, Nordberg A, Jack C, Jagust W, Johnson K, Rowe C, Sperling R, Thies W, Wahlund L, Weiner M, Pasqualetti P, DeCarli C. Imaging Markers for Alzheimer’s Disease: Which versus How. Neurology 81:5, 2013.  PMC3776529.

Gray KR, Aljabar P, Heckemann RA, Hammers A, Rueckert D. Random forest-based similarity measures for multi-modal classification of Alzheimer's disease. Neuroimage 65:167-175, 2013.  PMC3516432.
Hayes T, Riley T, Mattek N, Pavel M, Kaye J. Sleep Habits in Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders, Forthcoming, 2013.

Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, Diedrich A, Green S, Tran H, Reese L, Woltjer RL, Hayflick SJ. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology 80:268-275, 2013.  PMC3589182.

Holton P, Ryten M, Nalls M, Trabzuni D, Weale ME, Hernandez D, Crehan H, Gibbs JR, Mayeux R, Haines JL, Farrer LA, Pericak-Vance MA, Schellenberg GD, Ramirez-Restrepo M, Engel A, Myers AJ, Corneveaux JJ, Huentelman MJ, Dillman A, Cookson MR, Reiman EM, Singleton A, Hardy J, Guerreiro R, Apostolova LG, Arnold SE, Baldwin CT, Barber R, Barmada MM, Beach TG, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Burke JR, Buros J, Buxbaum JD, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carrasquillo MM, Carroll SL, Chui HC, Clark DG, Cotman CW, Crane PK, Crocco EA, Cruchaga C, Cummings JL, De Jager PL, DeCarli C, DeKosky ST, Demirci FY, Diaz-Arrastia R, Dick M, Dickson DW, Duara R, Ellis WG, Ertekin-Taner N, Evans D, Faber KM, Fallon KB, Farlow MR, Ferris S, Foroud TM, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Goate AM, Graff-Radford NR, Green RC, Growdon JH, Hakonarson H, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jarvik GP, Jicha GA, Jin LW, Jun G, Kamboh MI, Karlawish J, Karydas A, Kauwe JS, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer P, Kukull WA, Lah JJ, Larson EB, Levey AI, Lieberman AP, Lopez OL, Lunetta KL, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Naj AC, Nowotny P, Parisi JE, Peskind E, Petersen RC, Poon WW, Potter H, Quinn JF, Raj A, Rajbhandary RA, Raskind M, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rogaeva E, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Shelanski ML, Smith CD, Sonnen JA, Spina S, St George-Hyslop P, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Tsuang DW, Valladares O, Van Deerlin VM, Vardarajan BN, Vinters HV, Vonsattel JP, Wang LS, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Wright CB, Younkin SG. Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci. Ann Hum Genet 77:85-105, 2013.  PMC3578142.

Huckans M, Hutson L, Twamley E, Jak A, Kaye J, Storzbach D. Efficacy of Cognitive Rehabilitation Therapies for Mild Cognitive Impairment (MCI) in Older Adults: Working Toward a Theoretical Model and Evidence-Based Interventions. Neuropsychol Rev 23:63-80, 2013.  PMC3640648.

Katsumata Y, Todoriki H, Higashiuesato Y, Yasura S, Ohya Y, Willcox DC, Dodge HH. Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA Project. Journal of Alzheimer's Disease 34:273-279, 2013.  PMC3586553.

Kaye J, Dodge H, Hayes T, Mattek N, Howieson D, Austin D, H J, Pavel M. Person-specific change in home computer use predicts the development of mild cognitive impairment (MCI). In: AAIC, 2013.

Klein EP, Kaye J. Dementia specialists and early adoption of amyloid imaging. Journal of Alzheimer's Disease 33:445-450, 2013.  PMC3640311.

Kurtz T, Mogle J, Sliwinski MJ, Hofer SM. Individual differences in task-specific paired associates learning in older adults: the role of processing speed and working memory. Exp Aging Res 39:493-514, 2013.  PMC3891359.

Linnertz C, Anderson L, Gottschalk W, Crenshaw D, Lutz M, Allen J, Saith S, Mihovilovic M, Burke J, Welsh-Bohmer K, Roses A, Chiba-Falek O. The cis-regulatory effect of an Alzheimer’s disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes. Alzheimer's and Dementia, Forthcoming, 2013.

Liu Y, Mattila J, Ruiz MA, Paajanen T, Koikkalainen J, van Gils M, Herukka SK, Waldemar G, Lotjonen J, Soininen H. Predicting AD conversion: comparison between prodromal AD guidelines and computer assisted PredictAD tool. PLoS One 8:e55246, 2013.  PMC3570420.

Martinez-Murcia FJ, Gorriz JM, Ramirez J, Puntonet CG, Illan IA. Functional activity maps based on significance measures and Independent Component Analysis. Comput Methods Programs Biomed 111:255-268, 2013.

Millard SP, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang D, Yu CE, Peskind ER, Bekris LM. Association of cerebrospinal fluid Abeta with A2M gene in cognitively normal subjects. Neurobiology of Aging, 2013.  PMC3859300.

Miller JA, Woltjer RL, Goodenbour JM, Horvath S, Geschwind DH. Genes and pathways underlying regional and cell type changes in Alzheimer's disease. Genome Med 5:48, 2013.  PMC3706780.

Miyashita A, Koike A, Jun G, Wang LS, Takahashi S, Matsubara E, Kawarabayashi T, Shoji M, Tomita N, Arai H, Asada T, Harigaya Y, Ikeda M, Amari M, Hanyu H, Higuchi S, Ikeuchi T, Nishizawa M, Suga M, Kawase Y, Akatsu H, Kosaka K, Yamamoto T, Imagawa M, Hamaguchi T, Yamada M, Moriaha T, Takeda M, Takao T, Nakata K, Fujisawa Y, Sasaki K, Watanabe K, Nakashima K, Urakami K, Ooya T, Takahashi M, Yuzuriha T, Serikawa K, Yoshimoto S, Nakagawa R, Kim JW, Ki CS, Won HH, Na DL, Seo SW, Mook-Jung I, St George-Hyslop P, Mayeux R, Haines JL, Pericak-Vance MA, Yoshida M, Nishida N, Tokunaga K, Yamamoto K, Tsuji S, Kanazawa I, Ihara Y, Schellenberg GD, Farrer LA, Kuwano R. SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One 8:e58618, 2013.  PMC3614978.

Nation D, Edland S, Bondi M, Salmon D, Delano-Wood L, Peskind E, Quinn J, Galasko D. Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults? Neurology 81:2024-2027, 2013.  PMC3854831.

Nikolich-Zugich J, Bennett M, Park B, Currier N, Uhrlaub J, Vesnam P, Martinez C, Kaye J, Wertheimer A. Aging and cytomegalovirus (CMV) infection differentially and jointly affect distinct circulating T cell subsets in humans. Journal of Immunology, Forthcoming, 2013. 

Pavel M, Jimison HB, Wactlar HD, Hayes TL, Barkis W, Skapik J, Kaye J. The role of technology and engineering models in transforming healthcare. IEEE Rev Biomed Eng 6:156-177, 2013.

Petersen J, Austin D, Kaye J, Pavel M, Hayes T. Unobtrusive in-home detection of time spent out-of-home with applications to loneliness and physical activity. IEEE Journal of Biomedical and Health Informatics, Forthcoming, 2013.

Quinn JF. Biomarkers for Alzheimer's disease: showing the way or leading us astray? Journal of Alzheimer's Disease 33:S371-376, 2013.  PMC3587291.

Rajagopalan P, Toga AW, Jack CR, Weiner MW, Thompson PM. Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly. NeuroReport 24:58-62, 2013.  PMC3635486.

Ramaker JM, Swanson TL, Copenhaver PF. Amyloid precursor proteins interact with the heterotrimeric G protein Go in the control of neuronal migration. J Neurosci 33:10165-10181, 2013.  3682380.

Rana R, Austin D, Jacobs P, Karunanithi M, Kaye J. Passive In-home Estimation of Gait Velocity From Motion Sensors. Forthcoming, 2013. 

Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue M, Baldwin CT, Green RC, Barnes LL, Cantwell LB, Fallin MD, Go RC, Griffith P, Obisesan TO, Manly JJ, Lunetta KL, Kamboh MI, Lopez OL, Bennett DA, Hendrie H, Hall KS, Goate AM, Byrd GS, Kukull WA, Foroud TM, Haines JL, Farrer LA, Pericak-Vance MA, Schellenberg GD, Mayeux R. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4,and the risk of late-onset Alzheimer disease in African Americans. JAMA: The Journal of the American Medical Association 309:1483-1492, 2013.  PMC3667653.

Reitz C, Mayeux R. TREM2 and neurodegenerative disease. N Engl J Med 369:1564-1565, 2013.

Reitz C, Tosto G, Vardarajan B, Rogaeva E, Ghani M, Rogers RS, Conrad C, Haines JL, Pericak-Vance MA, Fallin MD, Foroud T, Farrer LA, Schellenberg GD, George-Hyslop PS, Mayeux R. Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP). Translational Psychiatry 3:e256, 2013.  PMC3669917.

Ridge P, Mukherjee S, Crane P, Kauwe J, Consortium AsDG. Alzheimer's disease: Analyzing the missing heritability. PLoS One, Forthcoming, 2013.

Rosso AL, Studenski SA, Chen WG, Aizenstein HJ, Alexander NB, Bennett DA, Black SE, Camicioli R, Carlson MC, Ferrucci L, Guralnik JM, Hausdorff JM, Kaye J, Launer LJ, Lipsitz LA, Verghese J, Rosano C. Aging, the central nervous system, and mobility. J Gerontol A Biol Sci Med Sci 68:1379-1386, 2013.  PMC3805295.

Scimemi A, Meabon JS, Woltjer RL, Sullivan JM, Diamond JS, Cook DG. Amyloid-beta1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1. J Neurosci 33:5312-5318, 2013.

Tong T, Wolz R, Coupe P, Hajnal JV, Rueckert D. Segmentation of MR images via discriminative dictionary learning and sparse coding: application to hippocampus labeling. Neuroimage 76:11-23, 2013.

Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP. APOE 4 Increases Risk for Dementia in Pure Synucleinopathies. JAMA Neurol 70:223-228, 2013.  PMC3580799.

Umegaki H, Takechi H, Dodge HH. Care for Alzheimer's Disease. Int J Alzheimers Dis 2013:516852, 2013.  PMC3654367.

Wild K, Mattek N, Stone B, Kaye J. Self-reported activity in older adults: Challenges and innovations. In: Alzheimer Association International Conference. July ed. Boston, MA: Alzheimer's & Dementia, 2013: P342.

Wu X, Li J, Ayutyanont N, Protas H, Jagust W, Fleisher A, Reiman E, Yao L, Chen K. The receiver operational characteristic for binary classification with multiple indices and its application to the neuroimaging study of Alzheimer's disease. IEEE/ACM Trans Comput Biol Bioinform 10:173-180, 2013.

Wyman BT, Harvey DJ, Crawford K, Bernstein MA, Carmichael O, Cole PE, Crane PK, DeCarli C, Fox NC, Gunter JL, Hill D, Killiany RJ, Pachai C, Schwarz AJ, Schuff N, Senjem ML, Suhy J, Thompson PM, Weiner M, Jack CR, Jr. Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimers Dement 9:332-337, 2013.

Aggarwal NT, Tripathi M, Dodge HH, Alladi S, Anstey KJ. Trends in Alzheimer's disease and dementia in the asian-pacific region. Interntational Journal of Alzheimers Disease 2012:171327, 2012.  PMC3523465.

Anderson V, Lenar D, Berryhill P, Quinn J, Kaye J, Rooney W. Quantitative 7T detection of gadoteridol in the ventricles of the aging human brain Proceedings of the International Society for Magentic Resonane in Medicine 20:3760, 2012.  PMC Journal in Process.

Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A 109:3985-3990, 2012.  PMC3309762.

Bekris L, Lutz F, Li G, Galasko D, Farlow M, Quinn J, Kaye J, Leverenz J, Tsuang D, Montine T, Peskind E, Yu C. ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiology of Aging 33:2229e2221-2229e2229, 2012.  PMC3391324.

Bekris LM, Millard S, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Yu CE, Peskind ER. Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 159B:874-883, 2012.

Bjorklund NL, Reese LC, Sadagoparamanujam VM, Ghirardi V, Woltjer RL, Taglialatela G. Absence of amyloid beta oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology. Mol Neurodegener 7:23, 2012.  PMC3403985.

Bonner-Jackson A, Okonkwo O, Tremont G, Initiative AsDN. Apolipoprotein E epsilon2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 20:584-593, 2012.  PMC3188382.

Bowman GL. Ascorbic acid, cognitive function, and Alzheimer's disease: A current review and future direction. Biofactors 38:114-122, 2012.

Bowman GL, Kaye JA, Quinn JF. Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease. Curr Gerontol Geriatr Res 2012:184042, 2012.  PMC3359662.

Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology 78:241-249, 2012.  PMC3280054.

Chu C, Hsu AL, Chou KH, Bandettini P, Lin C. Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images. Neuroimage 60:59-70, 2012.

Damoiseaux JS, Seeley WW, Zhou J, Shirer WR, Coppola G, Karydas A, Rosen HJ, Miller BL, Kramer JH, Greicius MD. Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. Journal of Neuroscience 32:8254-8262, 2012.  PMC3394933.

Desikan RS, McEvoy LK, Thompson WK, Holland D, Brewer JB, Aisen PS, Sperling RA, Dale AM. Amyloid-beta--associated clinical decline occurs only in the presence of elevated P-tau. Archives of Neurology 69:709-713, 2012.  PMC3423526.

Dodge HH, Mattek NC, Austin D, Hayes TL, Kaye JA. In-home walking speeds and variability trajectories associated with Mild Cognitive Impairment. Neurology 78:1946-1952, 2012.  PMC3369505.

Erten-Lyons D, Dodge H, Woltjer R, Silbert L, Howieson D, Kramer P, Kaye J. Neuropathological Basis of Age-Associated Brain Atrophy. Archives of Neurology, Forthcoming, 2012.  NIHMS#440270.

Erten-Lyons D, Sherbakov LO, Piccinin AM, Hofer SM, Dodge HH, Quinn JF, Woltjer RL, Kramer PL, Kaye JA. Review of selected databases of longitudinal aging studies. Alzheimers and Dementia 8:584-589, 2012.  PMC3483563.

Fonareva I, Amen A, Ellison R, Oken B. Differences in stress-related ratings between research center and home environments in dementia caregivers using ecological momentary assessment. International Psychogeriatrics 24:90-98, 2012.  PMC3353126.

Fried-Oken M, Rowland C, Daniels D, Dixon M, Fuller B, Mills C, Noethe G, Small J, Still K, Oken B. AAC to Support Conversation in Persons with Moderate Alzheimer's Disease. Augment Altern Commun 28:219-231, 2012.

Gagyi E, Kormos B, Castellanos KJ, Valyi-Nagy K, Korneff D, LoPresti P, Woltjer R, Valyi-Nagy T. Decreased oligodendrocyte nuclear diameter in Alzheimer's disease and Lewy body dementia. Brain Pathology 22:803-810, 2012.  PMC Journal in Process.

Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P. Antioxidants for Alzheimer Disease: A Randomized Clinical Trial With Cerebrospinal Fluid Biomarker Measures. Archives of Neurology, 2012.

Gibbons C, Oken B, Fried-Oken M. Augmented input reveals word deafness in a man with frontotemporal dementia. Behav Neurol 25:151-154, 2012.  PMC3552095.

Haley GE, Berteau-Pavy F, Berteau-Pavy D, Raber J. Novel image-novel location object recognition task sensitive to age-related cognitive decline in nondemented elderly. Age (Dordr) 34:1-10, 2012.  PMC3260359.

Han SD, Gruhl J, Beckett L, Dodge HH, Stricker NH, Farias S, Mungas D. Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease. Brain Imaging Behav, 2012.

Holland D, Desikan RS, Dale AM, McEvoy LK. Rates of decline in Alzheimer disease decrease with age. PLoS One 7:e42325, 2012.  PMC3410919.

Hurko O, Black SE, Doody R, Doraiswamy PM, Gamst A, Kaye J, Obisesan TO, Rusinek H, Scharre D, Sperling R, Weiner MW, Green RC. The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage 59:4196-4200, 2012.

Irizarry MC, Jin S, He F, Emond JA, Raman R, Thomas RG, Sano M, Quinn JF, Tariot PN, Galasko DR, Ishihara LS, Weil JG, Aisen PS. Incidence of new-onset seizures in mild to moderate Alzheimer disease. Archives of Neurology 69:368-372, 2012.

Johnstone D, Milward EA, Berretta R, Moscato P. Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset. PLoS One 7:e34341, 2012.  PMC3317783.

Jun G, Vardarajan BN, Buros J, Yu CE, Hawk MV, Dombroski BA, Crane PK, Larson EB, Mayeux R, Haines JL, Lunetta KL, Pericak-Vance MA, Schellenberg GD, Farrer LA. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Archives of Neurology 69:1270-1279, 2012.  PMC3579659.

Katsumata Y, Todoriki H, Higashiuesato Y, Yasura S, Ohya Y, Wilcox D, Dodge H. Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA project. Journal of Alzheimer's Disease, Forthcoming, 2012.  NIHMS# 442202.

Katsumata Y, Todoriki H, Higashiuesato Y, Yasura S, Willcox D, Ohya Y, Willcox B, Dodge H. Metabolic Syndrome and Cognitive Decline among the Oldest-Old in Okinawa: in Search of a Mechanism. The KOCOA Project. The Journal of Gerontology: Biological Sciences 67:126-134, 2012.  PMC3261441.

Klein EP, Kaye J. Dementia Specialists and Early Adoption of Amyloid Imaging. Journal of Alzheimer's Disease, 2012.  Not funded by the NIH.

Koikkalainen J, Polonen H, Mattila J, van Gils M, Soininen H, Lotjonen J. Improved classification of Alzheimer's disease data via removal of nuisance variability. PLoS One 7:e31112, 2012.  PMC3278425.

Martin ZS, Neugebauer V, Dineley KT, Kayed R, Zhang W, Reese LC, Taglialatela G. alpha-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. J Neurochem 120:440-452, 2012.  PMC3253169.

Mata IF, Checkoway H, Hutter CM, Samii A, Roberts JW, Kim HM, Agarwal P, Alvarez V, Ribacoba R, Pastor P, Lorenzo-Betancor O, Infante J, Sierra M, Gomez-Garre P, Mir P, Ritz B, Rhodes SL, Colcher A, Van Deerlin V, Chung KA, Quinn JF, Yearout D, Martinez E, Farin FM, Wan JY, Edwards KL, Zabetian CP. Common variation in the LRRK2 gene is a risk factor for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society, 2012.

Mattila J, Koikkalainen J, Virkki A, van Gils M, Lotjonen J. Design and application of a generic clinical decision support system for multiscale data. IEEE Transactions on Biomedical Engineering 59:234-240, 2012.

Meyer DJ, Messer J, Singh T, Thomas PJ, Woyczynski WA, Kaye J, Lerner AJ. Random local temporal structure of category fluency responses. J Comput Neurosci 32:213-231, 2012.

Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kovari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology 71:362-381, 2012.

Petersen J, Larimer N, Kaye J, Pavel M, Hayes T. SVM to detect the presence of visitors in a smart home environment Engineering in Medicine and Biology Society:5850-5853, 2012.

Peterson A, Mattek N, Clemons A, Bowman G, Buracchio T, Kaye J, Quinn J. Serum vitamin D concentrations are associationed with falling and cognitive function in older adults. The Journal of Nutrition, Health & Aging 16:898-901, 2012.  PMC3593063.

Rasmussen JM, Lakatos A, van Erp TG, Kruggel F, Keator DB, Fallon JT, Macciardi F, Potkin SG. Empirical derivation of the reference region for computing diagnostic sensitive (1)(8)fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample. Biochim Biophys Acta 1822:457-466, 2012. 

Reitz C, Tosto G, Vardarajan B, Rogaeva E, Robert R, Christopher C, Haines J, Pericak-Vance M, Fallin M, Foroud T, Farrer L, Schellenberg G, St. George-Hyslop P, Mayeux R, Consortium AsDG. Independent and epistatic effects of variants in VPS10 sortilin receptors on Alzheimer’s disease risk and processing of the amyloid precursor protein (APP). Annal of Neurology, Forthcoming, 2012.

Rodgers MM, Cohen ZA, Joseph L, Rossi W. Workshop on personal motion technologies for healthy independent living: executive summary. Archives of Physical Medicine and Rehabilitation 93:935-939, 2012.

Seelye AM, Wild KV, Larimer N, Maxwell S, Kearns P, Kaye JA. Reactions to a remote-controlled video-communication robot in seniors' homes: a pilot study of feasibility and acceptance. Telemed J E Health 18:755-759, 2012.  PMC3523242.

Silbert LC, Dodge HH, Perkins LG, Sherbakov L, Lahna D, Erten-Lyons D, Woltjer R, Shinto L, Kaye JA. Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology 79:741-747, 2012.  PMC3421153.

Silver M, Montana G. Fast identification of biological pathways associated with a quantitative trait using group lasso with overlaps. Stat Appl Genet Mol Biol 11:Article 7, 2012.  PMC3491888.

Soumyanath A, Zhong YP, Henson E, Wadsworth T, Bishop J, Gold BG, Quinn JF. Centella asiatica Extract Improves Behavioral Deficits in a Mouse Model of Alzheimer's Disease: Investigation of a Possible Mechanism of Action. International Journal of Alzheimer's Disease 2012:9 pages, 2012.  PMC3296229.

Stark A, Shafran I, Kaye J. Hello, Who is Calling?:  Can Words Reveal the Social Nature of Conversations? . In: Proceedings of the 2012 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies; Montreal, Canada: The Association for Computational Linguistics, Forthcoming, 2012: 112-119.

Stricker NH, Dodge HH, Dowling NM, Han SD, Erosheva EA, Jagust WJ. CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade. Brain Imaging Behav, 2012.  PMC Journal in Process.
Tractenberg RE, Yumoto F, Aisen PS, Kaye JA, Mislevy RJ. Using the Guttman Scale to Define and Estimate Measurement Error in Items over Time: The Case of Cognitive Decline and the Meaning of "Points Lost". PLoS One 7:e30019, 2012.  PMC3281811.

Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Trojanowski JQ, Schellenberg GD, Yearout D, Huston H, Fritts-Penniman A, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology 79:1944-1950, 2012.  PMC3484986.

Wild K, Mattek N, Maxwell S, Dodge H, Jimison H, Kaye J. Computer related self-efficacy and anxiety in older adults with and without mild cognitive impairment. Alzheimer’s & Dementia 8:544-552, 2012.  PMC3483565

Yuan L, Wang Y, Thompson PM, Narayan VA, Ye J. Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data. Neuroimage 61:622-632, 2012.  PMC3358419.

Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, Lincoln S, Bisceglio G, Georgescu C, Kouri N, Kolbert CP, Jen J, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet 8:e1002707, 2012.  PMC3369937.

Anderson V, Lenar D, Quinn J, Rooney W. The blood -brain barrier adn microvascular water exchange in Alzheimer's disease. Cardiovascular Psychiatry and Neurology, 2011: 615829, 2011. PMC3114411

Anekonda T, Wadsworth T, Frahler K, Harris C, Petriko B, Ralle M, Woltjer R, Quinn J. Phytic acid as a potential treatment for Alzheimer's pathology:  Evidence from animal and in vitro models. Journal of Alzheimer's Disease 23:21-35, 2011.  PMC3021000.

Austin D, Hayes TL, Kaye J, Mattek N, Pavel M. On the Disambiguation of Passively Measured In-home Gait Velocities from Multi-person Smart Homes. J Ambient Intell Smart Environ 3:165-174, 2011.  PMC3093199

Austin D, Jimison H, Hayes T, Mattek N, Kaye J, Pavel M. Measuring motor speed through typing: a surrogate for the finger tapping test. Behav Res Methods, 43(4):903-909, 2011.  PMC3151309

Bowman GL, Shannon J, Ho E, Traber MG, Frei B, Oken BS, Kaye JA, Quinn JF. Reliability and Validity of Food Frequency Questionnaire and Nutrient Biomarkers in Elders With and Without Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders 25:49-57, 2011.  PMC3042482.

Britschgi M, Rufibach K, Bauer S, Clar C, Kaye J, Li G, Peskind E, Quinn J, Galasko D, Wyss-Coray T. Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. Molecular & Cellular Proteomics, Forthcoming, 2011. PMC3205866

Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL, 3rd, Brooks WS, Halliday GM, Kril JJ, Gearing M, Beach TG, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Pickering-Brown SM, Snowden J, van Swieten JC, Heutink P, Seelaar H, Murrell JR, Ghetti B, Spina S, Grafman J, Kaye JA, Woltjer RL, Mesulam M, Bigio E, Llado A, Miller BL, Alzualde A, Moreno F, Rohrer JD, Mackenzie IR, Feldman HH, Hamilton RL, Cruts M, Engelborghs S, De Deyn PP, Van Broeckhoven C, Bird TD, Cairns NJ, Goate A, Frosch MP, Riederer PF, Bogdanovic N, Lee VM, Trojanowski JQ, Van Deerlin VM. Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Archives of Neurology 68:488-497, 2011.  PMC3160280

Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang S, Jack CR, Jr., Weiner MW. Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology 259:844-851, 2011.  PMC3099048.

Copenhaver PF, Anekonda TS, Musashe D, Robinson KM, Ramaker JM, Swanson TL, Wadsworth TL, Kretzschmar D, Woltjer RL, Quinn JF. A translational continuum of model systems for evaluating treatment strategies in Alzheimer's disease: isradipine as a candidate drug. Dis Model Mech, 2011.  PMC3180227

Dodge H, Chang C, Kamboh I, Ganguli M. Risk of Alzheimer’s Disease Incidence Attributable to Vascular Disease in the Population.  . Alzheimer’s & Dementia 7:356-360, 2011.  PMC21575878.

Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ. Predictive value of APOE-{varepsilon}4 allele for progression from MCI to AD-type dementia: a meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry, 2011.  PMC Journal in Process.

Erten-Lyons D, Wilmot B, Anur P, McWeeney S, Westaway S, Silbert L, Kramer P, Kaye J. Microcephaly Genes and Risk of Late-onset Alzheimer Disease. Alzheimer Disease and Associated Disorders, 25(3): 276-282, 2011.  PMC3136560

Evans DA, Grodstein F, Loewenstein D, Kaye J, Weintraub S. Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 2. Alzheimers Dement 7:110-123, 2011.  PMC3033654.

Fonareva I, Amen A, Zajdel D, Ellingson R, Oken B. Assessing sleep architecture in demential caregivers at home using an ambulatory polysomnographic system. Journal of Geriatric Psychiatry and Neurology 24:50-59, 2011.  NIHMSID#371227

Fried-Oken M, Rowland C, Oken B. Evidence to support augmentative communication treatment for primary progressive aphasia. In: Neurology, 2011: A76.

Howieson D, Mattek N, Seelye A, Dodge H, Wasserman D, Zitzelberger T, Kaye J. Serial Position Effects in Mild Cognitive Impairment. Journal of Clinical and Experimental Neuropsychology 2:1-8, 2011.  PMC3058855.
Hurko O, Black S, Doody R, Doraiswamy P, Gamst A, Kaye J, Obisesan T, Rusinek H, Scharre D, Sperling R, Weiner M, Green R. The ADNI Publication Policy:  Commensurate recognition of critical contributors who are not authors. Neuroimage, Forthcoming, 2011.  PMC Journal in Process.

Katsumata Y, Todoriki H, Higashiuesato Y, Yasura S, Willcox D, Ohya Y, Willcox B, Dodge H. Metabolic Syndrome and Cognitive Decline among the Oldest-Old in Okinawa: in Search of a Mechanism. The KOCOA Project. The Journal of Gerontology: Biological Sciences, 67(2): 126-134, 2011.  PMC3261441

Kaye, J, Mattek N, Dodge H, Buracchio T, Austin D, Hagler S, Pavel M, Hayes T. One Walk a Year to 1000 Within a Year: Continuous In-home Unobtrusive Gait Assessment of Older Adults. Gait and Posture, 35(2): 197-202, 2011. PMC3278504
Kaye J, Maxwell S, Mattek N, Hayes T, Dodge H, Pavel M, Jimison H, Wild K, Boise L, Zitzelberger T. Intelligent systems for assessing aging changes: Home-based, unobtrusive, and continuous assessment of aging. Journal of Gerontology:  Psychological Sciences, 66 Suppl 1, i180-i190, 2011.  PMC3132763

Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, Foroud T, Shaw LM, Trojanowski JQ, Potkin SG, Huentelman MJ, Craig DW, DeChairo BM, Aisen PS, Petersen RC, Weiner MW, Saykin AJ. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology 76:69-79, 2011.  PMC2964649

Lu Z, Leen TK, Kaye J. Kernels for longitudinal data with variable sequence length and sampling intervals. Neural Comput 23:2390-2420, 2011.  PMC Journal in Process

Montine TJ, Peskind ER, Quinn JF, Wilson AM, Montine KS, Galasko D. Increased Cerebrospinal Fluid F(2)-Isoprostanes are Associated with Aging and Latent Alzheimer's Disease as Identified by Biomarkers. Neuromolecular Medicine 13:37-42, 2011.  PMC3000441

Naj A, Jun  G, G B, L W, Vardarajan B, Buros J, Gallins P, Buxbaum  J, Jarvik G, Crane P, Larson E, Bird T, Boeve B, Graff-Radford N, De Jager P, Evans D, Schneider J, Carrasquillo M, Ertekin-Taner N, Younkin S, Cruchaga C, Kauwe J, Nowotny P, Kramer P, Hardy J, Huentelman M, Myers A B, M , Demirci F, Baldwin C, Green R, Rogaeva E, P G-H, Consortium ADG. Common variants in MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics, 2011.  PMC3090745

Oken B, Amen A. Electroencephalography and Evoked Potentials in Geriatrics. In: Knoefe lJ, Albert M, eds. Clinical Neurology of Aging: Oxford University Press; 113-127, 2011.

Oken B, Fonareva I, Wahbeh H. Stress-related cognitive dysfunction in dementia caregivers. In: Neurology, 2011: A511.

Oken B, Fonareva I, Wahbeh H. Stress-related cognitive dysfunction in dementia caregivers. Journal of Geriatric Psychiatry and Neurology, 24(4): 191-198,  2011. NIHMSID#370251

Perrin R, Craig-Schapiro R, Malone J, Shah A, Gilmore P, David A, Roe C, Peskind E, Li G, Galasko D, Clark C, Quinn J, Kaye J, Morris J, Holtzman D, Townsend R, Fagan A. Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease. PLoS ONE 6:e16032, 2011.  PMC3020224

Roark B, Mitchell M, Hosom J, Hollingshead K, Kaye J. Spoken language derived measures for detecting mild cognitive impairment. Transactions on Audio, Speech and Language Processing, 19(7):2081-2090, 2011.  PMC3244269

Shulman JM, Chipendo P, Chibnik LB, Aubin C, Tran D, Keenan BT, Kramer PL, Schneider JA, Bennett DA, Feany MB, De Jager PL. Functional Screening of Alzheimer Pathology Genome-wide Association Signals in Drosophila. The American Journal of Human Genetics 88:232-238, 2011.  PMC3035702

Snyder PJ, Jackson CE, Petersen RC, Khachaturian AS, Kaye J, Albert MS, Weintraub S. Assessment of cognition in mild cognitive impairment: A comparative study. Alzheimers Dement 7:338-355, 2011.  PMC Journal in Process.

Sonnen J, Santa Cruz K, Hemmy L, Woltjer R, Leverenz J, Montine K, Jack C, Kaye J, Lim K, Larson E, White L, Montine T. Ecology of aging human brain. Archives of Neurology 68:1049-1056, 2011.  PMC3218566

Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement, 2011. PMC3220946

Tosun D, Schuff N, Mathis C, Jagust W, Weiner M, Alzheimer's Disease Neuroimaging Initiative . Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.  Brain 134:1077-1088, 2011.  PMC3069703

Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Despres S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477:90-94, 2011. PMC3170097
Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. The American Journal of Pathology 178:1509-1516, 2011.  PMC Journal in Process.  PMC3078443

Katsumata Y, Todoriki H, Yasura S, Dodge H. Timed Up & Go Test Predicts Cognitive Decline among Healthy Elderly Aged 80 and Older in Okinawa: KOCOA project. Journal of American Geriatrics Society,59(11): 2188-2189, 2011. PMC3291095

Austin D, Leen T, Hayes TL, Kaye J, Jimison H, Mattek N, Pavel M. Model-based inference of cognitive processes from unobtrusive gait velocity measurements. Conference Proceedings : Engineering in Medicine and Biology Society 1:5230-5233, 2010.

Boise L, Eckstrom E, Fagnan L, King A, Goubaud M, Buckley DI, Morris C. The rural older adult memory (ROAM) study: A practice-based intervention to improve dementia screening and diagnosis. Journal of the American Board of Family Medicine 23:486-498, 2010.  PMC Journal in Progress.

Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. Uric acid as a CNS antioxidant. Journal of Alzheimer's Disease 19:1331-1336, 2010.  PMC2859185.

Bowman GL, Shannon J, Ho E, Traber MG, Frei B, Oken BS, Kaye JA, Quinn JF. Reliability and Validity of Food Frequency Questionnaire and Nutrient Biomarkers in Elders With and Without Mild Cognitive Impairment. Alzheimer Disease and Associated Disorders, 2010. PMC3042482

Buracchio T, Arvanitakis Z, Leurgans S, Bennett DA. Parkinsonian signs and incident falls in older persons without Parkinson's disease. In: Journal of the American Geriatrics Society. 2010/02/04 ed, 2010: 205-206.

Buracchio T, Dodge H, Howieson D, Wasserman D, Kaye J. The trajectory of gait speed preceding mild cognitive impairment. Archives of Neurology 67:980-986, 2010.  PMC2921227.

Chaves ML, Camozzato AL, Kohler C, Kaye J. Predictors of the progression of dementia severity in brazilian patients with Alzheimer's disease and vascular dementia. Int J Alzheimer Dis 2010, 2010.  PMC2925083.

Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry 68:903-912, 2010.  PMC3011944.

Dodge HH, Katsumata Y, Todoriki H, Yasura S, Willcox DC, Bowman GL, Willcox B, Leonard S, Clemons A, Oken BS, Kaye JA, Traber MG. Comparisons of Plasma/Serum Micronutrients Between Okinawan and Oregonian Elders: A Pilot Study. J Gerontol A Biol Sci Med Sci, 2010.  PMC3031451

Hare J. Trafficking of amyloid beta-precursor protein products C83 and C99 on the endocytic pathway. Biochem Biophys Res Commun 401:219-224, 2010.  PMC Journal In Process.

Hayes TL, Riley T, Pavel M, Kaye JA. Estimation of rest-activity patterns using motion sensors. Conference Proceedings : Engineering in Medicine and Biology Society 1:2147-2150, 2010. PMC3057896

Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR, Jr., Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A 107:8404-8409, 2010.  PMC2889537.

Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 133:713-726, 2010.  PMC2842513.

Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, Arnold SE, Baldwin CT, Barber R, Beach T, Bigio EH, Bird TD, Boxer A, Burke JR, Cairns N, Carroll SL, Chui HC, Clark DG, Cotman CW, Cummings JL, Decarli C, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Gearing M, Geschwind DH, Ghetti B, Gilman S, Giordani B, Glass J, Graff-Radford NR, Green RC, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman A, Lopez OL, Mack WJ, Markesbery W, Marson DC, Martiniuk F, Masliah E, McKee AC, Mesulam M, Miller JW, Miller BL, Miller CA, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon W, Quinn JF, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider JA, Schneider LS, Seeley W, Shelanski ML, Smith CD, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Woltjer RL, Younkin SG, Cantwell LB, Dombroski BA, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Lunetta KL, Martin ER, Montine TJ, Goate AM, Blacker D, Tsuang DW, Beekly D, Cupples LA, Hakonarson H, Kukull W, Foroud TM, Haines J, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD. Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes. Archives of Neurology, 67(12): 1473-1484, 2010. PMC3048805

Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, Erten-Lyons D, Kaye JA, Welsh-Bohmer KA, Troncoso JC, Markesbery WR, Petersen RC, Turner RS, Kukull WA, Bennett DA, Galasko D, Morris JC, Ott J. Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study. Neurobiology of Aging, 32(12): 2113-2122, 2010. PMC2990809.

Kruer MC, Koch TK, Bourdette DN, Chabas D, Waubant E, Mueller S, Moscarello MA, Dalmau J, Woltjer RL, Adamus G. Nmda receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology 74:1473-1475, 2010.  PMC2872802.

Montine TJ, Peskind ER, Quinn JF, Wilson AM, Montine KS, Galasko D. Increased Cerebrospinal Fluid F(2)-Isoprostanes are Associated with Aging and Latent Alzheimer's Disease as Identified by Biomarkers. Neuromolecular Medicine [Epub ahead of print, 2010.  NIHMS203909.

Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF Abeta(42) and tau in Parkinson's disease with cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society, 25(15): 2682-2685, 2010.  PMC2978754

Quinn JF, Harris CJ, Cobb KE, Domes C, Ralle M, Brewer G, Wadsworth TL. A Copper-Lowering Strategy Attenuates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease, 2010.  PMC2931577.

Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Jr., Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA: The Journal of the American Medical Association 304:1903-1911, 2010.  PMC3259852

Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson disease. Neurosci Lett,480(1): 78-82, 2010. PMC2943649

Silbert LC, Kaye J. Neuroimaging and cognition in Parkinson's disease dementia. Brain Pathology 20:646-653, 2010.  NIHMS# 165062.

Sonnen JA, Montine KS, Quinn JF, Breitner JC, Montine TJ. Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia. Journal of Alzheimer's Disease 19:301-309, 2010.  PMC2891184.

Subramanian S, Ayala P, Wadsworth TL, Harris CJ, Vandenbark AA, Quinn JF, Offner H. CCR6: A Biomarker for Alzheimer's-like Disease in a Triple Transgenic Mouse Model. Journal of Alzheimer's Disease, 22(2): 619-629, 2010. PMC2988888

Takechi H, Dodge HH. Scenery Picture Memory Test: a new type of quick and effective screening test to detect early stage Alzheimer's disease patients. Geriatr Gerontol Int 10:183-190, 2010.  PMC2892033.

Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White CL, 3rd, Ferrer I, Llado A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller BL, Alzualde A, de Munain AL, McKee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IR, Feldman HH, Hamilton RL, Dekosky ST, van der Zee J, Kumar-Singh S, Van Broeckhoven C, Mayeux R, Vonsattel JP, Troncoso JC, Kril JJ, Kwok JB, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, McLean CA, Decarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tunon MT, Martinez MC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, Trojanowski JQ, Lee VM. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nature Genetics 43:234-239, 2010.  PMC2828525.

Wolk DA, Dickerson BC, Weiner M, Aiello M, Aisen P, Albert MS, Alexander G, Anderson HS, Anderson K, Apostolova L, Arnold S, Ashford W, Assaly M, Asthana S, Bandy D, Bartha R, Bates V, Beckett L, Bell KL, Benincasa AL, Bergman H, Bernick C, Bernstein M, Black S, Blank K, Borrie M, Brand C, Brewer J, Brown AD, Burns JM, Cairns NJ, Caldwell C, Capote H, Carlsson CM, Carmichael O, Cellar JS, Celmins D, Chen K, Chertkow H, Chowdhury M, Clark D, Connor D, Correia S, Crawford K, Dale A, de Leon MJ, De Santi SM, Decarli C, Detoledo-Morrell L, Devous M, Diaz-Arrastia R, Dolen S, Donohue M, Doody RS, Doraiswamy PM, Duara R, Englert J, Farlow M, Feldman H, Felmlee J, Fleisher A, Fletcher E, Foroud TM, Foster N, Fox N, Frank R, Gamst A, Given CA, 2nd, Graff-Radford NR, Green RC, Griffith R, Grossman H, Hake AM, Hardy P, Harvey D, Heidebrink JL, Hendin BA, Herring S, Honig LS, Hosein C, Robin Hsiung GY, Hudson L, Ismail MS, Jack CR, Jr., Jacobson S, Jagust W, Jayam-Trouth A, Johnson K, Johnson H, Johnson N, Johnson KA, Johnson S, Kachaturian Z, Karlawish JH, Kataki M, Kaye J, Kertesz A, Killiany R, Kittur S, Koeppe RA, Korecka M, Kornak J, Kozauer N, Lah JJ, Laubinger MM, Lee VM, Lee TY, Lerner A, Levey AI, Longmire CF, Lopez OL, Lord JL, Lu PH, Macavoy MG, Malloy P, Marson D, Martin-Cook K, Martinez W, Marzloff G, Mathis C, Mc-Adams-Ortiz C, Mesulam M, Miller BL, Mintun MA, Mintzer J, Molchan S, Montine T, Morris J, Mulnard RA, Munic D, Nair A, Neu S, Nguyen D, Norbash A, Oakley M, Obisesan TO, Ogrocki P, Ott BR, Parfitt F, Pawluczyk S, Pearlson G, Petersen R, Petrella JR, Potkin S, Potter WZ, Preda A, Quinn J, Rainka M, Reeder S, Reiman EM, Rentz DM, Reynolds B, Richard J, Roberts P, Rogers J, Rosen A, Rosen HJ, Rusinek H, Sabbagh M, Sadowsky C, Salloway S, Santulli RB, Saykin AJ, Scharre DW, Schneider L, Schneider S, Schuff N, Shah RC, Shaw L, Shen L, Silverman DH, Simpson DM, Sink KM, Smith CD, Snyder PJ, Spann BM, Sperling RA, Spicer K, Stefanovic B, Stern Y, Stopa E, Tang C, Tariot P, Taylor-Reinwald L, Thai G, Thomas RG, Thompson P, Tinklenberg J, Toga AW, Tremont G, Trojanowki JQ, Trost D, Turner RS, van Dyck CH, Vanderswag H, Varon D, Villanueva-Meyer J, Villena T, Walter S, Wang P, Watkins F, Williamson JD, Wolk D, Wu CK, Zerrate M, Zimmerman EA. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A, 2010.  PMC2890481.

Woltjer R, Duerson K, Fullmer F, Mookherjee P, Ryan A, Montine T, Kaye J, Quinn J, Silbert L, Erten-Lyons D, Leverenz J, Bird T, Pow D, Watson G, Cook D. Aberrant Detergent-insoluble EAAT2 accumulates in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 69:667-676, 2010.  PMC3097122

Yu C, Bird T, Bekris L, Montine T, Leverenz J, Steinbart E, Galloway N, Feldman H, Woltjer R, Miller C, McCarthy Wood E, Grossman M, McCluskey L, Clark C, Neumann M, Danek A, Galasko D, Arnold S, Chen-Plotkin A, Karydas A, Miller B, Trojanowski J, Lee V, Schellenberg G, Van Deerlin V. The spectrum of mutations in progranulin:  A collaborative study screening 545 cases of neurodegeneration. Archives of Neurology 67:161-170, 2010.  PMC2901991.

Bowman G, Dodge H, Calabrese C, Oken B, Frei B, Kaye J, Quinn J. Ascorbic acid and rates of cognitive decline in Alzheimer's disease. The Journal of Alzheimer's Disease 16:93-98, 2009.  PMC2674290.

Britschgi M, Olin CE, Johns HT, Takeda-Uchimura Y, LeMieux MC, Rufibach K, Rajadas J, Zhang H, Tomooka B, Robinson WH, Clark CM, Fagan AM, Galasko DR, Holtzman DM, Jutel M, Kaye JA, Lemere CA, Leszek J, Li G, Peskind ER, Quinn JF, Yesavage JA, Ghiso JA, Wyss-Coray T. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc Natl Acad Sci U S A 106:12145-12150, 2009.  PMC2715538.

Calvert JF, Jr., Kaye J, Leahy M, Hexem K, Carlson N. Technology use by rural and urban oldest old. Technol Health Care 17:1-11, 2009.  PMC2830255.

Carmine-Simmen K, Proctor T, Tschape J, Poeck B, Triphan T, Strauss R, Kretzschmar D. Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function. Neurobiol Dis 33:274-281, 2009. 

Chaves ML, Camozzato AL, Eizirik CL, Kaye J. Predictors of Normal and Successful Aging Among Urban-Dwelling Elderly Brazilians. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 64:597-602, 2009.  PMC2800815.

Chaves ML, Camozzato AL, Godinho C, Piazenski I, Kaye J. Incidence of Mild Cognitive Impairment and Alzheimer Disease in Southern Brazil. Journal of Geriatric Psychiatry and Neurology 22:181-187, 2009.  PMC Journal in Process.

Dodge H. The early detection of cognitive impairment:  Two approaches to assess longitudinal trajectories. In: National Alzheimer's Coordinating Center (NACC). Baltimore, MD, 2009.

Dodge H, Katsumata Y, Todoriki H, Willcox D, Leahy M, Michael Y, Kaye J. Social interaction as a potential key to optimal cognitive aging:  Okinawa-Oregon comparative study of sucessful aging. In: The Gerontological Society of America. Atlanta, GA, 2009.

Dodge H, Traber M, Leonard S, Katsumata Y, Todoriki H, Bowman G, Suzuki M, Willcox D, Yasura S, Oken B, Kaye J. Circulating micronutrients in Okinawan and Oregonian elderly. In: Linus Pauling Diet and Optinal Aging Annual Meeting; Portland, Oregon  2009.

Dodge HH, Meguro K, Ishii H, Yamaguchi S, Saxton JA, Ganguli M. Cross-cultural comparisons of the Mini-mental State Examination between Japanese and U.S. cohorts. Int Psychogeriatr 21:113-122, 2009. PMC2639652.

Duerson K, Woltjer RL, Mookherjee P, Leverenz JB, Montine TJ, Bird TD, Pow DV, Rauen T, Cook DG. Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients. Brain Pathology 19:267-278, 2009.  PMC2657182.

Erten-Lyons D, McWeeney S, Wilmot B, Kramer P, Kaye J. A polymorphism in ASPM and brain size. In: American Academy of Neurology: Neurology, 2009.

Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, Leahy M, Montine T, Kaye J. Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology 72:354-360, 2009.  PMC275065.

Hagler S, Austin D, Hayes T, Kaye J, Pavel M. Unobtrusive and Ubiquitous In-Home Monitoring: A Methodology for Continuous Assessment of Gait Velocity in Elders. IEEE Transactions on Biomedical Engineering, 2009.  PMC2846826

Hatt WJ, Vanbaak EA, Jimison HB, Hagler S, Hayes TL, Pavel M, Kaye J. The exploration & forensic analysis of computer usage data in the elderly. Conference Proceedings : Engineering in Medicine and Biology Society 2009:1216-1219, 2009.  PMC284625

Hayes T, Kaye J. Gathering the evidence:  Supporting large-sale research deployments.  . Intel Technology Journal 13:148-167, 2009. Not a peer-reviewed journal article.

Hayes TL, Cobbinah K, Dishongh T, Kaye JA, Kimel J, Labhard M, Leen T, Lundell J, Ozertem U, Pavel M, Philipose M, Rhodes K, Vurgun S. A study of medication-taking and unobtrusive, intelligent reminding. Telemed J E Health 15:770-776, 2009. Not an NIH Funded Manuscript.

Hayes TL, Hagler S, Austin D, Kaye J, Pavel M. Unobtrusive assessment of walking speed in the home using inexpensive PIR sensors. Conference Proceedings : Engineering in Medicine and Biology Society 1:7248-7251, 2009.  PMC2664300

Hayes TL, Larimer N, Adami A, Kaye JA. Medication adherence in healthy elders: small cognitive changes make a big difference. Journal of Aging Health 21:567-580, 2009.  PMC2910516

Holland D, Brewer JB, Hagler DJ, Fenema-Notestine C, Dale AM, Weiner M, Thal L, Petersen R, Jack CR, Jr., Jagust W, Trojanowki J, Toga AW, Beckett L, Green RC, Gamst A, Potter WZ, Montine T, Anders D, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Harvey D, Kornak J, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Vorobik R, Quinn J, Schneider L, Pawluczyk S, Spann B, Fleisher AS, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Mintun MA, Schneider S, Marson D, Griffith R, Badger B, Grossman H, Tang C, Stern J, Detoledo-Morrell L, Shah RC, Bach J, Duara R, Isaacson R, Strauman S, Albert MS, Pedroso J, Toroney J, Rusinek H, de Leon MJ, De Santi SM, Doraiswamy PM, Petrella JR, Aiello M, Clark CM, Pham C, Nunez J, Smith CD, Given CA, 2nd, Hardy P, Dekosky ST, Oakley M, Simpson DM, Ismail MS, Porsteinsson A, McCallum C, Cramer SC, Mulnard RA, McAdams-Ortiz C, Diaz-Arrastia R, Martin-Cook K, Devous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Laubinger MM, Bartzokis G, Silverman DH, Lu PH, Fletcher R, Parfitt F, Johnson H, Farlow M, Herring S, Hake AM, van Dyck CH, Macavoy MG, Bifano LA, Chertkow H, Bergman H, Hosein C, Black S, Graham S, Caldwell C, Feldman H, Assaly M, Hsiung GY, Kertesz A, Rogers J, Trost D, Bernick C, Gitelman D, Johnson N, Mesulam M, Sadowsky C, Villena T, Mesner S, Aisen PS, Johnson KB, Behan KE, Sperling RA, Rentz DM, Johnson KA, Rosen A, Tinklenberg J, Ashford W, Sabbagh M, Connor D, Obradov S, Killiany R, Norbash A, Obisesan TO, Jayam-Trouth A, Wang P, Auchus AP, Huang J, Friedland RP, Decarli C, Fletcher E, Carmichael O, Kittur S, Mirje S, Johnson SC, Borrie M, Lee TY, Asthana S, Carlsson CM, Potkin SG, Highum D, Preda A, Nguyen D, Tariot PN, Hendin BA, Scharre DW, Kataki M, Beversdorf DQ, Zimmerman EA, Celmins D, Brown AD, Gandy S, Marenberg ME, Rovner BW, Pearlson G, Blank K, Anderson K, Saykin AJ, Santulli RB, Pare N, Williamson JD, Sink KM, Potter H, Ashok Raj B, Giordano A, Ott BR, Wu CK, Cohen R, Wilks KL, Safirstein BE. Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proceedings of the National Academy of Science USA 106:20954-20959, 2009.  PMC2791580.

Hosom J. Speaker-independent phoneme alignment using transition-dependent states. Speech Communication 51:352-368, 2009.  PMC2682710

Kaye J. Ginkgo biloba prevention trials:  More than an ounce of prevention learned. Archives of Neurology 66:652-654, 2009.  Not a peer-reviewed journal article.

Kaye J, Micheal Y, Calvert J, Leahy M, Crawford D, Kramer P. Exceptional brain aging in rural population-based cohort. Journal of Rural Health 25:320-325, 2009. NIHMSID#371470

Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, Deves A, Ferris S, Greenberg BD, Johnson C, Kukull WA, Poirier J, Schenk D, Thies W, Gauthier S, Gilman S, Bernick C, Cummings JL, Fillit H, Grundman M, Kaye J, Mucke L, Reisberg B, Sano M, Pickeral O, Petersen RC, Mohs RC, Carrillo M, Corey-Bloom JP, Foster NL, Jacobsen S, Lee V, Potter WZ, Sabbagh MN, Salmon D, Trojanowski JQ, Wexler N, Bain LJ. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement 5:85-92, 2009.  PMC2544623.

Lavery L, Dodge H, Snitz B, Ganguli M. Cognitive decline and mortality in a community-based cohort: The Monongahela Valley independent elders survey Journal of the American Geriatrics Society 57:94-100, 2009.  PMC2768614

Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, Montine TJ. Cognitive impairment and dementia in patients with Parkinson disease. Curr Top Med Chem 9:903-912, 2009.  PMC2804995.

Michael YL, Keast EM, Chaudhury H, Day K, Mahmood A, Sarte AF. Revising the senior walking environmental assessment tool. Preventative Medicine 48:247-249, 2009.  NIHMS106679.

Price JL, McKeel DW, Jr., Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiology of Aging 30:1026-1036, 2009.  PMC2737680.

Quinn J, Clark C. Failure of biomarkers in clinical trials of Alzheimer's disease:  Blaming the messenger? Journal of  Alzheimers Disease Epub ahead of print 2009. Not a peer-reviewed journal article.

Quinn J, Crane S, Harris C, Wadworth T. Copper in Alzheimer’s disease: too much or too little? . Expert Reviews in Neurotherapeutics 9:631-639, 2009.  PMC Journal in Process.

Roher AE, Esh CL, Kokjohn TA, Castano EM, Van Vickle GD, Kalback WM, Patton RL, Luehrs DC, Daugs ID, Kuo YM, Emmerling MR, Soares H, Quinn JF, Kaye J, Connor DJ, Silverberg NB, Adler CH, Seward JD, Beach TG, Sabbagh MN. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement 5:18-29, 2009. PMC2663406.

Seelye A, Howieson D, Wild K, Sauceda L, Kaye J. Living well with MCI:  Behavioral interventions for older adults with mild cognitive impairment. In: Brougham R, ed. New Directions in Aging Research:  Health and Cognition. New York: Nova Scient Publishers, Inc., 2009.

Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 73:120-125, 2009.  PMC2713187.

Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ, Craft S. Different Patterns of Cerebral Injury in Dementia With or Without Diabetes. Archives of Neurology 66:315-322, 2009.  PMC2766529.

Sonnen JA, Montine KS, Quinn JF, Breitner JC, Montine TJ. Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia. Journal of Alzheimer's Disease, 2009.  PMC2891184

Tian W, Fu Y, Garcia-Elias A, Fernandez-Fernandez JM, Vicente R, Kramer PL, Klein RF, Hitzemann R, Orwoll ES, Wilmot B, McWeeney S, Valverde MA, Cohen DM. A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia. Proc Natl Acad Sci U S A 106:14034-14039, 2009.  PMC2729015.

Bekris LM, Millard SP, Galloway NM, Vuletic S, Albers JJ, Li G, Galasko DR, DeCarli C, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Tsuang D, Peskind ER, Yu CE. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. Journal of Alzheimers Disease 13:255-266, 2008.

Boise L. Ethnicity and the experience of dementia. Berkshire: McGraw-Hill; 52-69, 2008.

Bowman G, Quinn J. Alzheimer's disease and the blood-brain barrier:  Past present and future. Aging Health 4:47-57, 2008.  PMC2778025.

Buenafe AC, Zwickey H, Moes N, Oken B, Jones RE. A telemetric study of physiologic changes in mice with induced autoimmune encephalomyelitis. Lab Animal 37:361-368, 2008.

Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: A randomized, double-blind, placebo-controlled trial. Journal of Alternative and Complementary Medicine 14:707-713, 2008.

Carlson NE, Moore MM, Dame A, Howieson D, Silbert LC, Quinn JF, Kaye JA. Trajectories of brain loss in aging and the development of cognitive impairment. Neurology 70:828-833, 2008.

Dodge H, Shen C, Ganguli M. Application of the pattern-mixture latent trajectory model in an epidemiological study with non-ignorable missingness. The Journal of Data Science 6:231-246, 2008.

Dodge HH, Kita Y, Takechi H, Hayakawa T, Ganguli M, Ueshima H. Healthy cognitive aging and leisure activities among the oldest old in Japan: Takashima study. J Gerontol A Biol Sci Med Sci 63:1193-1200, 2008.  PMC2646000.

Dodge HH, Zitzelberger T, Oken BS, Howieson D, Kaye J. A randomized placebo-controlled trial of ginkgo biloba for the prevention of cognitive decline. Neurology 70:1809-1817, 2008.  PMC2639649.

Erten-Lyons D. When should patients with Alzheimer disease stop driving? Neurology 70:e45-47, 2008.

Erten-Lyons D, Jacobs A, Kramer P, Grupe A, Kaye J. The FAS gene is associated with brain volume in mild cogntive Impairment and Alzheimer's disease. Neurology 70:A103, 2008.

Erten-Lyons D, Oken B, Woltjer RL, Quinn J. Relapsing polychondritis: an uncommon cause of dementia. Journal of Neurology, Neurosurgery, and Psychiatry 79:609-610, 2008.

Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ. Phase II safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Archives of Neurology 65:1031-1038, 2008.  PMC2682361.

Hayes T, Pavel M, Kaye J. An approach for deriving continuous health assessment indicators from in-home sensor data. In: Mihailidis A, Boger J, Kautz H, Normie L, eds. Technology and Aging: Selected papers from the 2007 International Conference on Technology and Aging. Amsterdam, The Netherlands: IOS Press; 130-137, 2008.

Hayes TL, Abendroth F, Adami A, Pavel M, Zitzelberger TA, Kaye JA. Unobtrusive assessment of activity patterns associated with mild cognitive impairment. Alzheimers and  Dementia 4:395-405, 2008.  PMC2664300.

Hill JM, Ball MJ, Neumann DM, Azcuy AM, Bhattacharjee PS, Bouhanik S, Clement C, Lukiw WJ, Foster TP, Kumar M, Kaufman HE, Thompson HW. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. Journal of Virology 82:8230-8234, 2008.  PMC2519549.

Howieson DB, Carlson NE, Moore MM, Wasserman D, Abendroth CD, Payne-Murphy J, Kaye JA. Trajectory of mild cognitive impairment onset. Journal of the International Neuropsychological Society 14:192-198, 2008.

Hutter CM, Samii A, Factor SA, Nutt JG, Higgins DS, Bird TD, Griffith A, Roberts JW, Leis BC, Montimurro JS, Kay DM, Edwards KL, Payami H, Zabetian CP. Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease. European Journal of Neurology 15:134-139, 2008.

Kay DM, Factor SA, Samii A, Higgins DS, Griffith A, Roberts JW, Leis BC, Nutt JG, Montimurro JS, Keefe RG, Atkins AJ, Yearout D, Zabetian CP, Payami H. Genetic association between alpha-synuclein and idiopathic Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 147B:1222-1230, 2008.

Kaye J. Home-based technologies: A new paradigm for conducting dementia prevention trials. Alzheimer's & Dementia 4:S60-S66, 2008.

Kaye J, Hayes T, Zitzelberger T, Yeargers J, Pavel M, Jimison H, Larimer N, Payne-Murphy J, Earl E, Wild K, Boise L, Williams D, Lundell J, Dishman E. Deploying wide scale in-home assessment technology. In: Mihailidis A, Boger J, Kautz H, Normie L, eds. Technology and Aging: Selected papers from the 2007 International Conference on Technology and Aging. Amsterdam, The Netherlands: IOS Press; 19-26, 2008.

Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & Dementia 4:156-163, 2008.  PMC2544623.

Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R. Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci. Archives of Neurology 65:1518-1526, 2008.  PMC2694670.

Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ. Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathology 18:220-224, 2008.  PMC2689097.

Liu C, Takahashi M, Li Y, Song S, Dillon TJ, Shinde U, Stork PJ. Ras is required for the cyclic AMP-dependent activation of Rap1 via Epac2. Mol Cell Biol 28:7109-7125, 2008.  PMC2593374.

Lovell MA, Lynn BC, Xiong S, Quinn JF, Kaye J, Markesbery WR. An aberrant protein complex in CSF as a biomarker of Alzheimer disease. Neurology 70:2212-2218, 2008.

Michael Y, McGregor E, Allen J, Fickas S. Observing outdoor activity using global positioning system-enabled cell phones. In: Helal S, Mitra S, Wong J, Chang C, Mokhtari M, eds. Smart Homes and Health Telematics. Ames, IA: Springer, Berlin, Heidelberg; 177-184, 2008.

Nagel CL, Carlson NE, Bosworth M, Michael YL. The relation between neighborhood built environment and walking activity among older adults. American Journal of Epidemiology 168:461-468, 2008.

Oken BS. Placebo effects: Clinical aspects and neurobiology. Brain 131:2812-2823, 2008.

Oken BS, Flegal K, Zajdel D, Kishiyama S, Haas M, Peters D. Expectancy effect: Impact of pill administration on cognitive performance in healthy seniors. Journal of Clinical and Experimental Neuropsychology 30:7-17, 2008.

Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T, Zhang J. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform. Journal of Proteome Research 7:720-730, 2008.

Pavel M, Jimison H, Hayes T, Kaye J, Dishman E, WIld K, Williams D. Continuous, Unobtrusive Monitoring for the Assessment of Cognitive Function. In: Hofer SM, Alwin DF, eds. Handbook of Cognitive Aging: Interdisciplinary Perspetives. Thousand Oaks, CA: Sage Publications, Inc.; Chapter 31, 2008.

Pavel M, Jimison H, Hayes T, Kaye J, Dishman E, Wild K, Williams D. Continuous, unobtrusive monitoring for the assessment of cognitive function. In: Hofer S, Alwin D, eds. Handbook of Cognitive Aging: Interdisciplinary Perspectives. Thousand Oaks, CA.: Sage Publications, Inc., 2008.

Powers KM, Kay DM, Factor SA, Zabetian CP, Higgins DS, Samii A, Nutt JG, Griffith A, Leis B, Roberts JW, Martinez ED, Montimurro JS, Checkoway H, Payami H. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Movement Disorders : Official Journal of the Movement Disorder Society 23:88-95, 2008.

Quinn J, Sabbagh MN. Detecting Alzheimer disease before it happens: The key to prevention? Neurology 71:78-79, 2008.

Raber J. AR, apoE, and cognitive function. Horm Behav 53:706-715, 2008.  PMC2409114.

Reddy PH. Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Medicine 10:291-315, 2008.

Reddy PH, Beal MF. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14:45-53, 2008.

Seelye AM, Howieson DB, Wild KV, Moore MM, Kaye JA. Wechsler Memory Scale-III Faces test performance in patients with mild cognitive impairment and mild Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology:1-7, 2008.  NIHMS# 97312.

Sheldahl LC, Shapiro RA, Bryant DN, Koerner IP, Dorsa DM. Estrogen induces rapid translocation of estrogen receptor beta, but not estrogen receptor alpha, to the neuronal plasma membrane. Neuroscience 153:751-761, 2008.  PMC2587260.

Shinto L, Calabrese C, Morris C, Yadav V, Griffith D, Frank R, Oken BS, Baldauf-Wagner S, Bourdette D. A randomized pilot study of naturopathic medicine in multiple sclerosis. Journal of Alternative and Complementary Medicine 14:489-496, 2008.

Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 71:108-113, 2008.  PMC2676966.

Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic Biol Med 45:219-230, 2008.  PMC2459222.

Sonnen JA, Montine KS, Quinn JF, Kaye JA, Breitner JC, Montine TJ. Biomarkers for cognitive impairment and dementia in elderly people. Lancet Neurology 7:704-714, 2008.  PMC2710375.

Szekely CA, Green RC, Breitner JC, Ostbye T, Beiser AS, Corrada MM, Dodge HH, Ganguli M, Kawas CH, Kuller LH, Psaty BM, Resnick SM, Wolf PA, Zonderman AB, Welsh-Bohmer KA, Zandi PP. No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology 70:2291-2298, 2008.

Wadsworth TL, Bishop JA, Pappu AS, Woltjer RL, Quinn JF. Evaluation of coenzyme q as an antioxidant strategy for Alzheimer's disease. Journal of  Alzheimers Disease 14:225-234, 2008.  NIHMS#102025.

Wahbeh H, Elsas SM, Oken BS. Mind-body interventions: Applications in neurology. Neurology 70:2321-2328, 2008.

Wahbeh H, Kishiyama SS, Zajdel D, Oken BS. Salivary cortisol awakening response in mild Alzheimer disease, caregivers, and noncaregivers. Alzheimer's Disease and Associated Disorders 22:181-183, 2008.  PMC - Journal in Process.

Wang W, Shinto L, Connor WE, Quinn JF. Nutritional biomarkers in Alzheimer's disease: The association between carotenoids, n-3 fatty acids, and dementia severity. Journal of  Alzheimers Disease 13:31-38, 2008.

Wild K, Boise L, Lundell J, Foucek A. Unobtrusive in-home monitoring of cognitive and physical health: Reactions and perceptions of Older Adults. Journal of Applied Gerontology 27:181-200, 2008.  PMC2629437.

Wild K, Howieson D, Webbe F, Seelye A, Kaye J. The status of computerized cognitive testing in aging: A systematic review. Alzheimers and  Dementia 4:428-437, 2008.  PMC2645803.

Wilmot B, McWeeney SK, Nixon RR, Montine TJ, Laut J, Harrington CA, Kaye JA, Kramer PL. Translational gene mapping of cognitive decline. Neurobiology of Aging 29:524-541, 2008.  PMC2684335.

Woltjer RL, Sonnen JA, Sokal I, Rung LG, Yang W, Kjerulf JD, Klingert D, Johnson C, Rhew I, Tsuang D, Crane PK, Larson EB, Montine TJ. Quantitation and Mapping of Cerebral Detergent-Insoluble Proteins in the Elderly. Brain Pathology:Epub ahead of print, 2008.  NIHMSID #69069.

Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. American Journal of Clinical Pathology 129:526-529, 2008.  PMC2688655.

Borenstein AR, Mortimer JA, Schofield E, Wu Y, Salmon DP, Gamst A, Olichney J, Thal LJ, Silbert L, Kaye J, Craig UL, Schellenberg GD, and Galasko DR. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology. 68(21): p. 1764-71, 2007.

Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF. Blood-brain barrier impairment in Alzheimer's disease: stability and functional significance. Neurology. 2007 May 22;68(21):1809-14.

Carlson N, Moore M, Dame A, Howieson D, Silbert L, Quinn J, and Kaye J. Trajectories of brain loss in aging and the development of cognitive impairment. Neurology. In Press, 2007.

Chaves ML, Camozzato AL, Godinho C, Kochhann R, Schuh A, de Almeida VL, Kaye J. Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients. Alzheimer Dis Assoc Disord. 21(3): p. 210-7, 2007.

Chun LS, Samii A, Hutter CM, Griffith A, Roberts JW, Leis BC, Mosley AD, Wander PL, Edwards KL, Payami H, and Zabetian CP. DBH -1021C-->T does not modify risk or age at onset in Parkinson's disease. Ann Neurol. 62(1): p. 99-101, 2007.

Coehlo DP, Hooker K, Bowman S. Institutional placement of persons with dementia: what predicts occurrence and timing? J Fam Nurs. 2007 May;13(2):253-77.

Dodge H, Zitzelberger T, Oken B, Howieson D, and Kaye J. A Randomized Placebo-Controlled Trial of Ginkgo Biloba for the Prevention of Cognitive Decline. Neurology. In Press, 2007.

Galasko D, Salmon D, Gamst A, Olichney J, Thal LJ, Silbert L, Kaye J, Brooks P, Adonay R, Craig UK, Schellenberg G, and Borenstein AR. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology. 68(21): p. 1772-81, 2007.

Gordon D, Haynes C, Yang Y, Kramer PL, and Finch SJ. Linear trend tests for case-control genetic association that incorporate random phenotype and genotype misclassification error. Genet Epidemiol. 31(8): p. 853-70, 2007.

Hayes T, Pavel M, and Kaye J. An approach for deriving continuous health assessment indicators from in-home sensor data. Technology and Aging (IOS Press). In Press, 2007.

Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J, Factor SA, Yu CE, Montimurro JS, Keefe RG, Schellenberg GD, Payami H. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.  Ann Neurol. 2007 Jan;61(1):47-54.

Kaye J. Home-based technologies: a new paradigm for conducting dementia prevention trials. Alzheimer's & Dementia. In Press, 2007.

Kaye J, Hayes T, Zitzelberger T, Yeargers J, Pavel M, Jimison H, Larimer N, Payne-Murphy J, Wild K, Boise L, Williams D, Lundell J, and Dishman E. Deploying wide scale in-home assessment technology. Technology and Aging (IOS Press). In Press, 2007.

Kaye JA, Moore MM, Galasko D, Craig UK, Adonay R, and Silbert LC. Brain volumes in Guam dementia vs. Parkinson dementia complex vs. aging Charmorro adults. Neurology. 69(2): p. 196-199, 2007.

Kaye J, Zitzelberger T.  Living laborabory tests new models of home assessment.  Aging Today, 28 (5): p. 7-10, 2007.

Leen T, Zhengdong L, Hayes T, and Kaye J. Detection of early cognitive loss from medication adherence behavior. Technology and Aging (IOS Press). In Press.

Li G, Sokal I, Quinn J, Leverenz J, Brodey M, Schellenberg G, Kaye J, Raskind M, Zhang J, Peskind E, and Montine T. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment:  A follow-up study. Neurology. 69(7): p. 631-639, 2007.

Lundell J, Hayes TL, Vurgun S, Ozertem U, Kimel J, Kaye J, Guilak F, Pavel M. Continuous activity monitoring and intelligent contextual prompting to improve medication adherence.  Conf Proc IEEE Eng Med Biol Soc. 2007;1:6286-9, 2007.

Montine TJ, Quinn J, Kaye J, Morrow JD.F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease. J Mol Neurosci. 33(1):p. 114-9, 2007.

Nakashima-Yasuda H, Uryu K, Robinson J, Xie S, Hurtig H, Duda J, Arnold S, Siderowf A, Grossman M, Leverenz J, Lopez O, Hamilton R, Tsuang D, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Montine T, Lee V, and Trojanowski J. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathologica. 114: p. 221-229, 2007.

Pan S, Zhu D, Quinn JF, Peskind ER, Montine TJ, Lin B, Goodlett DR, Taylor G, Eng J, Zhang J. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics. 2007 Feb;7(3):469-73. Review.
Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, and Stackman RW, Jr. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging. 28(2): p. 213-25, 2007.

Raber J. Role of apolipoprotein E in anxiety. Neural Plast. p. 91236, 2007.

Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, and Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med. 13(11): p. 1359-62, 2007.

Roark B, Hosom J, Mitchell M, and Kaye J. Automatically derived spoken language markers for detecting mild cognitive impairment. Technology and Aging (IOS Press). In Press, 2007.

Roark B, Mitchell M, and Hollingshead K. Syntactic complexity measures for detecting Mild Cognitive Impairment, in BioNLP: Biological, Translational and Clinical  Language Processing. The Association for Computational Linguistics: Prague. p. 1-8, 2007.

Sheng P, Zhu D, Quinn JF, Peskind E, Montine TJ, Lin B, Goodlett DR, Taylor G, Eng J, and Zhang J. A combined dataset of human cerebrospinal fluid proteins identified by multidimensional chromatography and tandem mass spectroscopy. Proteomics. 7(3): p. 469-473, 2007.

Shie F and Woltjer R. Manipulation of microglial activation as a therapeutic strategy in Alzheimer's disease. Current Medicinal Chemistry. In Press, 2007.

Sumic A, Michael YL, Carlson NE, Howieson DB, Kaye JA.  Physical Activity and the Risk of Dementia in Oldest Old Journal Of Aging Health.  2007; Apr;19(2): 242-259.

Taylor JP, Hulihan MM, Kachergus JM, Melrose HL, Lincoln SJ, Hinkle KM, Stone JT, Ross OA, Hauser R, Aasly J, Gasser T, Payami H, Wszolek ZK, Farrer MJ. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.  Neurogenetics. 2007Apr;8(2):95102. Epub 2007 Jan 16. PMID: 17225181 [PubMed - in process].

Wahbeh H, Kishiyama S, Zajdel D, and Oken B. Salivary cortisol awakening response in mild Alzheimer's disease, caregivers and non-caregivers. Alzheimer's Disease and Related Disorders. In Press, 2007.

Yang W, Woltjer RL, Sokal I, Pan C, Wang Y, Brodey M, Peskind ER, Leverenz JB, Zhang J, Perl DP, Galasko DR, and Montine TJ. Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy. Am J Pathol. 171(3): p. 993-1002, 2007.

Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, and Payami H. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann Neurol. 62(2): p. 137-44, 2007.

Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R,Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, Montine TJ, Zhang J. Detection of biomarkers with a multiplex quantitative proteomic platform incerebrospinal fluid of patients with neurodegenerative disorders. Journal of Alzheimer's Disease. 2006 Aug;9(3):293-348.

Ball M. The essential lesion of Alzheimer's disease:  A surprise in retrospect. Journal of Alzheimer's Disease. 9(3  suppl): p. 29-33, 2006.

Brickell KL, Steinbart EJ, Rumbaugh M, Payami H, Schellenberg GD, Van Deerlin V, Yuan W, Bird TD.    Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease. Archives of Neurology  2006 Sep;63(9):1307-11. PMID: 16966510

Calvert JF Jr, Hollander-Rodriguez J, Kaye J, Leahy M. Dementia-free survival among centenarians: an evidence-based review. J Gerontol A Biol Sci Med Sci. 2006 Sep;61(9):951-6.

Cotrell V, Wild K, and Bader T. Medication management and adherence among cognitively impaired older adults. J Gerontol Soc Work. 47(3-4): p. 31-46, 2006.

Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Kruger R, Marder KS, Mayeux RP, Mellick GD, Nutt JG, Ritz B, Samii A, Tanner CM, Van Broeckhoven C, Van Den Eeden SK, Wirdefeldt K, Zabetian CP, Dehem M, Montimurro JS, Southwick A, Myers RM, and Trikalinos TA. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol. 5(11): p. 917-23, 2006.

Erten-Lyons D, Howieson D, Moore MM, Quinn J, Sexton G, Silbert L, Kaye J. Brain volume loss in MCI predicts dementia. Neurology. 2006 Jan 24;66(2):233-5.

Galasko D, Bennett DA, Sano M, Marson D, Kaye J, and Edland SD. ADCS prevention instrument project: Assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Disease and Associated Disorders. 20 Suppl 3(3): p. S152-S169, 2006.

Hare JF. Intracellular pathways of folded and misfolded amyloid precursor protein degradation. Arch Biochem Biophys. 451(1): p. 79-90, 2006.

Hayes TL, Hunt JM, Adami A, Kaye JA. An electronic pillbox for continuous monitoring of medication adherence. Conf Proc IEEE Eng Med Biol Soc.1: p. 6400-3, 2006.

Kammerman E, Neumann D, Ball M, Lukiw W, and Hill J. Senile plaques in Alzheimer's diseased brains: Possible association of beta-amyloid with herpes simplex virus type 1 (HSV-1) L-particles. Medical  Hypotheses. 66: p. 294-9, 2006.

Kay DM, Bird TD, Zabetian CP, Factor SA, Samii A, Higgins DS, Nutt J, Roberts JW, Griffith A, Leis BC, Montimurro JS, Philpott S, and Payami H. Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease. Genet Test. 10(3): p. 221-7, 2006.
Kay DM, Moran D, Moses L, Poorkaj P, Zabetian CP, Nutt J, Factor SA, Yu CE, Montimurro JS, Keefe RG, Schellenberg GD, and Payami H. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Ann Neurol. 22: p. 22, 2006.

Kay DM, Zabetian CP, Factor SA, Nutt JG, Samii A, Griffith A, Bird TD, Kramer P, Higgins DS, Payami H. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Mov Disord. 2006 Apr;21(4):519-23
Kaye JA and Hayes T. Home health monitoring:  A system to assess motor and cognitive function. Generations. 30(2): p. 61-63, 2006.

Li D, Parks SB, Kushner JD, Nauman D, Burgess D, Ludwigsen S, Partain J, Nixon RR, Allen CN, Irwin RP, Jakobs PM, Litt M, and Hershberger RE. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet. 79(6): p. 1030-9, 2006.

Lovera J, Bagert B, Smoot KH, Wild K, Frank R, Bogardus K, Oken BS, Whitham RH, Bourdette DN. Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory with Beck Depression Inventory and neuropsychological tests. J Rehabil Res Dev. 2006 Jan-Feb;43(1):73-82.

Maia AL, Godinho C, Ferreira ED, Almeida V, Schuh A, Kaye J, Chaves ML. Application of the Brazilian version of the CDR scale in samples of dementia patients Arq Neuropsiquiatr. 2006 Jun;64 2B:485-9. Portuguese.

Manczak, Maria Thimmappa S. Anekonda, Edward Henson, Byung S. Park, Joseph Quinn, and P. Hemachandra Reddy Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Human Molecular Genetics, 1 May 2006; 15: 1437 - 1449.

Michael Y, Beard T, Choi D, Farquhar S, and Carlson N. Measuring the influence of built neighborhood environments on walking in older adults. J Aging Phys Act. 14(3): p. 302-12, 2006.

Morgan NV, Westaway SK, Morton JE, Gregory A, Gissen P, Sonek S, Cangul H, Coryell J, Canham N, Nardocci N, Zorzi G, Pasha S, Rodriguez D, Desguerre I, Mubaidin A, Bertini E, Trembath RC, Simonati A, Schanen C, Johnson CA, Levinson B, Woods CG, Wilmot B, Kramer P, Gitschier J, Maher ER, Hayflick SJ. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet. 2006 Jul;38(7):752-4. PMID: 16783378

Oken BS, Flegal K, Zajdel D, Kishiyama SS, Lovera J, Bagert B, Bourdette DN. Cognition and fatigue in multiple sclerosis: Potential effects of medications with central nervous system activity. J Rehabil Res Dev. 2006 Jan-Feb;43(1):83-90.

Oken BS, Salinsky MC, Elsas SM. Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol. 2006 Sep;117(9):1885-1901.

Oken BS, Zajdel D, Kishiyama S, Flegal K, Dehen C, Haas M, Kraemer DF, Lawrence J, Leyva J. Randomized, controlled, six-month trial of yoga in healthy seniors: effects on cognition and quality of life. Altern Ther Health Med. 2006 Jan-Feb;12(1):40-7.

Pan S, Wang Y, Quinn JF, Peskind ER, Waichunas D, Wimberger JT, Jin J, Li JG, Zhu D, Pan C, Zhang J. Identification of Glycoproteins in Human Cerebrospinal Fluid with a Complementary Proteomic Approach. J Proteome Res. 2006 Oct 6;5(10):2769-2779.

Pavel M, Hayes TL, Adami A, Jimison H, Kaye J.  Unobtrusive assessment of mobility. Conf Proc IEEE Eng Med Biol Soc.1: p. 6277-80, 2006.

Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, Clark CM, Farlow MR, DeCarli C, Raskind MA, Schellenberg GD, Lee VM, Galasko DR. Age and apolipoprotein E4;allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol. 2006 Jul;63(7):936-9.

Plassman B, Khachaturian A, Townsend J, Ball M, Steffens D, Leslie C, Tschanz J, Norton M, Burke J, Welsh-Bohmer K, Hulette C, R N, Tyrey M, and Breitner J. Comparison of clinical and neuropathological  diagnoses of AD in three epidemiological samples. Alzheimer's & Dementia. 2(1): p. 2-11, 2006.

Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, Stackman RW Jr. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging. 2006 Jan 28;

Quinn J and Kaye J. Healthy Brain Aging, in Handbook of Dementing Illnesses (second addition), J Morris, J Galvin, and D Holtzman, Editors.  Marecel-Dekker: New York, 2006.

Reddy P. Amyloid precursor protein-mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease. Journal of Neurochemistry. 96: p. 1-13, 2006.

Reddy PH. Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics. J Biomed Biotechnol. 2006(3): p. 31372, 2006.

Rizk-Jackson AM, Acevedo SF, Inman D, Howieson D, Benice TS, Raber J. Effects of sex on object recognition and spatial navigation in humans. Behav Brain Res. 2006 Oct 16;173(2):181-90. Epub 2006 Aug 2.

Siemers ER, Quinn JF, Kaye J, Farlow MR, Porsteinsson A, Tariot P, Zoulnouni P, Galvin JE, Holtzman DM, Knopman DS, Satterwhite J, Gonzales C, Dean RA, May PC. Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology. 2006 Feb 28;66(4):602-4.

Silbert LC, Nelson C, Holman S, Eaton R, Oken BS, Lou JS, Kaye JA. Cortical excitability and age-related volumetric MRI changes. Clin Neurophysiol. 2006 May;117(5):1029-36. Epub 2006 Mar 27.

Tandon R, Adak S, Kaye JA. Neural networks for longitudinal studies in Alzheimer's disease. Artif Intell Med. 2006 Mar;36(3):245-55. Epub 2006 Jan 19.

Tractenberg RE, Singer CM, Kaye JA. Characterizing sleep problems in persons with Alzheimer's disease and normal elderly. J Sleep Res. 2006 Mar;15(1):97-103.

Wilmot B, McWeeney SK, Nixon RR, Montine TJ, Laut J, Harrington CA, Kaye JA, and Kramer PL. Translational gene mapping of cognitive decline. Neurobiology of  Aging. 13(Dec 13): p. 1558-1497, 2006.

Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. American Journal of Human Genetics 2006 Oct;79(4):752-8. PMID: 16960813

Zabetian CP, Lauricella CJ, Tsuang DW, Leverenz JB, Schellenberg GD, and Payami H. Analysis of the LRRK2 G2019S mutation in Alzheimer's Disease. Arch Neurol. 63(1): p. 156-7, 2006.

Anderson VC, Litvack ZN, Kaye JA. Magnetic resonance approaches to brain aging and Alzheimer disease-associated neuropathology. Topics in Magnetic Resonance Imaging 16:439-452, 2005.  

Boise L. Improving dementia care through physician education:  Some challenges. Clinical Gerontologist 29:3-10, 2005.  

Boise L. Diagnosing dementia: What to tell the patient and family. Geriatrics and Aging 8:48-51, 2005.  

Cui JG, Zhao Y, Lukiw WJ. Isolation of high spectral quality RNA using run-on gene transcription; application to gene expression profiling of human brain. Cell Mol Neurobiol 25:789-794, 2005. 

Dowling GA, Mastick J, Colling E, Carter JH, Singer CM, Aminoff MJ. Melatonin for sleep disturbances in Parkinson's disease. Sleep Med 6:459-466, 2005.  

Erten-Lyons D, Ferguson F, Howieson D, Moore M, Silbert L, Quinn J, Kaye J. Elderly with more medical illneses have smaller brains and are more resistant to cognitive decline. Neurology 64 (suppl 1):A230, 2005. 

Fleisher A, Grundman M, Jack CR, Jr., Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Archives of Neurology 62:953-957, 2005.  

Hall DA, Leehey MA, Filley CM, Steinbart E, Montine T, Schellenberg GD, Bosque P, Nixon R, Bird T. PRNP H187R mutation associated with neuropsychiatric disorders in childhood and dementia. Neurology 64:1304-1306, 2005.  

Hill J, Gebhardt B, Azcuy A, Matthews K, Lukiw W, Steiner I, Thompson H, Ball M. Can a herpes simplex virus type 1 neuroinvasive score be correlated to other risk factors in Alzheimer's disease? Medical  Hypotheses 64:320-327, 2005.  

Hill J, Steiner I, Matthews K, Trahan S, Foster T, Ball M. Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1. Medical  Hypotheses 64:53-58, 2005.  

Kay DM, Kramer P, Higgins D, Zabetian CP, Payami H. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Movement Disorders : Official Journal of the Movement Disorder Society 20:1077-1078, 2005.  

Kaye J, Carlson N, Moore M, Dame A, Howieson D. The clinical transition to dementia is characterized by a two-phase process of accelerating brain loss. Neurology 64 (suppl 1):A390, 2005.  

Kaye J, Moore M, Galasko D, Miller F, Craig U, Silbert L, Adonay R. Healthy Chamorro adults and those with Marianas dementia (MD) are distinguished by patterns of cortical atrophy which differ from European and African American elderly. Neurology (suppl) 64:A391, 2005.  

Kaye JA, Moore MM, Dame A, Quinn J, Camicioli R, Howieson D, Corbridge E, Care B, Nesbit G, Sexton G. Asynchronous regional brain volume losses in presymptomatic to moderate AD. Journal of Alzheimer's Disease 8:51-56, 2005.  

Kishiyama SS, Leahy MJ, Zitzelberger TA, Guariglia R, Zajdel DP, Calvert JF, Jr., Kaye JA, Oken BS. Patterns of dietary supplement usage in demographically diverse older people. Altern Ther Health Med 11:48-53, 2005.  PMC1255934.

Leahy MJ, Thurber D, Calvert JF, Jr. Benefits and challenges of research with the oldest old for participants and nurses. Geriatric nursing (New York, N.Y.) 26:21-28, 2005.  

Montine T, Quinn J, Montine K, Kaye J, Breitner J. Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease. Journal of Alzheimer's Disease 8:359-367, 2005.  

Montine TJ, Montine KS, McMahan W, Markesbery WR, Quinn JF, Morrow JD. F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid Redox Signal 7:269-275, 2005.  

Morris J, Quaid K, Holtzman D, Kantarcic K, Kaye J, Reiman E, Klunk W, Siemers E. Role of biomarkers in studies of presymptomatic Alzheimer's disease. Alzheimer's & Dementia 1:145-151, 2005.  

Nixon RR. Prion-associated increases in Src-family kinases. The Journal of Biological Chemistry 280:2455-2462, 2005.  

Payami H, Zhu M, Montimurro J, Keefe R, McCulloch CC, Moses L. One step closer to fixing association studies: evidence for age- and gender-specific allele frequency variations and deviations from Hardy-Weinberg expectations in controls. Hum Genet 118:322-330, 2005.  

Peskind ER, Riekse R, Quinn JF, Kaye J, Clark CM, Farlow MR, Decarli C, Chabal C, Vavrek D, Raskind MA, Galasko D. Safety and acceptability of the research lumbar puncture. Alzheimer Disease and Associated Disorders 19:220-225, 2005.  

Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352:2379-2388, 2005.  

Quinn J, Kulhanek D, Nowlin J, Jones R, Pratico D, Rokach J, Stackman R. Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials. Brain Res 1037:209-213, 2005.  

Reddy PH, Beal MF. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain research. Brain Research Reviews 49:618-632, 2005.  

Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell W, Jr., Kaye J, Manczak M. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. Journal of Alzheimer's Disease 7:103-117; discussion 173-180, 2005.  

Robertson J, Curley J, Kaye J, Quinn J, Pfankuch T, Raber J. ApoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiology of Aging 26:637-643, 2005.  

Tractenberg RE, Singer CM, Kaye JA. Symptoms of sleep disturbance in persons with Alzheimer's disease and normal elderly. Journal of Sleep Research 14:177-185, 2005.  

Vuletic S, Peskind ER, Marcovina SM, Quinn JF, Cheung MC, Kennedy H, Kaye JA, Jin LW, Albers JJ. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. J Neurosci Res 80:406-413, 2005.  

Woltjer RL, Cimino PJ, Boutte AM, Schantz AM, Montine KS, Larson EB, Bird T, Quinn JF, Zhang J, Montine TJ. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease. The FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 19:1923-1925, 2005.  

Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, Wang Q, Pan C, Yi E, Eng J, Aebersold RH, Montine TJ. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiology of Aging 26:207-227, 2005.  

Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, Zhou Y, Pan C, Yi E, Eng J, Wang Q, Aebersold RH, Montine TJ. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. Journal of Alzheimer's Disease 7:125-133; discussion 173-180, 2005.

Adair JC, Charlie J, Dencoff JE, Kaye JA, Quinn JF, Camicioli RM, Stetler-Stevenson WG, Rosenberg GA. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke 35:e159-162, 2004.

Adak S, Illouz K, Gorman W, Tandon R, Zimmerman EA, Guariglia R, Moore MM, Kaye JA. Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology 63:108-114, 2004.

Boise L, Neal M, Kaye J. Dementia assessment in primary care: Results from a study in three managed care systems. Journal of Gerontology:  Medical Sciences 59:M621-622, 2004.

Boise L, White D. The Family’s role in person-centered care:  Practice considerations. Journal of Psychosocial Nursing 42:12-20, 2004.

Bongers G, Leurs R, Robertson J, Raber J. Role of H(3)-receptor-mediated signaling in anxiety and cognition in wild-type and Apoe(-/-) mice. Neuropsychopharmacology 29:441-449, 2004.

Connell C, Boise L, Stuckey J, Holmes S, Hudson M. Attitudes toward the diagnosis and disclosure of dementia among primary care physicians and family caregivers. The Gerontologist 44:500-507, 2004.

Goddard K, Olson J, Payami H, van der Voet M, Kuivaniemi H, Tromp G. Evidence of linkage and association on chromosome 20 for late onset Alzheimer disease. Neurogenetics 5:121-128, 2004.

Grundman M, Petersen R, Ferris S, Thomas R, Aisen P, Bennett D, Foster N, Jack C, Galasko D, Doody R, Kaye J, Sano M, Mohs R, Gautheir S, Kim H, Jin S, Schultz A, Schafer K, Mulnard R, van Dyck C, Mintzer J, Zamrini E, Cahn-Weiner D, Thal L, Study AsDC. Mild cognitive impairment can be distinguished from Alzheimer’s disease and normal aging for clinical trials. Archives of Neurology 61:59-66, 2004.

Gutala R, Reddy H. The use of real-time analysis in a gene expression study of Alzheimer's disease post-mortem brains. Journal of Neuroscience Methods 132:101-107, 2004.
Hayes T, Pavel M, Kaye J. An unobtrusive in-home monitoring system for detection of key motor changes preceding cognitive decline. In: 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society; San Francisco, California, 2004: 2480-2483.

Howieson D, Moore M, King N, Quinn J, Camicioli R, Silbert L, Dame A, Sexton G, Kaye J. Temporal lobe correlates of episodic and semantic word retrieval in Alzheimer’s disease. Neurology 62 (suppl 5):A236, 2004.

Itzhaki R, Wozniak M, Appelt D, Balin B. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiology of Aging 25:619-627, 2004.

Kaye J, Moore M, Galasko D, Craig U, Adonay R, Silbert L. Family history of Mariana's dementia (MD) or parkinsonism-dementia complex (PDC) is associated with differences in brain volume among chamoro adults. Neurology 62 (suppl 5):A344, 2004.

Kaye J, Samit P, Sudeshna A, Gorman W, Zimmerman E, Moore M, Silbert L. High signal intensity volume predicts the time to dementia among normal aging and early cognitive impairment. Neurology 62 (suppl 5):A254, 2004.

Lezak M, Howieson D, Loring D. Neuropsychological assessment; 2004.

Manczak M, Park BS, Jung Y, Reddy PH. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Medicine 5:147-162, 2004.

Meuser T, Boise L, Morris J. Clinician beliefs and practices in dementia care: Implications for health educators. Educational Gerontology 30:491-516, 2004.

Montine K, Quinn J, Zhang J, Fessel J, Roberts L, Morrow J, Montine T. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chemistry and Physics of Lipids 128:117-124, 2004.

Quinn J, Kaye J, Montine T, Stackman R. Phytochemicals in Alzheimer Disease: The Development of Clinical Trials. Archives Of Physiology And Biochemistry 42:64-73, 2004.
Quinn JF, Montine KS, Moore M, Morrow JD, Kaye JA, Montine TJ. Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. Journal of Alzheimer's Disease 6:93-97, 2004.

Reddy P, McWeeney S, Park B, Manczak M, Gutala R, Jung J, Yau V, Searles R, Mori M, Quinn J. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes Is an early cellular change in Alzheimer’s disease. Human Molecular Genetics 13:1225-1240, 2004.

Wijsman E, Daw E, Yu C, Payami H, Steinbart E, Nochlin D, Conlon E, Bird T, Schellenberg G. Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. American Journal of Human Genetics 75:398-409, 2004.

Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA: The Journal of the American Medical Association 289:2819-2826, 2003. 

Camicioli R, Moore M, Kinney A, Corbridge E, Glassberg K, Kaye J. Parkinson's disease is associated with hippocampal atrophy. Movement Disorders 18:784-790, 2003. 

Clark C, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris J, McKeel Jr D, Farlow M, Weitlauf S, Quinn J, Kaye J, Knopman D, Arai H, Doody R, DeCarli C, Leight S, Lee Y, Trojanoski J. Cerebrospinal fluid tau and beta-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Archives of Neurology 60:1696-1702, 2003. 

Grundman M, Jack Jr. C, Petersen R, Kim H, Tayloer C, Datvian M, Weiner M, DeCarli C, DeKosky S, van Dyck C, Darvesh S, Yaffe K, Kaye J, Thomas R, Thal L. Hippocampal volume is associated with memory but not non-memory cognitive performance in patients with mild cognitive impairment. Journal of Molecular Neuroscience 20:241-248, 2003. 

Hansen L, Kaye J, Dorn R, Benson H, Davies V, Clark D, Ball M. Families' experiences permitting brain autopsy for the Oregon Brain Bank in the context of the neuropathology report. Brain Aging 3:28-35, 2003. 

Howieson D, Camicioli R, Quinn J, Silbert L, Care B, Moore M, Dame A, Sexton G, Kaye J. Natural history of cognitive decline in the old old. Neurology 60:1489-1494, 2003. 

Kaye J, Moore M, Dame A, Howieson D, Quinn J, Silbert L, Zitzelberger T, Friedman D. Distinguishing features of the oldest old with elite memory function. Neurology (Suppl) 60:A79, 2003. 

Payami H, Nutt J, Gancher S, Bird T, Gonzales McNeal M, Seltzer W K, Hussey J, Lockhart P, Gwinn-Hardy K, Singleton A, Singleton A, Hardy J, Farrer M. SCA2 may present as levodopa responsive Parkinsonism. Movement Disorders 18:425-429, 2003. 

Quinn J. Vascular Dementia. Journal of the American Medical Director Association 4:S155-161, 2003. 

Quinn J, Montine T, Morrow J, Woodward WR, Kulhanek D, Eckenstein F. Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease. J Neuroimmunol 137:32-41, 2003. 

Quinn J, Suh J, Moore M, Kaye J, Frei B. Antioxidants in Alzheimer's disease; Vitamin C delivery to a demanding brain. Journal of Alzheimer's Disease 5:309-313, 2003. 

Silbert L, Quinn J, Moore M, Corbridge E, Ball M, Murdock G, Sexton G, Kaye J. Changes in premorbid brain volume predict AD pathology. Neurology 61:487-492, 2003. 

Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, Sexton G, Kaye JA. Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology 61:487-492, 2003. 

Singer C, Tractenberg R, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal L. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer' disease. Sleep 26:893-901, 2003. 

Soderling S, Langeberg L, Soderling J, Davee S, Simerly R, Raber J, Schott J. Loss of WAVE-1 causes sensorimotor retardation and reduced learning and memory in mice. Proceedings of the National Academy of Sciences of USA 100:1723-1728, 2003. 

Spencer D, Spielman D, Zitzelberger T, Kaye J. Magnetic resonance spectroscopy in the "oldest old" may predict progression to dementia. Neurology 58:A402, 2003. 

Spencer D, Zitzelberger T, Spielman D, Kaye J. MRS in relation to hippocampal volume in the oldest old. Neurology 60:1194-1196, 2003. 

Stackman R, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn J. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic ginkgo biloba treatment. Experimental Neurology 184:510-520, 2003. 

Tractenberg R, Singer C, Cummings J, Thal L. The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease. Journal of Sleep Research 12:331-337, 2003. 

Wild K, Cotrell V. Identifying driving impairment in Alzheimer disease:  A comparison of self and observer reports versus driving evaluation. Alzheimer Disease and Associated Disorders 17:27-34, 2003. 

Wilmot B, Sheridan B, Fife D, O'Malley J, Murdoch G, Nagalla S, Kaye J, Kramer P. Effect of apolipoprotein e genotype on differential gene expression in control and Alzheimer's disease brain. Neurology 60 (suppl 1):A455, 2003. 

Yesavage J, Friedman L, Ancoli-Israel S, Bliwise D, Singer C, Vitiello M, Monjan A, Lebowitz B. Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. Journal of Gertiatric, Psychiatry and Neurology 16:131-139, 2003. 

Colangelo V, Schurr J, Ball M, Pelaez R, Bazan N, Lukiw W. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-Inflammatory signaling. Journal of Neuroscience Research 70:462-473, 2002. 

Erten-Lyons D, Camicioli R, Kaye J, Silbert L, Frank E, Quinn J. Lumbo-peritoneal shunt as a diagnostic aid in the management of normal pressure hydrocephalus: The Oregon Aging and Alzheimer Center experience. Canadian Journal of Neurological Sciences 29:S40, 2002. 

Friedman D, Moore M, Quinn J, Howieson D, Kaye J. Use it or lose it: A prospective evaluation of intellectual activity and the development of dementia. Neurology 58:A103, 2002. 

Haan M, Jagust W, Galasko D, Kaye J. Effect of extrapyramidal signs and lewy bodies on survival in patients with Alzheimer disease. Archives of Neurology 59:588-593, 2002. 

Hooker K, Bowman S, Coehlo D, Lim S, Kaye J, Guariglia R, Li F. Behavioral change in persons with dementia:  Relationships with mental and physical health of caregivers. Journal of Gerontology:  Psychological Sciences 57:453-460, 2002. 

Howieson D, Lezak M. Separating memory from other cognitive problems. In: (Eds.) ABaBW, ed. Handbook of Memory Disorders: John Wiley & Sons, 2002.

Howieson D, Lezak M. The neuropsychological evaluation. In: (Eds.) HaY, ed. The American Psychiatric Press Textbook of Neuropsychiatry: American Psychiatric Association, 2002.

Hussey J, Lockhart P, Seltzer W, Zbigniew K, Wszolek Z, Payami H, Hanson M, Gwinn-Hardy K, Farrer M. Accurate determination of ataxin-2 polyglutamine expansion in patients with intermediate-range repeats. Genetic Testing 6:217-220, 2002. 

Kaye J. Healthy Brain Aging. Archives of Neurology 59:1721-1723, 2002. 

Kaye J, Dame A, Moore M, Quinn J, Howieson D, Camicioli R, Sexton G. Hippocampal volume predicts dementia-free survival up to 12 years before symptom onset. Neurology 58:A400, 2002. 

Kaye J, Syms M, Thurber D, Calvert J, White S, Russell L. Exceptional survival is rarely associated with intact cognition in a rural population-based cohort. Neurobiology of Aging 23:S448, 2002. 

Kaye JA. Healthy brain aging. Archives of Neurology 59:1721-1723, 2002. 

Marquis S, Moore MM, Howieson DB, Sexton G, Payami H, Kaye JA, Camicioli R. Independent predictors of cognitive decline in healthy elderly persons. Archives of Neurology 59:601-606, 2002. 

Messecar D, Archbold P, Stewart B, Kirschling J. Home environmental modification strategies used by caregivers of elders. Research in Nursing and Health 25:357-370, 2002. 

Montine K, Montine T, Morrow J, Frei B, Milatovic D, Eckenstein F, Quinn J. Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment. Brain Research 930:75-82, 2002. 

Montine T, Neely M, Quinn J, Beal M, Markesbery W, Roberts L, Morrow J. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radical Biology and Medicine 33:620-626, 2002. 

Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ, 2nd, Kaye JA, Morrow JD. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Annals of Neurology 52:175-179, 2002. 

Payami H, Zareparsi S, James D, Nutt J. Familial aggregation of Parkinson's disease: A comparative study of early-onset and late-onset disease. Archives of Neurology 59:848-850, 2002. 

Quinn J, Kulhanek D, Nowlin J, Murdoch G. Brain tissue expression of antioxidant enzymes in an animal model of Alzheimer's disease: Cellular specificity and changes with age. In: Society for Neuroscience Abstracts, 2002.

Quinn J, Montine T, Dang T, Rask T, Corbridge E, Moore M, Desrochers K, Coakley B, Kaye J. Rate of ventricular enlargement is the best biomarker predicting clinical progression of Alzheimer's disease over one year. Neurology 58:A142, 2002. 

Quinn J, Moore M, Benson DF, Clark CM, Doody R, Jagust W, Knopman D, Kaye JA. A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trial. Neurology 58:433-437, 2002. 

Riviere G, Riviere K, Smith K. Molecular and immunologic evidence of oral treponema in human brain and their association with Alzheimer's disease. Oral Microbiology and Immunology 17:113-118, 2002. 

Salat DH, Kaye JA, Janowsky JS. Greater orbital prefrontal volume selectively predicts worse working memory performance in older adults. Cereb Cortex 12:494-505, 2002. 

Singer C, Tractenberg R, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal L. ADCS clinical trial of melatonin for the sleep disturbance of Alzheimer's:  Case report of an unusual sleep/wake cycle and response to melatonin. American Journal of  Geriatric Psychiatry 10:92, 2002. 

Zareparsi S, Camicioli R, Sexton G, Bird T, Swanson P, Kaye J, Nutt J, Payami H. Age at onset of Parkinson disease and apolipoprotein E genotypes. American Journal of Medical Genetics 107:156-161, 2002. 

Zareparsi S, James D, Kaye J, Bird T, Schellenberg G, Payami H. HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer's disease. Neurology 58:973-975, 2002.